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ABSTRACT 
 
Synthetic Studies toward Palau’amine and Enantioselective Total Synthesis of 
Biogenetically Related (+)-Phakellin and (+)-Monobromophakellin. (May 2008) 
Shaohui Wang, B.S., Peking University, China 
Chair of Advisory Committee: Dr. Daniel Romo 
 
 Oroidin alkaloids, also known as pyrrole-imidazole alkaloids, have become a hot 
area of chemical and biological research due to their diverse and intriguing structural 
features and biological activities. Palau'amine (i), one of the hexacyclic oroidin-derived 
secondary metabolites, contains a fully substituted chloro-cyclopentane ring, a 
piperazinone moiety and two cyclic guanidines. With the uniqueness and complexity of 
its structure, palau’amine has been a synthetic challenge and has not yet succumbed to 
total synthesis. The overall objective of this work was to explore synthetic pathways 
toward palau’amine and biogenetically related congeners. 
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Most of the work was focused on developing a synthetic pathway for the 
palau’amine structure proposed in its isolation report dated back to 1993. Starting from a 
Diels-Alder adduct (iii), oxidation/chlorination followed by phakellin (ii) annulation 
afforded an advanced pentacyclic intermediate possessing all the carbon framework and 
all but one ring system of palau’amine. Recently, however, a series of reports questioned 
the originally proposed palau’amine structure and called for a revision of the 
stereochemistry of two carbon centers (iv). Now palau’amine has an identical 
chlorocyclopentane core with axinellamine (vi). With the target changed, we devised a 
new biomimetic pathway toward both natural products via a common intermediate (v), 
which was synthesized in 12 steps from the Diels-Alder adduct (iii). 
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CHAPTER I 
AN INTRODUCTION TO PALAU’AMINE AND RELATED 
OROIDIN-DERIVED MARINE ALKALOIDS: HISTORY AND 
RECENT DEVELOPMENTS 
 
A. Introduction 
Since the beginning of recorded history, Mother Nature not only provides human 
being’s material desire, but also serves as a source of remedies and cures for human 
illness. Natural herbs and plants have been used by Asian people since ancient times to 
treat many kinds of diseases and to maintain health. It is known that more than 80% of 
drugs used in traditional Chinese medicine (TCM) come from plants found in China 
mainland.1  Western medicines also take advantage of natural products extracted from 
plants as the major components of many pharmaceuticals. As a matter of fact, about 75% 
of anti-HIV drugs, 62% of anti-cancer drugs and roughly 52% of all drugs currently used 
are either derived directly from natural products or derived from natural product leads.2  
While terrestrial plants provide numerous natural products with medicinal properties, 
marine organisms living in oceans, are another incredibly rich source of bioactive natural 
products. 
Marine organisms, such as sponges, tunicates, algae, coelenterates, mollusks and 
microorganisms etc.,3 produce a broad range of structurally diverse and extremely 
 
____________________ 
This dissertation follows the style of Journal of the American Chemical Society. 
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bioactive compounds that demonstrate potent anti-tumor, anti-inflammatory, anti-viral, 
analgesic and immunosuppressive activities.4  Large numbers of new marine natural 
products are discovered each year. With their intriguing structures and often potent 
biological activities, many of these compounds have attracted chemists and biologists to 
pursue their total synthesis and evaluate the potential pharmaceutical applications of 
these natural products and their structural derivatives.5  There are many reasons to 
pursue a total synthesis, such as making large quantity of a certain natural product due to 
its limited accessibility from nature, making structurally diverse derivatives to study 
their biological activities, and discovering new organic reactions and synthetic 
methodology to advance the science of organic synthesis.  
 Among all those marine natural products there is one family of polycyclic 
alkaloids isolated from different species of marine sponge, i.e. Agelas, Hymeniacidon, 
Axinella, Acanthella, Cymbastella, Phakellia, known as pyrrole-imidazole alkaloids.6  
This family of fascinating alkaloids has a total of about 100 known members,7 and they 
are biogenetically related via a common key biosynthetic precursors, oroidin (1.1), 
composed of 3-amino-1-(2-aminoimidazolyl)prop-1-ene (AAPE, 1.2) and pyrrole (or 
dibromopyrrole) carboxylic acid (1.3) (Figure 1).8
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Figure 1. Oroidin (1.1), the key to the pyrrole-imidazole alkaloids 
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B. Isolation and Biological Activity 
The pyrrole-imidazole alkaloids include an array of structurally diverse and 
complex secondary metabolites, which often have some interesting bioactivities. 
Palau’amines (1.4-1.6), axinellamines (1.7, 1.8) and massadine (1.15) represent the 
complexity of the oroidin family of marine alkaloids (Figure 2). New members of 
pyrrole-imidazole alkaloids with unprecedented structural features are constantly being 
discovered in the course of searching for novel chemical entities with potential 
beneficial biological activities from oceanic organisms (vide infra). 
 
N
NH
H2N
H
N
O
HN
Br
Br
N
N
O
H
N
N
H2N
R2R1
Cl
NHR
RHN
N
HN
NHHN
NH
H
HN
R1O
N
N
O
H
N
HN
O
R2R1
NHR
NHR
O
HN
N
H
NH
HN
NH
HNN
H
N
NH
N
NH2
NH2
RHN
RHN
1.1: Oroidin
Palau'amines
1.4: R1 = H, R2 = H
1.5: R1 = H, R2 = Br
1.6: R1 = Br, R2 = Br
Axinellamines
1.7: R1 = H
1.8: R1 = Me
R = 4, 5-dibromopyrrolo-2-carboxamide
1.15: Massadine1.14: Ageliferin
Phakellstatins
1.12: R1 = H, R2 = H
1.13: R1 = Br, R2 = Br
Phakellins
1.9: R1 = H, R2 = H
1.10: R1 = H, R2 = Br
1.11: R1 = Br, R2 = Br
OH
OH
N
NN
HNN
HN
O
H2N
H2N
Cl
NH2
R1 R
2
HO H
H
 
Figure 2. Representative members of oroidin-derived alkaloids 
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 1. Palau’amines and Styloguanidines 
 Palau’amine (1.4) was first isolated in 1993 by Kinnel and Scheuer from the 
Belau sponge Stylotella aurantium obtained from Western Caroline Islands.9 Also 
isolated along with palau’amine were its monobrominated (1.5) and dibrominated (1.6) 
analogs (Figure 3). Palau’amine exhibits potent cytotoxicity against tumor cell lines P-
388 (IC50: 0.1 μg/ml), A549 (0.2 μg/mL), HT-29 (2 μg/mL), and KB (10 μg/mL), 
antibiotic activities, antifungal activities, and shows particularly potent 
immunosuppressive activity (IC50<42.8nM) as determined by mixed lymphocyte 
reaction.10  
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Figure 3. Palau’amines and structurally related natural products 
 
The structure of palau’amine was elucidated by extensive NMR analysis and 
chemical derivatization, but its absolute stereochemistry has not been determined 
unambiguously. The assigned structure was based on the similarity of the circular 
dichroism spectra of palau’amine and monobromophakellin hydrochloride (1.10), whose 
absolute stereochemistry was determined by X-ray crystallographic analysis of 
4
monoacetyldibromophakellin.11 Palau’amine is stable in weakly acidic conditions, but 
decomposes rapidly when the pH is over 6.5. Its instability and complex hexacylic and 
highly nitrogeneous structure make palau’amine a daunting target for total synthesis.12 
Much of the structural complexity of palau’amine resides in the central cyclopentane 
ring (E ring, Figure 3), which has five contiguous stereocenters, and each of the carbons 
is substituted on the concave α face. In addition, the two spirocyclic guanidine 
substructures also present challenges to synthesis. Another interesting structural feature 
is that palau’amine contains a phakellin subunit, which links the two natural products 
together biosynthetically and also when one considers the total syntheses of these 
alkaloids.   
 The structural isomers of the palau’amines, the styloguanidines (1.16-1.18, 
Figure 3), were isolated from the same sponge species (Stylotella aurantium obtained 
from the Yap Sea) by Kato and co-workers in 1995.13 In their 1998 report,10 Kinnel and 
Scheuer also mentioned that all the three styloguanidine analogues were present in the 
sponge they analyzed previously. Styloguanidine shows strong chitinase inhibiting 
ability against Schwanella sp. (2.5 μg/disk, assayed by the squid chitin agar plate 
method). 
  
2. Axinellamines 
Axinellamines are another series of natural products derived from oroidin. What 
links axinellamines and palau’amines together is the cyclopentane core. Both oroidin-
dimeric derivatives have a cyclopentane moiety that is substituted with similar functional 
5
groups, but with different stereochemistry. In 1999, axinellamines were isolated by 
Quinn and coworkers from the sponge Axinella sp. collected off the coast of Australia.14  
The structures were elucidated by extensive 1D and 2D NMR analysis, but the absolute 
stereochemistry was not known (Figure 4). Only axinellamines B-D were reported to 
have weak antibacterial activity (1000 μg/mL) against Helicobacter pylori, a bacterium 
associated with pepticular and gastric cancer.  
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3. Phakellins and Phakellstatins 
The phakellins (1.9-1.11, Figure 2) also belong to the pyrrole-imidazole family 
of marine alkaloids and are proposed to be derived biosynthetically from oroidin (1.1) 
and congeners.7 The monomeric oroidin derivative (-)-dibromophakellin (1.11) and (-)-
monobromophakellin (1.10) were initially isolated by Sharma and Burkholder in 196915 
from the marine sponge Phakellia flabellata and subsequently, the enantiomeric (+)-
dibromophakellin (ent-1.11) was isolated by Ahond, Poupat and co-workers from 
Pseudoaxinyssa cantharella in 1985.16 Since the initial isolation report, (-)-
6
dibromophakellin (1.11) has also been isolated from other different sponge species.17,18 
Phakellin (1.9) has not been isolated from a natural source, but was obtained by 
hydrogenolysis of dibromophakellin (1.11).15 The structures of dibromophakellin and 
monobromophakellin were determined by analysis of NMR and other spectroscopic data, 
and were confirmed by X-ray crystallography data of monoacetyl (-)-dibromophakellin. 
Dibromophakellin shows mild antibacterial activity against Bacillus subtilis and 
Escherichia coli, as well as antitumor activities (Table 1).  
The phakellstatins (1.12, 1.13) are related members of this family bearing a 
cyclic urea rather than a cyclic guanidine (Figure 2). The isolation of (-)-
dibromophakellstatin (1.13) was reported in 1997 by Pettit and co-workers.18 The 
alkaloid was isolated from Phakellia mauritiana through a bioassay-guided isolation 
procedure using human tumor cell lines (Table 1), and displayed far more potent 
antitumor activities than dibromophakellin. The structure and absolute stereochemistry 
of (-)-dibromophakellstatin (1.13) was determined by spectroscopic data and X-ray 
crystallography analysis. The presence of bromine heavy atoms helped the determination 
of absolute stereochemistry by pronounced anomalous dispersion effects. 
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Table 1. Cell growth inhibitory activity of dibromophakellin and dibromophakellstatin 
ED50 (μg/mL) Human cancer cell lines
Dibromophakellin Dibromophakellstatin 
ovary (OVCAR-3) 15.7 0.46 
brain (SF-395) 18.8 1.5 
kidney (A498) 17.8 0.21 
lung (H460) 22.0 0.62 
colon (KM20L2) 20.1 0.11 
melanoma (SK-MEL-5) 17.0 0.11 
 
 
C. Biosynthetic Pathways 
Kinnel and Scheuer proposed that palau’amine orginates from a Diels-Alder 
reaction between dehydrophakellin (1.23) and a truncated oroidin (AAPE, 1.2).10  
Subsequently, a presumed chloroperoxidase-mediated chlorination initiates a 1,2-shift 
/ring contraction sequence to deliver the palau’amine structure (Scheme 1), a process 
with some precedent.19  In this initial proposal, the idea that dehydrophakellin (1.23) 
could serve as a dienophile in the Diels-Alder reaction was unsettling as its reactivity 
would be expected to be low in this regard.  However, the ring-opened form of 
dehydrophakellin featuring an allylic acyliminium species (1.24), which may indeed be 
formed in an enzyme active site, would be a highly reactive denophile due to the strong 
electron withdrawing acyliminium functionality. Thus, Romo and co-workers proposed a 
refinement to the Kinnel/Scheuer biosynthetic pathway that proceeds through the ring-
opened acyliminium species 1.24 leading to Diels-Alder adduct 1.25.  Subsequent 
chlorination initiates the 1,2-pinacol-like shift/ring contraction cascade leading to the 
8
cyclopentane bearing the iminium species 1.27, which is then trapped with water to 
deliver palau’amine (1.4).20
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 With the discovery of a variety of structurally related oroidin-derived marine 
alkaloids, Al-Mourabit and Potier proposed universal chemical pathways towards 
numerous pyrrole-imidazole alkaloids of this family, based on the tautomerism and 
ambivalent reactivity of 2-aminoimidazole precursors.8 These chemical pathways 
provided helpful information and directions for biosynthetic investigations. According to 
their proposal, palau’amine and its congeners originate from a dimerization of oroidin 
tautomers 1.28 and 1.29 (Scheme 2). Chlorohydroxylation and subsequent cyclization 
give the chloro-cyclopentane structure 1.32. This intermediate then undergoes oxidation 
9
and different modes of intramolecular cyclization to form styloguanidines (C3-
cyclization), palau’amines (N1-cyclization) and axinellamines (N2-cyclization).  
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 Phakellins (1.9-1.11), one class of monomeric oroidin derivatives, can be 
generated from intramolecular cyclization of linear oroidin and congeners (hymenidin 
1.34 and clathrodin 1.35), as depicted by Al-Mourabit and Potier (Scheme 3).8  
10
 Scheme 3 
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D. Previous Synthetic Studies 
 Since the reports of the isolation of palau’amines, styloguanidines and 
axinellamines, many research groups took on the synthetic challenges this class of 
molecules present and reported their diverse approaches towards these hexacyclic 
marine alkaloids.7,12 The synthetic strategies towards the chloro-cyclopentane core 
structure 1.32, the proposed biosynthetic precursor of palau’amines, styloguanidines and 
axinellamines, can be classified into four distinctive groups (Scheme 4). Overman,21 
Austin22 and Carreira23 use a cycloaddition strategy to construct the cyclopentane (A 
ring). Romo20, 24 and Lovely25 apply a ring contraction strategy on the cyclohexene 
intermediate obtained from Diels-Alder reactions. Baran’s26 strategy includes a ring 
11
expansion of a cyclobutane structure to cyclopentane. Chen27 and Harran28 take 
advantage of linear oxidative cyclization to build the cyclopentane ring system.  
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E. New Isolates and Recent Structural Revision of Palau’amine 
 There are about 100 known pyrrole-imidazole alkaloids reported in literature.7 
Almost all of these secondary metabolites are the monomeric or dimeric derivatives of 
oroidin (1.1) and congeners (1.34, 1.35). So far, the ultimate complexity of pyrrole-
imidazole alkaloids is presented in the molecules of stylissadine A and B (1.39 and 1.40, 
Figure 5). Köck29 and Quinn30 discovered these two tetrameric oroidin-derivatives 
independently at the same time. Stylissadine A and B were isolated from the Caribbean 
12
sponge Stylissa caribica by Köck and from the Australian sponge Stylissa flabellata by 
Quinn, respectively. As the largest and most complex oroidin alkaloids, stylissadines 
were major challenges in terms of structural elucidation. Stylissadines have some minor 
activities against several pathogenic bacteria, fungi, and cultures of mice fibroblasts.29 
Most significantly, according to Quinn’s report,30  stylissadine A and B are antagonists 
of the P2X7 receptor, an important inflammatory target, having IC50 values of 0.7 μM 
and 1.8 μM respectively.  
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 Stylissadines are the dimers of a known oroidin-alkaloid massadine (1.15), which 
was isolated from marine sponge Stylissa aff. massa by Fusetani and coworkers.31  
Massadine chloride (1.41, Figure 5), which possesses the common chloro-cyclopentane 
core moiety found in many other dimeric oroidin-alkaloids such as palau’amines, 
styloguanidines and axinellamines, is thought to be the biosynthetic precursor of both 
massadine and stylissadines (vide infra, Chapter III). Recently, the isolation of 
massadine chloride from the Caribbean marine sponge Stylissa caribica by Köck and 
Baran provides sound ground for this speculation.32
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Figure 6. Konbu’acidin B and revised structure of dibromopalau’amine 
 
 Isolated together with stylissadines from the Australian sponge Stylissa flabellata 
were konbu’acidin B (1.43) and dibromopalau’amine (1.44).30 Advanced NMR 
techniques and close examination of ROSEY and proton coupling constant data allowed 
the assignment of the structure as shown in Figure 6. The structure of konbu’acidin B 
was determined to be quite different from the known konbu’acidin A,33  in terms of the 
hexacyclic main skeleton. The stereochemistry of C12 and C17 centers were proved to 
14
be opposite to what was proposed previously. Dibromopalau’amine also had the same 
structural discrepancy with the previously accepted structure, suggesting some possible 
misassignments in the original isolation report.9,10
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Figure 7. Structure of tetrabromostyloguanidine/carteramine A 
 
 The questions over the structural assignment of palau’amine and congeners were 
cleared when Köck reported isolation and structural elucidation of tetrabromo-
styloguanidine (1.45, Figure 7).34 Based on convincing evidence from 1D, 2D-NMR data 
and advanced computational analysis, the hexacyclic skeleton of tetrabromostylo- 
guanidine was determined to be different from the previously accepted structure of 
styloguanidine, with the C17 and C12 stereochemistry being revised. Another 
independent report on the isolation of the same natural product from the marine sponge 
Stylissa carteri by Matsunaga and co-workers also pointed to the same structural 
revision.35 Tetrabromostyloguanidine was named carteramine A in their report, and was 
found to inhibits the chemotaxis of neutrophils (IC50 = 5 μM). To directly confirm the 
necessity of a structural revision for palau’amine, Quinn and co-workers isolated 
15
palau’amine from the sponge Stylissa flabellata, the same marine sponge from which 
they isolated stylissadine A and B, and based on detailed analysis of 2D ROESY and 1D 
NOESY data, they concluded that the original structural assignment  was incorrect.36
 In summary, the structure of palau’amine was revised based on recent 
independent findings from three research groups. The revised structure (1.46, Figure 8) 
has the opposite stereochemistry on the C12 and C17 centers compared to the originally 
proposed structure (1.4), however the absolute stereochemistry of palau’amine is still not 
known. The most notable feature of the revised structure is a highly strained trans-fused 
azabicyclo[3.3.0]octane moiety. The original proposed cis-fused 5,5-bicycle is less 
strained by approximately 27.3 kJ/mol (6.52 kcal/mol). According to a literature survey, 
only 10 out of over 2000 bicyclo[3.3.0]octane structure fragments have trans-fused 
junctions.37  With the revised structures of many related oroidin alkaloids, a refined and 
more convergent biosynthetic pathway was laid out by Köck and Baran, 37 based on the 
original biosynthesis proposal by Al-Mourabit and Potier.8  
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Figure 8. Structure revision of palau’amine 
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 Overman’s recent work on the synthesis of palau’amine analogues also provides 
some strong evidence for the misassignment of palau’amine structure reported 14 years 
ago. Hexacyclic palau’amine analogues 1.52 and 1.53 (Scheme 5), which possess the 
two cyclic guanidine functional groups and the cis-fused azabicyclo[3.3.0]octane core, 
were synthesized in 16 steps from cycloadduct 1.47.38  Access to these analogues allows 
the first direct comparison of their NMR data with the data of natural palau'amine. This 
comparison provides convincing evidence supporting the revised trans configuration of 
the azabicyclo[3.3.0]octane ring system of palau'amine and congeners. 
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 F. Conclusion 
 Natural products, regardless of their isolation sources, can exhibit a large array of 
biological activities. In conjugation with their diverse and novel structural features, they 
have become an important sector in scientific research, studied in search for potential 
therapeutic agents, applied as probes for understanding biomechanistic pathways, 
pursued in the efforts of discovering novel chemical transformations, or targeted as pure 
synthetic challenges. Oroidin-derived marine alkaloids, also known as pyrrole-imidazole 
alkaloids, with their complex and challenging structures and potent bioactivities, are 
receiving increasing attentions from not only chemists but also chemical biologists.  
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CHAPTER II 
DEVELOPMENT OF A NOVEL ELECTRONICALLY ADJUSTABLE 
NITROGEN PROTECTING GROUP -- TOSYLVINYL (TSV) AND ITS 
APPLICATION IN PALAU’AMINE/AXINELLAMINE SYNTHESIS∗
 
A. Background 
Our initial approach towards palau’amine and related pyrrole-imidazole alkaloids 
was inspired by Kinnel and Scheuer’s biosynthetic proposal (Chapter I, Scheme 1) for 
palau’amine. A viable and rapid synthetic pathway was envisioned to assemble the 
spirocyclic core structure of axinellamines and related bisguanidine alkaloids, via a 
Diels-Alder reaction, oxidation, chlorination/1,2-shift sequence (Scheme 6). The diene 
(2.4) for the Diels-Alder reaction comes from DL-tartaric acid (2.7) and urea (2.6), and 
the dienophile (2.3) comes from the more readily available natural L-pyroglutamic acid 
(2.5),39  even though the originally proposed stereochemistry of palau’amine would 
require the use of D-pyroglutamic acid. Once the synthesis of palau’amine (ent-1.4) is 
accomplished and its absolute stereochemistry is validated, the total synthesis can be 
carried out in an enantiomeric fashion to give either enantiomer. 
 
 
 
                                                 
∗ Reproduced in part, with permission, from “Highly Regioselective Diels-Alder Reactions toward 
Oroidin Alkaloids: Use of a Tosylvinyl Moiety as a Nitrogen Masking Group with Adjustable Electronics”, 
P. J. Dransfield, S. Wang, A. Dilley and D. Romo, Org. Lett. 2005, 7, 1679-1682; copyright 2005, by 
American Chemical Society. 
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Regarding the Diels-Alder reaction, the first key step in our synthesis, there are 
some selectivity issues to be considered. The endo products are expected, as in reported 
cycloaddition reactions for related dienophiles.40 As for facial selectivity, the diene 
should approach the dienophile from the less sterically hindered face (Figure 9). The 
regioselectivity of the Diels-Alder reaction can be controlled by the two protecting 
groups on the imidazolone ring of the diene. We reasoned that use of a strongly electron 
withdrawing group (Ewg) on N1 and an electron donating group (Edg) on N2 would 
perturb the orbital coefficients of the diene and lead to high regioselectivity (Figure 9). 
Indeed, when benzyl protecting groups were used for both nitrogens in the diene 
imidazolone ring, only moderate regioselectivity was observed, yielding two 
regioisomeric Diels-Alder adducts 2.9 and 2.10 (Scheme 7). Changing the protecting 
group of N1 from benzyl to tosyl, a strong electron-withdrawing group, and the 
20
protecting group of N2 from benzyl to 3,4-dimethoxy benzyl, a more electron-rich group, 
did give exclusively only the desired regioisomer 2.12 (Scheme 7).39  
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Figure 9. Selectivity issues in the Diels-Alder reaction 
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Thus, the tosyl group at N1 had indeed provided the electronics for a highly 
regioselective Diels-Alder process. Subsequent oxidation of the TBDPS-protected Diels-
Alder adduct 2.16 to allylic alcohol 2.17 in this case required the use of 
trifluorodimethyl dioxirane41 presumably due to the the tosyl group that rendered the 
olefin less nucleophilic (Scheme 8). Previously, oxidation of the TBS-protected 
dibenzylated adduct 2.13 could be achieved in near quantitative yield with dimethyl 
dioxirane42 and the subsequent chlorination went smoothly with NCS to give the 
chlorocyclopentane 2.15.24a However, attempts to effect the subsequent chlorination on 
the Ts-protected allylic alcohol 2.17 were unsuccessful using a range of chlorinating 
reagents including NCS, chloramine-T, sodium hypochlorite, 2,3,4,5,6,6-
hexachlorocyclohexa-2,4-dien-1-one, and chlorine gas.39
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B. Design of an Electronically Switchable Protecting Group 
These observations indicate that an electron-withdrawing protecting group (such 
as Ts) on N1 clearly benefits the regiochemical outcome of the Diels-Alder reaction, 
however the subsequent chlorination/1,2-shift cascade requires an electron-rich 
protecting group on N1, presumably to stabilize the partial positive charge developed on 
the tertiary N,O-hemiaminal carbon in the transition state of the pinacol-type 
rearrangement (Scheme 9). 
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Generally, this situation would require a protecting group switch. To circumvent 
this problem, we devised an electronically switchable protecting group which can serve 
as an electron withdrawing group (Ewg) in the Diels-Alder reaction and then can be 
reduced to an electron donating group (Edg) to fulfill the electronic requirement in the 
following rearrangement step. In this regard, we envisaged the use of a tosylvinyl (Tsv) 
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group43 (a vinylogous tosyl group), to approximate the electron-withdrawing nature of a 
tosyl group that is necessary for a regioselective Diels-Alder reaction (Scheme 10). 
Subsequent olefin reduction would generate a tosylethyl (Tse) protecting group44 that 
will serve as a more el     ectron rich group determined to be necessary for the 
chlorination/ring contraction sequence. 
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The utility of protecting groups in organic synthesis for controlling 
chemoselectivity continues to drive advances in this area.  The recent development of 
the p-nitrobenzenesulfonyl (nosyl) group by Fukuyama for nitrogen alkylation via 
Mitsunobu processes nicely illustrates an exciting new direction towards the 
development of protecting groups that, in addition to functional group masking, serve 
24
multiple roles including facilitating removal and altering reactivity.45  Protecting groups 
that alter the electronic properties of substrates have also proven useful for a variety of 
reactions such as the Friedel-Crafts and Diels-Alder. The application of the electron 
withdrawing tosylvinyl (Tsv) group, which can be readily converted to the more electron 
rich tosylethyl (Tse) group, in our Diels-Alder/oxidation/ring contraction strategy 
towards the oroidin alkaloids is just another example of protecting groups being used for 
controlling regioselectivity and altering the substrate reactivity (vide infra). 
 
C. Synthesis of Tsv-protected Diene 
Synthesis of the Tsv-protected diene began with the known imidazolone methyl 
ester 2.25 (Scheme 11).24 (Z)-1,2-di-p-toluenesulfonylethylene46 (2.26) was used to 
install the Tsv group at the more accessible nitrogen (N1) on the imidazolone ring, via a 
presumed addition-elimination process. Protection of N2 with 3,4-dimethoxybenzyl 
chloride (DMBCl) gave the bis-protected imidazolone ester 2.27 in 59% overall yield for 
the two protection steps.  Attempts to reduce the ester functionality in 2.27 directly to an 
alcohol using DIBAl-H, was successful but also led to concomitant reduction of the Tsv 
group to Tse.  A more lengthy but efficient sequence involving hydrolysis to the acid, 
acid chloride formation, and reduction with lithium borohydride gave the desired alcohol 
2.28 in 96% overall yield for the three steps.  Oxidation to the corresponding aldehyde 
and Horner-Wadsworth-Emmons olefination gave ester 2.29 in 82% yield. Again, a 
three-step reduction sequence was required to prevent reduction of the Tsv group. 
Hydrolysis of the ester, followed by mixed anhydride formation, and treatment with 
25
lithium borohydride provided dienyl alcohol 2.30 in 77% yield over the four steps and 
avoided reduction of the olefin in the Tsv group. 
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During the efforts towards synthesis of diene 2.30, it was found that the alkene 
functionality of the Tsv group could be reduced very easily with a stoichiometric amount 
of reducing agent, such as DIBAl-H, NaBH4, or BH3·THF. This is not surprising since 
that double bond is activated by the adjacent tosyl, a strong electron-withdrawing group 
(Scheme 12). The iminium species in the resonance structure 2.31 is even more reactive 
than an aldehyde. Therefore, in order to overcome the competing reduction of the Tsv 
alkene over the ester groups in 2.27 and 2.29, the ester functionality had to be converted 
into more reactive species, i.e., an acid chloride or a mixed anhydride (Scheme 11). 
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The synthesis of the Tsv-protected diene consists of 10 steps in total, which is 
lengthier than analogous dienes prepared previously.24  The advantage of this route, 
however, is that no column chromatography purification is necessary throughout the ten-
step sequence from imidazolone ester 2.25, because of the easy purification at the acid 
stages by acid-base extraction. 
 
D. The Diels-Alder Reaction and Tsv Reduction 
Heating diene 2.30 together with dienophile 2.3 in benzene at 95 °C for 96 h in 
the presence of 2,6-lutidine, pleasingly led to the formation of a single regioisomeric 
Diels-Alder adduct 2.32 in 48% overall yield following protection of the alcohol as the 
TBDPS ether (Scheme 13). Similar results were obtained using microwave irradiation at 
175 °C for 45 min. In agreement with previous studies, the double bond in the initial 
adduct had migrated to regenerate the imidazolone ring under the reaction conditions. 
Interestingly, a further product was isolated which has been tentatively assigned as a 
Diels-Alder adduct from two units of the Tsv-diene, in which one of the Tsv groups has 
served as a dienophile. This side reaction accounts for the relatively low yield obtained 
from the Diels-Alder reaction of diene 2.30 and dienophile 2.3. Most importantly, no 
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regioisomeric Diels-Alder adduct was observed from the reaction, proving the electron-
withdrawing ability of Tsv group via vinylogous conjugation/induction effects. 
Reduction of the Tsv group was readily accomplished by hydrogenation to yield 
the Tse-protected Diels-Alder adduct 2.34 in excellent yield (Scheme 13).  
Corroboration of this structure was obtained by independent synthesis of the same 
compound from the Tse-protected diene 2.33, which was prepared by a completely 
analogous process as that for diene 2.11 employing the mesylate of β-tosylethanol for 
N1 protection.20 Diene 2.33 provided a 2.5:1 ratio of regioisomeric Diels-Alder adducts 
after the reaction, with the major product being the desired regioisomer. Subsequent 
alcohol protection afforded TBDPS-protected adduct 2.34. NMR data comparison 
verified that the same Diels-Alder adduct had been obtained by the two routes. 
 
Scheme 13 
NDMBTsvN
O
2.30
OH
NDMBTseN
O
2.33
OH
Ts
N O
TIPSO
TsvN
N
DMBO
OTBDPS
Ts
N O
TIPSO
TseN
N
DMBO
OTBDPS
H2, Pd(OH)2/C,
EtOAc
(93%)
1) 2.3, 2,6-lutidine,
PhH, 95 oC, 96h
2) TBDPSCl, Et3N,
DMAP, CH2Cl2
(48%)
2.32
1) 2.3, 2,6-lutidine,
PhH, 90 oC, 72h
2) TBDPSCl, Et3N,
DMAP, CH2Cl2
2.34
(49%)
 
 
28
The use of the Tse-protected Diels-Alder adduct 2.34 in the oxidation and 
chlorination/1,2-shift resulted in the formation of the rearranged spirocycle 2.36 in an 
overall 65% yield over the two steps (Scheme 14), proving that the reduction of Tsv to 
Tse changed the electronics of the protecting group from electron-withdrawing to 
electron-donating, hence enabling the chlorination/1,2-shift cascade to occur.  
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E. Conclusion 
In summary, we have developed a strategy using an electronically adjustable 
protecting group to circumvent the need for a cumbersome protecting group switch. 
Importantly, this enabled a highly regioselective Diels-Alder process. While the 
efficiency of the Diels-Alder process using the Tsv-protected diene is not fully 
optimized, we anticipate that the concept of an electronically adjustable protecting group 
may find wider application in organic synthesis. The advanced spirocyclopentane 2.36 is 
a key intermediate in our synthetic efforts towards axinellamines and related oroidin-
alkaloids.   
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CHAPTER III 
STUDIES ON INSTALLATION OF THE α-CHLORO SUBSTITUENT FOR 
THE ORIGINALLY PROPOSED PALAU’AMINE STRUCTURE∗
 
A. Introduction 
Our interest in the oroidin alkaloids stemmed from the unique and complex 
structure presented by palau’amine in conjunction with its potent immunosuppressive 
activity. This falls into our group’s interest in natural products displaying potent, cell-
specific, physiological properties and the structurally distinct marine sponge isolates. 
Pateamine A, is an example of our continued interest in this field.47 In the course of our 
studies toward the originally proposed palau’amine, a unified strategy towards both 
axinellamine and palau’amine was developed, proceeding through a Diels-Alder reaction 
and then diverging to axinellamine or palau’amine by means of either an inter- or 
intramolecular chlorination, respectively (Scheme 15). 
This divergence addresses the difference in relative stereochemistry between the 
proposed structures of axinellamine (1.19) and palau’amine (1.4) at the chlorine bearing 
carbon C17 and also at C12. The anti relationship between C17 and C18 found in 
axinellamine could be accessed by intermolecular chlorination as a result of the 
topography of the tricyclic common intermediate 2.2, obtained from a Diels-Alder 
process.20,24 As previously shown, the oxidation/intermolecular chlorination/1,2-shift 
                                                 
∗ Reproduced in part, with permission, from “Planned and Unplanned Halogenations in Route to Selected 
Oroidin Alkaloids” S. Wang, A. S. Dilley, K. G. Poullennec and D. Romo, Tetrahedron 2006, 62, 7155-
7161; copyright 2006 by Elsevier Ltd. 
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sequence generated a chloro-cyclopentane structure possessing all the correct 
substituents and stereochemistry except for one stereocenter: C12 for axinellamine and 
C17 for palau’amine respectively (Chapter II, Scheme 14). A subsequent epimerization 
at C12 via enolization of a carbonyl functionality at C13 would be required to obtain the 
all anti configuration about the cyclopentane as found in axinellamine 1.19 (Scheme 15). 
Subsequent imidazolone annulation, guanidinylation, and an oxidative cyclization are 
proposed to form the final ring system and deliver axinellamine. 
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The chloro substituent of the cyclopentane 2.36 (Scheme 14), however, has the 
opposite stereochemistry for the originally proposed palau’amine (1.4). To address this 
problem, an intramolecular chlorination would be reasonable to set the required 
stereochemistry at C17 after DMDO oxidation of the Diels-Alder adduct 2.2. The 
cycloaddition has already set the required syn stereochemistry at C11 and C12, thus 
epimerization at C12 is not required. Guanidinylation and annulation of the phakellin 
substructure onto core structure 3.2 would deliver palau’amine (Scheme 15). 
 
B. Intramolecular Chlorination Studies 
Installation of a sulfonamide at the C19 position would be necessary for an 
intramolecular chlorination process. After functional group conversions, a chlorinated p-
toluenesulfonamide 3.6 might be accessible from the Diels-Alder adduct 3.4 (Scheme 
16). DMDO oxidation would trigger a cascade reaction including epoxidation, epoxide 
ring opening, deprotonation, intramolecular chlorination and 1,2-shift, delivering the 
desired stereochemistry. We envisioned this pendant electrophilic chlorine source, i.e. 
the chloro-p-toluenesulfonamide, would deliver the chlorine in an intramolecular fashion 
to the concave face of tricycle 3.9 to yield cyclopentane 3.11 following ring contraction. 
This strategy is reminiscent of an intramolecular, directed chlorination reported by 
Breslow.48 While the proposed 5-endo-tet transition state would be an exception to 
Baldwin’s rule,49  there are numerous exceptions including attack at heteroatoms.50  The 
desired α-chloro spirocycle 3.11 should have a coupling constant of 8 Hz between Ha 
and Hb as shown in Scheme 16.39
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Synthesis of the substrate (3.5) for the intramolecular chlorination studies began 
with Diels-Alder adduct 3.4. Tosylation of the primary alcohol, followed by 
displacement of the tosylate by an azide and reduction of the azide afforded a primary 
amine 3.13 (Scheme 17). The amine was then converted to a p-toluenesulfonamide 3.5. 
Direct azide formation from alcohol 3.4 via Mitsunobu conditions was unsuccessful. 
Attempts to displace the tosylate functional group in 3.12 directly with tosylamine to 
form sulfonamide 3.5 also failed.  
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 Although there are literature precedents about N-chlorination of p-toluenesulfon- 
amide and other amides,51 it was still desirable to carry out a model study on this 
reaction, and a simple n-butyl-p-toluenesulfonamide 3.14 was selected as the model 
system (Table 2). N-Chlorosuccinimide (NCS) was not able to chlorinate 3.14, even after 
deprotonation of the amide. Apparently the tosyl group is more electron-withdrawing 
than the double carbonyls in NCS, making the nitrogen anion in the deprotonated 3.14 
less nucleophilic than the succinimide nitrogen anion. Chloramine-T did not work either. 
The reagents that were able to convert 3.14 to 3.15 were t-butylhypochlorite, 
trichloroisocyanuric acid (TCIA) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadiene-1-one 
(HCCO) (Table 2). The chlorinated sulfonamide 3.15 can be reduced easily by 
dimethylsulfide and is not stable to silica gel chromatography. Both tBuOCl and TCIA 
were able to chlorinate 3.14 without deprotonation of the sulfonamide. In the real system 
3.5, however, deprotonation would be necessary to generate a more nucleophilic 
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nitrogen anion, which we expected to be more reactive towards chlorine cation source 
than the electron-rich double bond in the imidazolone ring moiety.  
 
Table 2. Model studies on N-chlorination 
conditions
3.14 3.15
NHTs NClTs
 
entry conditions results a
1 NaH, THF; NCS S.M. 
2 nBuLi, THF, -78 °C; NCS S.M. 
3 nBuLi, THF, -78 °C; chloramine-T S.M. 
4 nBuLi, THF, -78 °C; tBuOCl 95% 
5 tBuOCl, CH2Cl2,  -78 °C 91% 
6 nBuLi, THF, -78 °C; TCIA 100% 
7 nBuLi, THF, -78 °C; HCCO 75% 
a: percent conversion by NMR analysis 
 
With these results in hands, chlorination of sulfonamide 3.5 was studied, but 
disappointingly, none of those conditions gave the desired product 3.6 (Scheme 18). 
When the reactions were carried out at -78 °C, no chlorination was observed (starting 
material was recovered). At higher temperatures (-50 °C, 20 °C), side products that 
presumably resulted from the reactions of the chlorinating agents with the electron-rich 
double bond in imidazolone ring were formed predominantly. In fact, sulfonamide 3.5 is 
not even compatible with N-chlorosulfonamide functionality. When sulfonamide 3.5 was 
treated with N-chlorosulfonamide 3.15, an unidentified complex mixture of products was 
formed, suggesting that the substrate reacts with the chlorinating reagent to form 
undesired products, or that even though the desired product 3.6 could be formed under 
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the chlorination condition, it is not stable and can undergo degradation easily via 
intermolecular reactions with itself. 
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With the consideration that N-chlorosulfonamide 3.6 might be generated in situ 
but could not be isolated due to its instability, a one-pot N-chlorination/oxidation/1,2-
shift reaction was tried with sulfonamide 3.5 (Scheme 19). A rearranged compound with 
the same molecular mass as desired compound 3.11 was isolated. If the chlorine 
stereochemistry was correct, a coupling constant of 8 Hz between Ha and Hb should 
have been observed.39 However the observed coupling constant Jab was 11.5 Hz, 
indicating the chlorine was on the β-face, as in 3.11’s diastereoisomer 3.17. Through 
known intermolecular chlorination procedures, 3.17 was synthesized independently via 
allylic alcohol 3.16, and was identical, based on spectra data comparision, with the 
product isolated from the aforementioned one-pot reaction. This result indicated that the 
desired intramolecular chlorination/1,2-shift did not occur and the product isolated from 
that reaction was actually β-chlorocyclopentane 3.17. The formation of 3.17 was 
probably a result of more facile intermolecular chlorination/1,2-shift reaction between 
allylic alcohol 3.16 generated in situ with chlorinating agent trichloroisocyanuric acid 
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(TCIA). The same one-pot reaction was tried again in highly diluted solution (0.6 mM in 
THF), but resulted in mainly recovered starting material with trace amount of β-
chlorinated product 3.17. 
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 β-Chlorocyclopentane 3.17 is a foam, and cannot form crystals. In an attempt to 
obtain a crystal structure of the β-chlorinated cyclopentane core structure, 3.17 was 
desilylated with TBAF (Scheme 20) and the resulting alcohol was treated with 
trityldimethylbromosilane to form a trityldimethylsilyl protected compound, which is 
known to form crystals readily.52 Unfortunately, the desired product was not observed 
under such reaction conditions. 
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Molecular modeling studies showed the main reason behind these unsuccessful 
attempts on intramolecular chlorination. In an energy minimized 3D model of the 
chlorination intermediate 3.9 (protecting groups are removed for clarity), one can clearly 
see that the central six-membered ring is in a boat conformation, and the chlorine atom 
on the sulfonamide nitrogen is far away from the projected reaction site, i.e., the 
enamine terminal carbon (Figure 10). It would be energy demanding for the chloro-
sulfonamide group to go under the concave face of the tricyclic structure. 
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Figure 10. Molecular modeling of the chlorination intermediate 
 
C. Effects of the Tosyl Protecting Group 
In the molecular model of allylic alcohol intermediate 3.20 prior to chlorination, 
the tosyl protecting group on the lactam nitrogen resides beneath the concave face of the 
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tricyclic system, blocking chlorinating reagents from reaching the sp2 enamine carbon 
reaction center (Figure 11). On the other hand, the convex face of the molecule is open 
to chlorinating reagents without any steric hindrance. If the tosyl group was removed 
(3.21), the concave face of the allylic alcohol would be more open to chlorinating 
reagents, hence making chlorination on both the convex face and the concave face 
possible, generating mixture of β-chloro and α-chloro cyclopentane products. Once this 
hypothesis was validated, the allylic alcohol in 3.21 could be protected by TMS, to 
generate steric hindrance on the convex face, therefore making chlorination happen on 
the concave face to form α-chloro cyclopentane product.  
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Figure 11. Molecular models of allylic alcohols prior to chlorination 
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After detosylation of the Diels-Alder adduct 3.4,53 lactam 3.22 was oxidized to 
give allylic alcohol 3.23, resulting in a mixture of two diastereomers, as expected 
(Scheme 21). The crude product from the oxidation was subjected to the chlorination/ 
ring contraction conditions, but did not yield the desired diastereomeric mixture of 
chlorinated products 3.24. 
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To circumvent the problem of generating diastereomers of the allylic alcohol 
3.23, Diels-Alder adduct 3.4 was first oxidized to form allylic alcohol 3.25 as a single 
diastereomer (Scheme 22), which was then detosylated to give allylic alcohol 3.23. 
Subsequent chlorination, disappointingly, gave only the β-chloro product 3.24. Some β-
chlorocyclopentane 3.25 was also isolated from the chlorination reaction, due to some 
unreacted allylic alcohol 3.25 in the detosylation step. The identity of compound 3.24 
was further confirmed by spectral data comparison with the detosylation product of β-
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chlorocyclopentane 3.26. No α-chlorination was observed on substrate 3.23, suggesting 
that the chlorinating reagent still approaches the allylic alcohol intermediate from the 
convex face, even without a tosyl group blocking the concave face. 
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D. Studies on the Initial Diels-Alder Adduct 
 While experiencing difficulties on directed intramolecular chlorination, various 
other methods to install the α-chlorine were investigated. One alternative way to obtain 
the α-chloro spirocyclic structure was proposed as shown in Scheme 23. The Diels-
Alder reaction of dienophile 2.3 and Tse-diene 2.33 could be optimized in such a way 
that the initial Diels-Alder adduct 3.27 was formed as the major product. According to 
Lovely’s observations in a similar system,25d silyl protected adduct 3.27 can be oxidized 
to allylic alcohol 3.28. Mesylation of the alcohol will make the hydroxyl group a good 
leaving group, after which α-chlorine can be installed via SN2 displacement of the 
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mesylate intermediate. The subsequent second DMDO oxidation will give intermediate 
3.30, which may rearrange to give desired α-chloro cyclopentane structure (3.32) for 
palau’amine. 
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 Under careful control of the reaction time, the Diels-Alder reaction did give the 
proposed initial Diels-Alder adduct along with its inseparable regioisomer. Following 
immediate protection of the primary alcohol by TBDPSCl, adduct 3.27 could be isolated 
from its regioisomer and was obtained in 48% yield over the two steps (Scheme 24). 
Treatment with one equivalent of DMDO successfully generated allylic alcohol 3.28, but 
unfortunately, the following transformation to form the proposed chloro-cyclohexene 
intermediate 3.29 failed under various conditions. Attempts on converting the allylic 
alcohol 3.28 to its corresponding mesylate 3.33 or tosylate 3.34 were not successful 
either. A complex mixture of products was often observed during these reactions, 
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presumably due to the reactivity of the allylic alcohol functionality, which might 
undergo elimination easily and further degrade to aromatic compounds. 
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E. Studies on SN2 Displacement of β-Iodides 
 As previously shown, subjecting allylic alcohol 2.35 to chloramine-T causes an 
intermolecular, stereoselective chlorination and a concomitant suprafacial 1,2-shift/ring 
contraction to yield functionalized chlorocyclopentane 2.36 (Chapter II, Scheme 14). 
This cyclopentane contains five stereocenters, identical to the proposed structure of 
axinellamine with the exception of C12. The high stereoselectivity of the chlorination is 
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due to the distinctly cup-shaped topology of allylic alcohol 2.35. In order to install the 
stereochemistry at the chlorine center C17 as proposed for palau’amine (Scheme 15), 
which is opposite to that of axinellamine, a reverse Finkelstein strategy involving SN2 
displacement of an appropriate leaving group such as bromide or iodide, was considered. 
Bromination of allylic alcohol 2.14 with N-bromosuccinimide also initiated the ring 
contraction process and delivered β-bromocyclopentane 3.35 (Scheme 25). However, 
attempts to displace the bromide with excess chloride anion under a variety of conditions 
led to no reaction. 39
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 Allylic alcohol 2.35 could also be iodinated and following ring contraction 
provided β-iodocyclopentane 3.37 (Scheme 26). Iodide 3.37 was prepared with the 
expectation that this compound may undergo a more facile reverse Finkelstein process 
under forcing conditions; however no displacement was observed under several 
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conditions to provide the desired α-chloro compound 3.38. Silyl deprotection was 
attempted to remove any steric hindrance, however this did not facilitate the projected 
displacement. α-Chloro cyclopentane 3.40 was not observed under forcing conditions; 
instead, the only observed product in this case was lactam opening by the pendant 
alcohol to deliver lactone 3.41. To prevent lactam cleavage, the N-tosyl group was 
removed to give free lactam 3.42,53 but unfortunately further attempts to chlorinate were 
also unsuccessful. The stability of these spirocyclic systems toward SN2 displacement by 
chloride anion is likely due to steric issues since the nucleophile must enter the concave 
face with an adjacent spiro quaternary center for an SN2-type process. 
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 Chloride displacement was ultimately achieved unexpectedly during conversion 
of the pendant tosylate of spirocycle 3.44 to an azide during studies toward 
axinellamine.39 The chlorine atom was also displaced concomitantly but surprisingly 
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with retention of configuration, as determined by coupling constant analysis, to yield 
bisazide 3.45 (Scheme 27). As expected, displacement of iodide in spirocycle 3.37 was 
more facile and led to higher yields of the corresponding azide 3.46. Retention of 
configuration may be rationalized by invoking neighboring group participation 
proceeding through an aziridinium intermediate 3.47 (Scheme 27). Under heating 
condition, intramolecular substitution by the proximal, benzylated nitrogen atom, which 
appears well situated to displace the iodide of spirohydantoin 3.37, leads to net retention 
of configuration upon ring opening of the aziridinium by azide nucleophile. 
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 Considering the relative facility of this process with spirohydantoins 3.44 and 
3.37, it is reasonable to speculate that this type of transformation may be a more facile 
process with the electron rich cyclic guanidine found in these natural products (e.g. 3.48), 
especially under the catalysis of enzymes. Thus, a possible biosynthetic pathway leading 
to massadine31 may involve a related retentive displacement of a chloride from the 
chloro-derivative of massadine 3.48, followed by ring opening of the aziridine by water 
and ultimately leading to massadine 1.15 (Scheme 28). A related process was recently 
proposed for the natural product fasicularin.54 Same type of pathway could be drawn for 
the biogenesis of dimeric massadine derivatives: stylissadine A and B (1.39, 1.40), in 
which a second molecule of massadine acts as a nucleophile to open the aziridine ring 
system in intermediate 3.49 to form stylissadines. Recent isolation and chemical 
derivatization studies of massadine chloride (1.41) also provided evidence for this 
proposal.32
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 F. Conclusion 
 In efforts to achieve the correct stereochemistry at C17 for the originally 
proposed palau’amine structure, an intramolecular, directed chlorination was studied, 
based on previously achieved chlorination/ring contraction sequence leading to the 
highly functionalized chlorocyclopentane core structure of axinellamine and related 
oroidin alkaloids. However, this projected intramolecular chlorination did not give the 
desired α-chloro product. Instead, exclusive intermolecular chlorination was observed. 
Attempts to obtain a α-chloro spirocycle through initial Diels-Alder adduct did not meet 
with success either. In an alternative way to install the α-chloro substituent on C17,   the 
previously developed intermolecular chlorination process was extended to provide β-
brominated and β-iodinated cyclopentanes. Subsequent attempts on SN2 displacement of 
these halogens by excess chloride anion were unsuccessful. An unexpected displacement 
of chloride/iodide by azide anion proceeding with retention of configuration prompted us 
to propose a related process in the biogenesis of massadine and stylissadines. These 
results proved that installing the α-chloro substituent on C17 of the originally proposed 
palau’amine structure is a highly challenging task. Even though the recent structural 
revision of palau’amine pointed out that the stereochemistry of C17 was misassigned 
(Chapter I, section E), making the efforts described here futile, many intriguing aspects 
of oroidin-alkaloid chemistry were explored, and findings from these studies provided 
useful information for further synthetic efforts towards palau’amine and axinellamine.  
48
CHAPTER IV 
SYNTHESIS OF AN ADVANCED PENTACYCLIC INTERMEDIATE  
TOWARD EPI-PALAU’AMINE 
 
A. Introduction 
Due to its structurally complex nature, palau’amine has thus far eluded total 
synthesis, despite much attention from synthetic chemists. Few reports have been 
published regarding the synthesis of palau’amine,12 although there are at least ten 
research groups working on this subject. The synthetic challenges of palau’amine 
continue to drive us on the adventure of making palau’amine.20,24 After extensive studies 
on the installation of the α-chlorine substituent onto the central cyclopentane moiety 
without success (Scheme 29), we decided to pursue the synthesis of presumed epi-
palau’amine with a β-chlorine on C17 (4.3, Scheme 30). The completed synthesis of epi-
palau’amine would serve the purpose of verifying palau’amine’s structural assignment 
and also provide a synthetic platform for the derivatization of palau’amine for structure-
activity relationship investigations.  
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 The planned synthesis of epi-palau’amine started with chlorocyclopentane 2.36 
(Scheme 30). Now that we had all the three ring systems of the lower hemisphere of 
palau’amine, the remaining tasks were phakellin annulation, guanidinylation and late 
stage functional group manipulation (Chapter II, Scheme 6). Phakellin annulation 
strategy involves a few key transformations such as pyrrole acylation, reduction of the 
lactam, oxidation/cyclization, installation of guanidine and C-H insertion (vide infra).  
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B. Pyrrole-acylation Studies 
 1. Pyrrole-acylation Attempts before Lactam Reduction 
The spirocyclic β-chlorine-containing intermediate 2.36 could be obtained in 
around 65% yield over two steps from TBDPS-protected Diels-Alder adduct 2.34 via 
oxidation/chlorination/1,2-shift cascade (Chapter II, Scheme 14). Removal of the tosyl 
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group from the lactam ring in compound 2.36 was accomplished by using SmI2 in THF. 
4,5-Dibromo-2-trichloroacetylpyrrole 4.8 was prepared from the readily available 2-
trichloroacetylpyrrole via bromination.55 Acylation attempts of chlorocyclopentane 4.7 
with trichloroacylpyrrole 4.8 were unsuccessful under the two typical conditions shown 
in Scheme 31, probably due to the insufficient reactivity of both the nucleophile and the 
electrophile. (In an attempt to get a crystal structure of a chlorocyclopentane, 4.7 was 
deprotected with HF to give diol 4.10. However, diol 4.10 did not form crystals.) 
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 To improve the reactivity of the electrophile, trichloroacylpyrrole 4.8 was 
hydrolyzed into an acid and subsequently converted to an acid chloride 4.11 (Scheme 
32).56 However, the attempt to couple the acid chloride with the lactam 4.7 failed again 
to yield the desired pyrrole-acylated product 4.9, as shown by NMR data. 
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 2. Pyrrole-acylation after Lactam Reduction 
Unsuccessful attempts to acylate the lactam nitrogen in lactam 4.7 warranted the 
reduction of the lactam to a pyrrolidine, since the pyrrolidine nitrogen would be more 
nucleophilic and easier to be acylated. Reduction of the lactam could be carried out 
either before the oxidation/chlorination on the protected Diels-Alder adduct 2.34 or after 
the formation of chlorocyclopentane 4.7 (Scheme 33). The first route was studied 
initially. 
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Silyl protected Diels-Alder adduct 2.34 was detosylated with SmI2 to give lactam 
4.13 quantitatively. However, the lactam reduction using known conditions57 did not 
give the desired pyrrolidine product 4.15 (Scheme 34). The isolated product was 
characterized as alcohol 4.14, where both the TIPS and Tse protecting groups were 
removed, probably during the workup process.  
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Redutction of the lactam was finally achieved via a three-step sequence. DIBAl-
H reduction of lactam 2.34 to the corresponding aminal, acetylation and subsequent BF3 
mediated reduction afforded the tosyl-protected pyrrolidine 4.17 in high yield over three 
steps (Scheme 35).58 The oxidation/chlorination/1,2-shift sequence also worked on the 
deoxygenated compound 4.17 (Scheme 6), yielding the desired chlorocyclopentane ring 
system 4.18. This observation was contrary to the result obtained from an earlier study in 
the group.39
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 Detosylation of chlorocyclopentane 4.18 using sodium naphthalenide at low 
temperature gave product 4.19,59 with Tse also being removed concomitantly. Acylation 
in CH3CN under heating conditions gave degraded material. A second attempt to acylate 
pyrrolidine 4.19 in DMF did not give the desired product either, based on NMR and MS 
analysis (Scheme 36). 
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A 3D model of compound 4.19 (Figure 12) shows that the TIPS protecting group 
is blocking the β-face of the pyrrolidine, while the α-face is congested. So it would be 
necessary to remove the TIPS group selectively before the acylation of the pyrrolidine. 
This seemingly trivial step60 actually failed under various conditions, yielding either a 
mixture of products as a result of nonselective desilylation or completely desilylated 
product (Scheme 37). Attempts to selectively remove the TIPS group from analogous 
compound 4.18 before detosylation were also unsuccessful. 
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Figure 12. Molecular modeling of pyrrolidine 4.19 
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 While selective desilylation could not be achieved on substrate 4.18, the TIPS 
group in Diels-Alder adduct 2.34 could be easily cleaved without affecting the TBDPS 
group (Scheme 38). The resulting compound 4.23 was converted to the protected 
pyrrolidine 4.26 successfully via the three-step process used to prepare pyrrolidine 4.17. 
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The following oxidation/chlorination/rearrangement sequence gave chlorinated 
compound 4.27 with some inseparable aromatic by-product (Scheme 39). Subsequent 
sodium naphthalenide condition gave the detosylated product in less than 45% yield. 
However, further studies revealed that the product was not the desired acetate 
pyrrolidine 4.28, but actually an acetamide (4.29), which was formed in situ directly 
after the removal of the tosyl group via intramolecular acetyl transfer. The acetyl group 
in acetamide 4.29 could not be removed under various conditions. To prevent the acetyl 
transfer onto pyrrolidine nitrogen, protection of the primary alcohol after TIPS removal 
was necessary. 
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 TBS reprotection of alcohol 4.23 gave TBS-silyl ether 4.30, which was subjected 
to the following three-step deoxygenation sequence to give protected pyrrolidine 4.33 in 
high yield (Scheme 40). The oxidation/chlorination reactions also worked well on Ts-
pyrrolidine 4.33 to give chlorocyclopentane 4.34 in 60% yield, after which both Ts and 
Tse were removed using sodium naphthalenide to give pyrrolidine 4.35. Disappointingly, 
attempts to acetylate pyrrolidine 4.35 with 2-trichloroacetyl pyrrole failed to give the 
desired product 4.36. 
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 After unsuccessful acylation attempts on TBS-protected pyrrolidinol 4.35, 
pyrrolidinol 4.38 was prepared via selective deprotection of TBS and detosylation from 
4.34 (Scheme 41). However, the following attempts to acylate the pyrrolidine nitrogen, 
without any steric hindrance from the pendant alcohol protecting group, were still 
unsuccessful, even under harsh microwave conditions. The unexpected reactivity of 
pyrrolidinol 4.38 raised questions about its true indentity, and also those of 4.34 and 4.18. 
A different synthetic route to reach pyrrolidine 4.18 was planned to corroborate the 
presumably identical compound synthesized previously (Scheme 35).  
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Ts-protected pyrrolidine 4.18 was obtained via selective reduction of the lactam 
carbonyl in chlorocyclopentane 2.36, followed by acetylation and reduction (Scheme 42). 
This verified the identity of 4.18 obtained previously. Notably, two diastereomers of 
alcohol 4.40 were observed (dr 10:7), contrary to previous cases, i.e., the reduction of 
tricycles 2.34, 4.23 and 4.30, where only one diastereomer of the resulting alcohol was 
observed. This is due to the fact that in spirocycle 2.36, the α-face of lactam carbonyl is 
not totally blocked by the bulky TBDPS, allowing reduction from both faces. 
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  Eventually the pyrrole-acylation was achieved when pyrrole-2-carbonyl chloride 
(4.41) was used as the coupling partner. After conversion of the commercially available 
pyrrole-2-carboxylic acid to acid chloride 4.41,61 pyrrolidine 4.19 was successfully 
acylated with the pyrrole-2-carbonyl chloride, generating the desired product 4.42 in 
high yield (Scheme 43). 
 
Scheme 43 
NH
TIPSO
HN
N
O
DMB
O
Cl
TBDPSO
4.19
N
H
Cl
O
Et3N, CH2Cl2
N
TIPSO
HN
N
O
DMB
O
Cl OTBDPS
O
HN
4.42
(90%)
4.41
 
 
C. Synthesis of an Advanced Pentacyclic Intermediate 
 Attempts on selective removal of TIPS over TBDPS from tetracycle 4.42 using 
TBAF at low temperature (Table 3, entry 1) resulted in no reaction. At ambient 
temperature, non-selective desilylation was observed, giving 22% yield of desired 
product 4.43 and 78% yield of diol 4.44 (entry 2). Presence of excess amount of AcOH 
totally deactivated TBAF and no reaction was observed even at ambient temperature, 
while use of 0.2 equivalents of AcOH slightly enhanced the selectivity of the 
desilylation (entry 4). Finally, selective TIPS removal was achieved under acidic 
conditions using pTSA. With proper control of reaction time (around 18 h), the desired 
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alcohol 4.43 could be isolated in 82% yield. Longer reaction time led to the formation of 
diol 4.44. 
 
Table 3. Selective removal of TIPS over TBDPS 
conditionsN
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O
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N
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HN
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O
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O
Cl OH
O
HN
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entry conditions results 
1 TBAF, THF, -50-0 °C no reaction 
2 TBAF, THF, 20 °C 22% 4.43, 78% 4.44 
3 TBAF, AcOH (5 eq.), THF, 20 °C no reaction 
4 TBAF, AcOH (0.2 eq.), THF, 20 °C 31% 4.43, 69% 4.44 
5 pTSA, MeOH, 20 °C, 18 h 82% 4.43 
 
 According to literature precedent on a simplified system,62 IBX oxidation of 
alcohol 4.43 was projected to give aminal 4.46 directly as a result of in situ cyclization 
of the pyrrole nitrogen onto the aldehyde formed from oxidation. However, subjecting 
alcohol 4.43 to IBX oxidation gave aldehyde 4.45 as the only product (Scheme 44). 
Attempts to cyclize the pyrrole onto the aldehyde intramolecularly failed under various 
heating conditions and Lewis acid mediated conditions. Eventually, heating pure 
aldehyde 4.45 in DMSO to 70 °C provided the desired product 4.46 in 70% yield along 
with a small amount of the diastereomeric aminal 4.47. N,O-Hemiaminal 4.46 could be 
separated from its diastereomer 4.47 via column chromatography. The purified aminal 
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4.47 could be equilibrated back to the desired diastereomer 4.46 under thermodynamic 
conditions.  
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 The stereochemistry of the hemiaminal carbon (C6, Figure 13) in 4.46 was 
determined by two factors: coupling constants and 1D NOESY correlations. In an 
analogous but much simpler system,62 the coupling constant between the aminal proton 
(with β-OH on the aminal carbon) and its vicinal proton was reported to be 2.6 Hz. This 
coupling constant corresponds to the H6-H10 coupling constant in hemiaminal 4.46 
(Figure 13), which was found to be 3.0 Hz. These similar values suggest that the C6 
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hydroxyl group is in the β-face. This stereochemical assignment was confirmed 
undoubtedly by 1D NOESY NMR data. By irradiating aminal proton H6, nOe 
correlations were observed at the hydroxyl proton, vicinal proton H10 and neighboring 
pyrrole proton H5, meaning that H6 is in a syn relationship with vicinal proton H10. The 
relative stereochemistry of the central cyclopentane ring system, i.e., C11, C12, C16, 
C17 and C18 was also confirmed by NOESY correlations as shown in Figure 13.  
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Figure 13. 1D NOESY data of N,O-hemiaminal 4.46 
 
 Conversion of the hydroxyl group in hemiaminal 4.46 to an amine functionality 
(4.49) was accomplished by Mitsunobu type azidation63 and subsequent azide reduction 
by samarium diiodide64 (Scheme 45). The stereochemistry of C6 center was inverted 
during the azidation step, leading to the α-NH2 in N,N-hemiaminal 4.49. This 
stereochemical outcome was confirmed by coupling constant analysis and 1D NOESY 
NMR data (Figure 14). 
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 The observed coupling constant of 10.0 Hz between H6 and H10 (Figure 14) in 
4.49 was consistent with the literature value of 9.7 Hz for a related system,62 indicating 
an anti relationship between H6 and H10. Therefore the amino group was determined to 
be α-NH2 at the aminal carbon C6. 1D NOESY data revealed correlation between proton 
H6 and adjacent bridgehead proton H11, but no correlation between H6 and vicinal 
proton H10. In contrast, before the azide formation, NOESY data of aminal 4.46 showed 
strong nOe correlation between H6 and H10 (Figure 13). This result further verified the 
stereochemistry of the hemiaminal carbon center C6. 
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Figure 14. 1D NOESY data of N,N-hemiaminal 4.49 
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 The original plan to access the final ring system in epi-palau’amine (Scheme 30) 
involves a C-H amination strategy based on Du Bois’s Rh(II)-catalyzed C-H insertion 
reactions.65 To this end, a Tces-protected guanidine needed to be installed onto the 
amino group in pentacycle 4.49. An isothiourea functionality was installed first with 
imidoyl chloride 4.5065 to give isothiourea 4.51 (Scheme 46). The coupling constant of 
the aminal proton (Ha as shown in Scheme 46) with its vicinal proton was 9.5 Hz, 
consistent with the corresponding coupling constant observed in intermediate 4.49. 
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 However, removal of the thiomethyl group to generate guanidine 4.52 was 
problematic. A brief study on this reaction did not meet with success (Table 4). When 
the substrate 4.51 was treated with mercury dichloride and hexamethyldisilazane 
(HMDS),65 a complex mixture of unidentified products was observed. Use of ammonia66 
only resulted in recovery of N,N-hemiaminal precursor 4.49. Other possible ways to 
effect this conversion remains to be explored. 
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Table 4. Attempts on conversion of isothiourea 4.51 to guanidine 4.52 
N
N
O
H
N
HN
O
DMB
O
Cl
OTBDPS
NHMeS
NTces
4.51
conditions
N
N
O
H
N
HN
O
DMB
O
Cl
OTBDPS
NHH2N
NTces
4.52  
entry conditions results 
1 HgCl2, HMDS, THF, 20 °C multiple products 
2 NH3 (xs), MeOH, 20 °C 4.49 (100%) 
3 NH3 (1.0 eq.), MeOH, 20 °C 4.49a
 a: product verified by NMR; yield not determined 
 
D. NMR Data Comparison with Palau’amine Isolation Data 
 With the purpose of determining the C6 stereochemistry of N,O-hemiaminal 4.46 
and verifying the structural assignment of the remainder part of the molecule, a thorough 
1D NOESY NMR analysis was performed, as briefly discussed in the previous section. 
At the same time, coupling constants of some key protons on the central aza-
bicyclo[3.3.0]octane system were also examined, and some significant discrepancies 
were discovered, as shown in Table 5. Two sets of coupling constants differ substantially 
from the originally reported values for the natural palau’amine. Protons H11 and H12 
have a coupling constant of 14.1 Hz in the natural product, while the corresponding 
coupling constant in synthesized pentacycle 4.46 with the proposed cis aza-
bicyclo[3.3.0]octane is 9.0 Hz. Protons H17 and H18 have a coupling constant of 7.9 Hz 
in the natural palau’amine, while the same set of protons have a 12.0 Hz coupling in 
66
pentacycle 4.46 (Table 5). These findings raised doubts regarding the original structural 
assignments of palau’amine. 
 
Table 5. Coupling constant comparison for palau'amine and pentacycles 4.46 and 4.49 
N
N
O
H
N
HN
O
DMB
O
Cl
OTBDPS
4.49
H2N
6
11
12
1317
18
19
N
N
O
N
HN
O
DMB
O
Cl
OTBDPS
HO
H
4.46  
proton position 
(mult, J Hz) palau'amine
10 pentacycle 4.46 pentacycle 4.49
11 d, 14.1 dd, 5.5, 9.0 dd, 4.0, 9.0 
12 dddd (14.6, 10.2, 9.0, 7.2)36 p, 9.0 p, 9.0 
13α dd, 10.4, 7.3 dd, 9.0, 12.5 dd, 8.0, 12.0 
13β dd, 10.3, 10.4 overlapped H10 t, 12.0 
17 d, 7.9 d, 12.0 d, 12.0 
18 dddd (qd, 9.0, 5.0) 36 m m 
19 dd, 13.2, 7.0 dd, 3.5, 11.0; dd, 7.5, 11.0 
dd, 3.5, 11.0; 
dd, 7.5, 11.0 
 
 
 A close comparison of NOESY data with the original isolation report10 also 
revealed a major discrepancy. For a cis fused aza-bicyclo[3.3.0]octane system, as in the 
originally proposed palau’amine structure, one would expect a strong nOe correlation 
between the two bridge head protons (H11 and H12). This was indeed observed in the 
advanced pentacycle 4.46 containing the cis fused aza-bicyclo[3.3.0]octane structural 
feature (Table 6), however, this important correlation was not reported in the isolation 
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paper. Since the ring fusion between the pyrrolidine and chlorocyclopentane ring 
systems in pentacycle 4.46 was obtained from a Diels-Alder cycloaddition, and with the 
NOESY data observed, it is evident that the two ring systems are cis fused. Hence these 
discrepancies discovered in coupling constant and nOe data suggested that the original 
palau’amine structural assignment could be incorrect. 
 
Table 6. 1D NOESY correlation comparison for palau'amine and pentacycle 4.46 
4.46
N
N
O
H
N
HN
O
O
Cl
OTBDPS
Ar
HO
H
11
12
18
H
19
a H13β
H13α
5
1
6
10
17
H
20
N
N
N O
Cl
NH2
HN
H2N
HO
H
N
N
H2N
H
H
1.46: revised structure
of palau'amine
 
proton position palau'amine36 pentacycle 4.46 
11 6, 13β, 18 12, 13β, 18 
13β 13α, 11, 18 13α, 12 
17 12, 19, 23 13α, 19 
18 11, 13β 12, 19 
 
 
 Recently, palau’amine was reisolated,36 along with the isolation of stylissadine A 
and B by Quinn and co-workers.30 Reexamination of ROESY and coupling constant data 
warranted a structural revision of palau’amine and related congeners (vide supra, 
Chapter I). The comparison of selected nOe correlations are listed in Table 6. Besides 
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the bridge head protons H11-H12 correlation, other major differences include 
correlations between H13β-H11 (1.46), H13β -H12 (4.46), H17-H12 (1.46), H17-H13α 
(4.46), H18-H11 (1.46), H18-H13β (1.46) and H18-H12 (4.46). The observed ROESY 
data clearly support a trans fused aza-bicyclo[3.3.0]octane system and revised C17 
stereochemistry.  
 
E. Conclusion 
 Synthetic efforts toward the intended epi-chloro palau’amine (C17 epimer) 
suffered from substantial difficulties in the early stage pyrrole-acylation studies. Finally 
application of pyrrole-2-carbonyl chloride successfully installed the pyrrole moiety. 
Subsequent transformations afforded advanced pentacyclic intermediate 4.51, possessing 
the whole carbon framework and all but one ring system of palau’amine. After reaching 
pentacycle 4.46, thorough examination of coupling constants and NOESY NMR data 
revealed a few significant discrepancies with the original palau’amine NMR data. 
Coupled with recent structural revision of palau’amine, it was found that advanced 
pentacycle 4.51 for the initial target C17 epi-palau’amine now becomes an intermediate 
for C12 epi-palau’amine. 
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CHAPTER V 
ENANTIOSELECTIVE TOTAL SYNTHESIS OF (+)-PHAKELLIN AND 
(+)-MONOBROMOPHAKELLIN: A CONCISE PHAKELLIN ANNULATION 
STRATEGY FOR PALAU’AMINE SYNTHESIS 
 
A. Introduction 
The phakellins (1.9-1.11) belong to the pyrrole-imidazole family of marine 
alkaloids and are proposed to be derived biosynthetically from oroidin (1.1) and 
congeners (Figure 15).7,8  This family of marine alkaloids has attracted interest from 
both the synthetic and biological perspectives, due to their intriguing structural features 
and, in some cases, potent biological activities (vide supra, Chapter I). The monomeric 
pyrrole-imidazole members (-)-dibromophakellin (1.11) and (-)-monobromophakellin 
(1.10) were initially isolated by Sharma and Burkholder in 1969 from the marine sponge 
Phakellia flabellata15 and subsequently enantiomeric (+)-dibromophakellin (ent-1.11) 
was isolated from Pseudoaxinyssa cantharella in 1985.16 Even though (+)-
monobromophakellin (ent-1.10) and (+)-phakellin (ent-1.9) have not been reported as 
isolates from natural sources, it is reasonable to expect that these alkaloids could be 
existent in nature as well. The phakellstatins (1.12, 1.13) are related members of this 
family bearing a cyclic urea rather than a cyclic guanidine.18 The dimeric oroidin 
alkaloids palau’amine (1.46) and related congeners contain a phakellin subunit within 
their structure. 
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Figure 15. Structure of tetracyclic oroidin alkaloids phakellins and phakellstatins 
 
The concise, biomimetic synthesis of rac-dibromophakellin reported by Büchi 
stands as a benchmark for syntheses of these alkaloids and most subsequent syntheses of 
phakellin have utilized related oxidative cyclization strategies.67 All reported racemic 
syntheses of the dibromophakellstatin have also utilized related strategies.68 We 
previously reported the enantioselective synthesis of (+)-dibromophakellstatin (ent-1.13) 
employing a Hoffman rearrangement to simultaneously introduce the second aminal 
center (C10) and cyclize the incipient isocyanate to deliver the cyclic urea.69  In 
connection with our synthetic efforts toward epi-palau’amine, we have sought expedient 
strategies to annulate the phakellin substructure onto a cyclopentane core (4.18, Scheme 
47). After an advanced pentacyclic intermediate 4.51 was synthesized, concerns 
regarding the projected C-H amination strategy (vide infra) to construct the final ring 
system granted necessity for a model study. Being a substructure of palau’amine, 
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phakellin would be a perfect model for this purpose. Studies on the cyclization of 
guanidine 5.2 would provide valuable information for palau’amine synthesis. In addition, 
the absence of an enantioselective phakellin synthesis in literature added further impetus 
to our synthetic efforts towards phakellins. 
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B. The C-H Amination Strategy 
Direct methods for the amination of C-H bonds have become established tools 
for the assembly of nitrogen-based heterocycles and related amine derivatives.70 Du Bois 
has reported catalytic, oxidative cyclizations of both primary carbamates and sulfamate 
esters to give the corresponding 5- and 6-membered ring products, respectively.71 A 
recent advance in this field reported by the same group showed that stereospecific 
intramolecular cyclization of urea and guanidine derivatives via rhodium (II) catalyzed 
C-H amination gave cyclic ureas and guanidines in high yields (Scheme 48).72  This 
72
methodology is potentially very useful for the synthesis of cyclic urea/guanidine 
containing natural products, such as saxitoxin,73 phakellstatins and phakellins. 
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In our previous studies, we recognized the stability of C6 aminals in these 
tricyclic systems74 and this led us to consider a strategy involving a key C-H amination 
disconnection (N9-C10, Scheme 49) towards phakellin, based on recent work by Du 
Bois,72 employing guanidine 5.2 as a substrate accessible from the known aminal 5.9 
derived from L-proline. This would enable a mild installation of the cyclic guanidine in a 
stereospecific fashion toward phakellins and would also be applicable towards more 
functionalized substrates leading to palau’amine. 
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 1. Synthesis of the C-H Amination Precursor 
 Initially, we set out to synthesize a guanidine substrate 5.12 with a prerequisite of 
obtaining the required cis-arrangement between the guanidine and vicinal C-H bond for 
subsequent intramolecular amination (Scheme 50). Unfortunately, this goal could not be 
reached due to an unexpected epimerization during the 6-step synthetic sequence from 
(L)-proline 5.10, leading to the diastereomeric guanidine 5.11, which was not suitable 
for intramolecular C-H amination.75
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 In an alternative approach to make a guanidine substrate with the required 
stereochemistry, (L)-Proline 5.10 was converted to the known hydroxydipyrrolopyra-
zinone 5.9 in three steps as an inseparable and inconsequential (vide infra) mixture of 
diastereomers, with a ratio of α-OH:β-OH ~ 3:1 (Scheme 51).76,62 Carbinolamines 5.9 
were converted to aminals 5.14/5.15 by azidation with diphenylphosphoryl azide and 
subsequent reduction by hydrogenolysis. Notably, azide 5.13 was obtained as an 
inseparable mixture of diastereomers, however, with a different diastereomeric ratio: α-
N3:β-N3 ~ 3:4. Starting from carbinolamines 5.9 with a 3:1 dr (α-OH:β-OH), one would 
expect a dr of 1:3 (α-N3:β-N3) for the azide products 5.13 after a Mitsunobu type 
azidation process. The ratio of 3:4 for α-N3:β-N3 suggested that epimerization happened 
during the azidation to yield more thermodynamically favored α-N3 product. Fortunately, 
after the azide reduction, the diastereomeric aminals 5.14/5.15 (dr ~3:4) could be 
separated by flash chromatography. They displayed a large and a small coupling 
constant between aminal proton and vicinal proton (Jab = 10.0 Hz and 3.0 Hz), 
respectively.62  
Based on the speculation that the α-N3 diastereomer is thermodynamically 
favored over the β-N3 (vide supra), we attempted to convert β-NH2 aminal 5.15 to the 
thermodynamically favored α-NH2 aminal 5.14 by warming in methanol under weakly 
basic conditions (Scheme 51). This indeed provided the epimerized product 5.14 in 94% 
yield, presumably via a ring-opened imine intermediate 5.16.  
 
 
75
Scheme 51 
H2, Pd/C
MeOH, 20 oC
N
N
O
H
N3DPPA, DBU,
THF, 20 oC
(63%)
N
N
O
Hb
H2N
5.14 (31%)
N
N
O
Hb
H2N
5.15 (39%)
+
K2CO3, MeOH
60 oC (94%)
N
N
O
H
HO
α-OH:β-OH ~ 3:1 α-N3:β-N3 ~ 3:4
N
N
O
H
HNBH
H
N
HO
O
3 steps
5.10
5.9 5.13
5.16
Ha Ha
Jab = 10.0 Hz Jab = 3.0 Hz
 
 
 With an efficient route to the required anti-substituted pyrazinone 5.14 in hand 
for the projected C-H amination, the trichloroethoxysulfonyl (Tces)-protected guanidine 
5.17 was synthesized in two steps via formation of an isothiourea intermediate and 
subsequent conversion of the isothiourea to guanidine 5.17 (Scheme 52).72  
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  The Tces-protected guanidine 5.17 was carefully crystallized via slow 
evaporation of its EtOH solution. The resulting crystals were subjected to X-ray analysis 
and found to be co-crystals of the guanidine 5.17 and EtOH. X-ray structure of 
guanidine 5.17 confirmed its identity and stereochemistry at the aminal carbon center C6 
(C(1A) in Figure 16). 
 
  
Figure 16. Crystal structure of guanidine 5.17 by X-ray crystallography 
 
2. C-H Amination Studies 
 With guanidine 5.17 in hand, we next studied the C-H amination process 
employing conditions reported by Du Bois.72 However, reactions using Rh2(esp)2 
catalyst (Scheme 48) did not give any promising results (Table 7, entry 1-3). It was 
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reasoned that the esp ligands on rhodium (II) are too bulky and therefore hamper the Rh-
nitrene species from approaching the tertiary C-H reaction center. Switching to a less 
bulky rhodium catalyst, i.e. Rh2(OAc)4, did not provide any desired product either 
(Table 7, entry 4-5). After some experimentation, we found that Tces-protected 
phakellin 5.18 could indeed be obtained in relatively low yield employing Rh2(OTFA)4 
as catalyst and CH2Cl2 as solvent under conventional heating or microwave heating 
conditions (Table 1, entry 6-7). CH2Cl2 proved to be a better solvent for this reaction 
compared with aromatic solvent such as benzene, toluene or benzotrifluoride77 (BTF). 
 
Table 7. Studies on C-H amination of guanidine 5.17 
O
H
N
HN
TcesN
N
NN
N
O
H
H
N
H2N
N
Tces
5.18
conditions a
5.17  
entry catalyst solvent heating conditions results 
1 Rh2(esp)2 toluene 40 °C recovered 5.17 
2 Rh2(esp)2 CH2Cl2 40 °C degradation 
3 Rh2(esp)2 BTFb 45 °C recovered 5.17 
4 Rh2(OAc)4 BTF 70 °C recovered 5.17 
5 Rh2(OAc)4 CH2Cl2 70 °C partial rcvd 5.17c
6 Rh2(O2CCF3)4 CH2Cl2 60 °C, 24 h 5.18 (30%)d
7 Rh2(O2CCF3)4 CH2Cl2 μw, 150W, 5 min 5.18 (31%)d
8 Rh2(O2CCF3)4 BTF μw, 200W, 10 min recovered 5.17 
9 Rh2(O2CCF3)4 benzene μw, 150W, 15 min 5.18 (<10%) 
Note: (a) Rhodium (II) catalyst, 2-3 equiv. PhI(OAc)2, 3 equiv. MgO, solvent; (b) benzotrifluoride, or 
α,α,α-trifluorotoluene; (c) partial decomposition; d) with 40-48% starting material recovery. 
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 C. The Oxidative Cyclization Pathway 
In order to better understand the C-H amination reaction so that proper 
conditions could be derived for improving the yield, a control experiment was tested 
without the use of any rhodium (II) catalyst. Interestingly, this experiment revealed that 
the rhodium (II) catalyst was not required for the formation of desired cyclized 
guanidine 5.18 (Scheme 53). This result suggested that rather than a C-H amination 
process, a simple oxidative cyclization mechanism might be operative, in which an 
acyliminium78 intermediate 5.21 was formed upon oxidation of the pyrazinone moiety in 
guanidine 5.17 by iodobenzenediacetate, and subsequent cyclization of the pendent 
guanidine onto the iminium gave the desired cyclic guanidine 5.18.  
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1. Optimizing the Reaction Conditions 
 
Table 8. Screening of the oxidative cyclization conditions 
reagents and conditons
N
N
O
H
NHH2N
NTces
5.17, R = H
R R
NBS,
CH2Cl2
O
H
N
HN
TcesN
N
N
R R
5.18, R = H
5.22, R = Br5.12, R = Br  
entry oxidant solvent heating conditions results 
1 PhI(OAc)2, MgO CH3CN μw, 150W, 10 min 5.18 (38%) 
2 PhI(OAc)2, MgO Tol./CH3CN μw, 150W, 20 min 5.18a
3 PhI(OAc)2 CH3CN 65 °C 5.18 (40%)b
4 PhI(OAc)2, Et3N    CH3CN 20-50 °C no 5.18c
5 PhI(O2CCF3)2 CH3CN 50 °C degradation 
6 IBX DMSO 60 °C no reaction 
7 CAN CH3CN/H2O 20 °C unidentified pdtd
8 Cu(OAc)2 CH3CN 20-65 °C no reaction 
9 PhI(OAc)2 CH3CN μw, 150W, 10 mine trace 5.22 
Note: (a) cleaner reaction, but still low yield; (b) conversion determined by NMR; (c) partially recovered 
5.17; (d) cude NMR showed it was the pyrrole-oxidized product; (e) 5.12 was used. 
 
 Attempts to optimize this oxidative cyclization process by changing solvents and 
reaction temperature (Table 8), did not lead to further improvements in yield and while 
complete conversion of starting materials was typically observed, the cyclized product 
was always accompanied by very polar decomposition products. Several other oxidants 
previously reported for amide oxidations to acyliminium species including 2-
iodoxybenzoic acid (IBX)79, cerium (IV) ammonium nitrate (CAN)80, and copper (II)81 
salts were investigated, however these resulted in either no reaction or primarily 
decomposition. Among the various oxidants and heating conditions studied, the initially 
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employed iodonium benzenediacetate in combination with MgO under microwave 
condition gave the highest yields of Tces-phakellin 5.18 (30-38%). While this reaction 
could be scaled up to 100 mg, a drop of yield to ~20% was observed. Considering that 
the pyrrole is known to be susceptible to oxidation, we also studied the oxidative 
cyclization of dibrominated guanidine 5.12, in hope that the dibrominated pyrrole should 
be less prone to oxidation and therefore render less side products and higher yield of the 
desired product. Disappointingly, this only led to trace amount of Tces-protected 
dibromophakellin 5.22, with mainly decomposition of the starting material (Table 8, 
entry 9). 
 
 2. Studies on Different Protecting Groups 
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According to the mechanistic speculation, a less electron-withdrawing protecting 
group on the pendent guanidine would improve the yield of the oxidative cyclization. 
Boc protecting group, which is a very mild electron withdrawing group compared with 
2,2,2-trichloroethoxysulfonyl (Tces), was studied initially for this purpose. Removal of 
the Tces group from guanidine 5.17 gave free guanidine 5.23 in good yield (Scheme 54). 
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Unfortunately, after unsuccessful attempts on installing the Boc group onto guanidine 
5.23 under various conditions, this route was abandoned. 
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The corresponding Ts-protected guanidine 5.25 was also studied (Scheme 55). 
Initial efforts to convert free guanidine 5.23 to Ts-guanidine 5.25 did not meet with 
success, so we turned to a route analogous to the one used for synthesis of Tces-
guanidine 5.17. Starting from amine 5.14, the isothiourea functionality was installed 
using imidoylchloride 5.26, which was obtained following known procedure72 from 
commercially available N-[bis(methylthio)methylene]-p-toluenesulfonamide. The 
following desulfuration of isothiourea 5.27 yielded Ts-guanidine 5.25. Disappointingly, 
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subjecting Ts-guanidine 5.25 to oxidative cyclization did not yield Ts-protected 
phakellin 5.28 under identical conditions, resulting in extensive degradation of the 
material. 
 
3. Studies on Piperazine-thione and Urea Substrates 
 In another effort to improve the oxidative cyclization reaction, we sought to 
explore the utility of the thio-version of guanidine 5.17, i.e. piperazine-thione 5.29 
(Scheme 56), based on the reasoning that a thio-carbonyl is more nucleophilic than the 
amide carbonyl in piperazinone 5.17 and can be oxidized more easily with iodonium 
type oxidants.82 This would make the oxidation more chemoselective and give better 
yield of the desired product.  
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 Conversion of the amide carbonyl to a thiocarbonyl was achieved by using 
Belleau’s reagent.83 However, the piperazine-thione 5.29 was not stable in the presence 
of oxidant PhI(OAc)2 and decomposed rapidly into very polar materials. Adding Hunig’s 
base (diisopropylethylamine) to the reaction, according to literature example on a similar 
type of reaction,68d  helped to prevent the rapid decomposition of the starting material 
5.29, but the major product observed was the piperazinone 5.17. 
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 Based on the results obtained from oxidative cyclization reactions, we envisioned 
that urea 5.31 would be worth studying for the synthesis of (+)-phakellstatin (ent-1.12, 
Scheme 57). This would provide a very efficient synthetic pathway for (+)-phakellstatin 
and (+)-dibromophakellstatin. Urea 5.31 could be obtained from amine 5.14 by reaction 
with trichloroacetyl isocyanate and subsequent cleavage of the trichloroacetyl group. 
Unfortunately, the oxidative cyclization did not work on this substrate, instead 
generating a complex reaction mixture and no signs of the desired phakellstatin 1.12 
were observed from NMR data. 
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 4. Mechanistic Speculation 
 As proposed previously, one possible mechanistic scenario of the oxidative 
cyclization involves trapping of an acyliminium 5.21, generated by oxidation of the 
vinylogous urea 5.17 with PhI(OAc)2, by the pendant guanidine (Scheme 53). If this 
pathway was valid, we would expected that C6 diastereomer of Tces-guanidine 5.17 
(5.32, Scheme 58) would give the opposite enantiomer of the cyclized product 5.18 (ent-
5.18), regardless of the stereochemistry at C10.    
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 Guanidine 5.32 was easily accessed from amine 5.15, C6 diastereomer of amine 
5.14, via the two-step procedure mentioned before. Interestingly, under the same 
oxidative conditions, the diastereomeric guanidine 5.32 did not provide Tces-protected  
(-)-phakellin. This result may point to the necessity of an intramolecular deprotonation 
by the pendant guanidine (Scheme 59), instead of intermolecular deprotonation. This 
mode of cyclization proceeding through an acyl iminium species is reminiscent of 
intermediates proposed by Al-Mourabit for interconversion of dibromoisophakellin and 
ugibohlin (Scheme 59, inset).84
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D. Synthesis of (+)-Phakellin and (+)-Monobromophakellin 
 Removal of the 2,2,2-trichloroethoxysulfonyl group from N-Tces-phakellin 5.18 
under reductive conditions (Scheme 60) afforded (+)-phakellin (ent-1.9) after 
purification by preparative, reverse phase HPLC. The synthetic material exhibited 
spectral data that correlated well with the reported data (Table 9).16
 
Table 9. Comparison of synthetic (+)-phakellin data and literature data 
reported16 synthetic
400 MHz: 8.54 (3H), 7.18 (1H), 6.90 (1H),
6.40 (1H), 6.12 (1H), 3.82(1H),
3.71 (1H), 2.39 (2H), 2.22 (2H)
500 MHz: 7.15 (1H), 6.93 (1H),
6.41 (1H), 6.08 (1H), 3.82 (1H),
3.68 (1H), 2.42 (2H), 2.22 (2H) a
IR (cm-1) (KBr): 1680, 1580, 1390
1H-NMR
(CD3OD,
ppm)
(thin f ilm): 1697, 1552, 1383
[α]D +5 (0.81, CH3OH) +5.6 (0.90, CH3OH)
MS (EI) M+: 231 (ESI) M+H+: 232.1191 (calc. 232.1198)
a: NH2 and NH peak not seen due to relative large amount of H2O
(+)-phakellin
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O
H
N
HN
TcesN
N
N
5.18 ent-1.9: (+)-phakellin
O
N
HN
H2N N
N
O
H
N
HN
TcesN
N
N
5.22
Br Br
O
N
HN
H2N N
N
Br
ent -1.10: (+)-monobromophakellin
Zn, AcOH
MeOH, 40 oC
(85%)
NBS, CH3CN
(84%)
Zn, AcOH
MeOH, 40 oC
(67%)
 
 
Bromination of N-Tces-phakellin 5.18 with NBS cleanly provided N-Tces-
dibromophakellin 5.22. Subsequent reduction with zinc in acidic methanol gave (+)-
monobromophakellin (ent-1.10) resulting from cleavage of the Tces group and selective 
cleavage of the C5-bromo substituent.85 Attempts to remove Tces group selectively 
using SmI2 was unsuccessful, leading to the same result mentioned above. The spectral 
and optical rotation data for our synthetic material correlated well with published data 
for (-)-monobromophakellin (hydrochloride salt) (synthetic ent-1.10: [α]D +112.5; 
literature15 1.10:  [α]D -123) with the exception of the sign of rotation. Since there is no 
data reported in literature for (+)-monobromophakellin, a comparison of spectral data 
was done with the enantiomeric (-)-monobromophakellin15 (Table 10). 
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Table 10. Comparison of synthetic (+)-monobromophakellin data and literature data 
reported a synthetic
9.87 (2H), 8.52 (2H), 7.46 (1H),
6.80 (1H), 6.08 (1H), ...(1H) b,
3.50 (1H), 2.13-2.50 (2H), 2.06 (2H)
9.94 (2H), 8.49 (2H), 7.46 (1H),
6.79 (1H), 6.05 (1H), 3.63 (1H),
3.54 (1H) c, 2.15-2.40 (2H), 2.01-2.08 (2H)
IR (cm-1) d (KBr): 3300, 1650, 1590,1480, 1420, 932, 618
1H-NMR
(DMSO-d6,
ppm)
(thin film): 3284, 1640, 1575
1481, 1421, 927, 610
[α]D -123 (3.015, CH3OH) +112.5 (0.10, CH3OH)
(+)-monobromo-
phakellin.HCl
a: (-)-monobromophakellin hydrochloride: Sharma, G.; Magdoff -Fairchild, B. J. Org. Chem. 1977, 42, 4118.
b: value in the ref erence was 6.35, which apparently was a mistake.
c: the peak partially overlapped with water peak.
d: free base without hydrochloride
MS (EI) M+: 309 (ESI) M+H+: 310.0302 (calc. 310.0303)
 
 
E. Conclusion 
 The first enantioselective total synthesis of two members of the phakellin family 
of pyrroloimidazole alkaloids, i.e. (+)-phakellin and (+)-monobromophakellin, has been 
accomplished. The synthesis relies on a unique oxidative cyclization from a chiral 
tricyclic guanidine precursor (5.17) and results in a highly concise, enantioselective 
route to these targets (9 steps to (+)-phakellin; 10 steps to (+)-monobromophakellin from 
commercially available (L)-proline). The synthesis was 6 steps (7 steps for ent-1.10) in 
total from the known intermediate 5.9, with the overall yield of ~10%, averaging 68% 
yield per step. Since the oxidative cyclization was a stereospecific process, the optical 
antipodes of these alkaloids would be accessible using (D)-proline as starting material.  
Importantly, this annulation process is a valuable contribution to palau’amine synthetic 
efforts as it provides an expedient annulation strategy onto cyclopentane precursors. 
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CHAPTER VI 
STUDIES TOWARD THE REVISED STRUCTURE OF PALAU’AMINE  
AND A UNIFIED STRATEGY TOWARD  
THE PALAU’AMINES AND AXINELLAMINES 
 
A. Introduction 
We proposed an approach to the originally accepted structures of palau’amine 
and axinellamine that involved a common synthetic intermediate derived from a Diels-
Alder reaction (Chapter III, Scheme 15). The projected routes then diverged to address 
the difference in stereochemistry of the substituents on the central chlorocyclopentane 
ring systems of palau’amine and axinellamine. An intermolecular chlorination followed 
by selective epimerization at C12 would provide an intermediate with the required 
stereochemistry for axinellamine, while an intramolecular chlorination would give us 
access to the previously accepted cis azabicyclo[3.3.0]octane core structure of 
palau’amine. Disappointingly, our endeavors to realize the proposed intramolecular 
chlorination of the Diels-Alder adduct met with no success, and we opted instead to 
pursue the synthesis of epi-chloro palau’amine (Chapter IV, Scheme 30). This C17 
epimer of palau’amine (4.3) features an inverted stereochemistry at the chlorine bearing 
carbon center, which could easily be accessed through an intermolecular chlorination 
pathway. An advanced pentacyclic intermediate (4.51) was accessed in 14 steps from the 
Diels-Alder adduct 2.34, setting the stage for the projected C-H amination to construct 
the final ring system of palau’amine (Scheme 61). To test this strategy, the first 
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enantioselective synthesis of (+)-phakellin (ent-1.9) was pursued, as it would provide 
valuable information for palau’amine synthesis. Though the synthesis of phakellin was 
accomplished via a different type of cylization, i.e., oxidative cyclization instead of 
intramolecular C-H insertion (vide supra, Chapter V), this pathway is also applicable 
towards palau’amine synthesis. 
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 The recent structural revision of palau’amine however, prompted us to reconsider 
our initial strategy towards palau’amine, as the stereochemistry of two carbon centers on 
the cyclopentane core was revised (Figure 8, Chapter I), opposite to what was accepted 
for 14 years since the 1993 isolation report.34-37  Comparing the advanced intermediate 
4.51, which was originally intended for C17 epi-palau’amine synthesis, with the revised 
structure of palau’amine (ent-1.46, absolute stereochemistry still not determined), it is 
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easy to see that the chlorine-bearing C17 actually has the correct stereochemistry while 
the stereochemistry of C12 needs to be inverted (Scheme 62).  
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 The revised palau’amine structure has a highly strained trans-fused azabicyclo- 
[3.3.0]octane moiety, which is rarely seen in literature.37  Therefore the initial challenge 
of our new synthetic plan is to build a highly strained trans-fused five-five bicyclic 
system (6.2). Once this unusual structure is obtained, the following phakellin annulation 
could take advantage of the chemistry developed for phakellin synthesis, to give a 
hexacyclic advanced intermediate 6.1, which possesses all the necessary components for 
palau’amine. Late stage guanidinylation and deprotection would then deliver 
palau’amine.  
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B. Strategies toward the Revised Structure 
 The rarely seen trans-fused azabicyclo[3.3.0]octane structure presents a 
significant challenge for our synthesis. Entry into this unusual ring system directly via a 
Diels-Alder cycloaddition was no longer a suitable option. Due to the very limited 
known methods to generate this type of structures,86 either a complete overhaul of 
synthetic plan, or an elaboration of the current strategy was necessary. Now that the 
relative stereochemical arrangement of the substituents on the cyclopentane core of 
palau’amine is identical to that of axinellamine, another target of interest in our 
laboratories, we can apply part of the methods used for axinellamine synthesis, namely 
the C12 epimerization method,87  to the new palau’amine target.  
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 Our initial thoughts on strategies to construct the trans-azabicyclo[3.3.0]octane 
system involved an intramolecular SN2 cyclization to form spiro tricycle 6.2, after 
epimerization of the C12 (Scheme 63, Route 1). However, whether this seemingly 
straightforward strategy will work is questionable, as there is no literature precedent of 
using similar type of reactions to build trans-fused five-five bicyclic structures. In 
addition, molecular models of the epimerized intermediate 6.3 also suggest that approach 
of the sulfonamide nitrogen to the carbon bearing a tosylate leaving group in an SN2 
fashion is unlikely to happen.  
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Figure 17. Comparison of the molecular models of cis-fused and trans-fused six-five 
systems (protecting groups removed for clarity) 
 
 Another approach is to form the trans-fused five-six bicyclic system 6.4 first, 
which should be much easier than building a trans-fused five-five bicyclic system, and 
93
make the chlorinated spirocycle subsequently (Scheme 63, Route 2). The major concern 
of this route is the stereoselectivity of the oxidation/chlorination. Diels-Alder adduct 
2.34 has a distinctive cup-shaped molecular conformation, as shown in the simplified 
model 6.5 (Figure 17). The shape of the molecule only allows the oxidant and 
chlorinating reagent to approach the corresponding reaction centers from the convex face, 
yielding spirocycle 2.36 as the only observed stereoisomer. Once the C12 is epimerized, 
the molecular shape will change drastically to a relatively flat conformation, as shown in 
the simplified model 6.6 (Figure 17). This change of molecular shape could result in low 
diastereoselectiviy for the oxidation/chlorination sequence. 
 Preliminary results from the studies on the second route were not encouraging, as 
we encountered difficulties on epimerization of C12 in Diels-Alder adduct 2.34. 
Alternatively, our attention was directed to the original synthesis of racemic 
dibromophakellin (rac-1.11) by Büchi and co-workers.67 The synthesis took advantage 
of an oxidative cyclization process to rapidly assemble the tetracyclic oroidin alkaloid  
rac-1.11 from the acyclic dihydrooroidin 6.7 (Scheme 64). Two decades later, Horne 
and co-workers applied the same strategy on the synthesis of racemic 
dibromophakellstatin (rac-1.13) from an acyclic imidazolone precursor 6.8.68a Since a 
phakellin moiety resides in the palau’amine skeleton, this method of making 
dibromophakellin hints a promising strategy applicable to palau’amine synthesis. A 
similar reaction pathway was actually proposed by Al-Mourabit and Potier as a possible 
biogenesis of palau’amine (Chapter I, Scheme 2).8  
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Al-Mourabit’s biosynthetic proposal for palau’amine prompted us to reconsider 
our initial common intermediate strategy towards palau’amine and axinellamine, and 
allowed us to design another common-intermediate-type synthetic plan (Scheme 65) in 
which the point of divergence would occur at a much later stage compared with the 
original strategy (Chapter III, Scheme 15). As the revised structure of palau’amine 
shares the same cyclopentane moiety with axinellamine, we envisioned a late stage 
intermediate 6.9 (Scheme 65) that would possess all the necessary carbon framework of 
both structures. C12 epimerization could be achieved from spirocycle 2.36 via a known 
method developed in our studies towards axinellamine synthesis.87 Subsequent 
imidazolone formation and pyrrole-acylation would incorporate the two necessary 
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functionalities for oxidative cyclizations (path a). With the common intermediate 6.9 in 
hand, the two natural products would then be accessed through different modes of 
oxidative cyclization, building on proposals by Al-Mourabit and Potier.8
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C. Synthesis of a Common Intermediate 
 Starting from tricycle 2.36, obtained from the oxidation/chlorination of Diels-
Alder adduct 2.34 as described before, selective removal of the TIPS protecting group 
over TBDPS yielded alcohol 6.10. After treatment of alcohol 6.10 with potassium tert-
butoxide in methanol (Scheme 66) and heating the reaction to 65 °C for 12 h, C12-
epimerized ester 6.11, which features the fully functionalized cyclopentane core of both 
palau’amine and axinellamine, was pleasingly isolated in good yield.87  With epimerized 
96
ester 6.11 in hand we then applied a 3-step sequence to generate imidazolone 6.13 in 
good yield. Dess-Martin oxidation of the free alcohol moiety of 6.11 produced the 
corresponding aldehyde quantitatively. Treatment of the aldehyde intermediate with 
tosylethylamine (TseNH2) smoothly formed an imine intermediate 6.12, which was then 
directly treated with triphosgene in the presence of triethylamine in THF at 65oC, 
providing the desired imidazolone 6.13 in 45-65 % yield over the three steps after flash 
chromatography purification. 
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 Reduction of the methyl ester 6.13 with DIBAl-H proceeded smoothly at low 
temperature and delivered the corresponding primary alcohol 6.14 quantitatively and in 
sufficient purity to be used directly for the following step (Scheme 67). Conversion of 
the primary alcohol into its corresponding tosylate 6.15, and subsequent SN2 
displacement of the tosylate functionality by azide anion afforded azide 6.16. Use of 
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DPPA under Mitsunobu conditions on alcohol 6.14 only led to the isolation of a 
phosphate. Treatment of azide 6.16 with excess samarium diiodide accomplished both 
the reduction of azide64 and the removal of imidazolone tosyl protecting group, leaving 
the tosylethyl groups unaffected. Primary amine 6.17 was then acylated with pyrrole-2-
carbonyl chloride61 generating the pyrrole-imidazolone intermediate 6.18, which is a 
viable precursor to palau’amine via intramolecular oxidative bis-cyclization (vide supra). 
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D. Conclusion 
 The synthesis of an advanced bio-inspired common intermediate 6.18 toward 
palau’amine, axinellamine and potentially styloguanidine and massadine was 
accomplished. Building on our previous work, spirocyclopentane 2.36 (obtained from 
Diels-Alder adduct 2.34 via oxidation/chlorination/ring contraction) was concisely 
converted to imidazolone 6.13 through a C12 epimerization and a three-step cyclization 
sequence. Elaboration of one of the chlorocyclopentane side-chains then efficiently 
delivered pyrrole 6.18, a suitable precursor not only for the palau’amine synthesis, but 
also for axinellamine synthesis. 
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CHAPTER VII 
CONCLUSION 
 
In summary, our synthetic efforts towards palau’amine and related oroidin-
alkaloids have been a rewarding adventure with many interesting chemistry being 
discovered and advanced synthetic intermediates being reached. After unsuccessful 
studies on obtaining the chlorine bearing C17 stereochemistry for the originally 
proposed palau’amine structure, we shifted our synthetic efforts toward the epi-chloro 
palau’amine (C17-epimer 4.3, Figure 18). An advanced pentacyclic intermediate 4.51 
bearing the whole carbon framework of palau’amine was synthesized from the Diels-
Alder adduct 2.34 via a 14-step sequence. After reaching this stage, thorough 
examination of the coupling constants and NOESY data revealed some significant 
discrepancies with the original palau’amine isolation data. In light of recent structural 
revision of palau’amine, it was found that pentacycle 4.51 actually has correct 
stereochemistry at C17 but wrong stereochemistry at C12. 
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In a model study of the phakellin annulation strategy for palau’amine synthesis, 
the first enantioselective total synthesis of two members of the phakellin family of 
pyrroloimidazole alkaloids, i.e., (+)-phakellin (ent-1.9) and (+)-monobromophakellin 
(ent-1.10), was accomplished. The synthesis relies on a unique oxidative cyclization 
from a chiral tricyclic guanidine precursor (5.17) and results in a highly concise, 
enantioselective route to these targets. Importantly, these results were valuable 
contributions to palau’amine synthesis as it provides an expedient annulation strategy 
onto cyclopentane precursors. 
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With the revised palau’amine structure, we envisioned a common intermediate 
synthetic plan towards palau’amine, axinellamine and related congeners. The synthesis 
of an advanced bio-inspired common intermediate 6.18 was accomplished through a 10-
step sequence starting from spirocyclopentane 2.36 (Scheme 68). 
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CHAPTER VIII 
EXPERIMENTAL PROCEDURES 
 
General Information  
All non-aqueous reactions were carried out under a nitrogen atmosphere in oven-
dried (120 °C) glassware unless noted otherwise. Tetrahydrofuran (THF, EM Science) 
and diethyl ether (Et2O, EM Science) were distilled prior to use from sodium metal. 
Methylene chloride (or dichloromethane, CH2Cl2, EM Science) and benzene (PhH, EM 
Science) were distilled from calcium hydride prior to use. Methanol (MeOH, EM 
Science) was distilled from magnesium methoxide. N,N-Dimethylformamide (DMF, 
ACROS) and methyl sulfoxide (DMSO, ACROS)  were used as purchased (extra dry, 
with molecular sieves, water<50 ppm). Alternatively, solvents (THF, CH2Cl2, CH3CN, 
toluene) used for reations were obtained from a solvent purification system using 
activated molecular sieves drying column (MBRAUN solvent purification system). 
Triethylamine (Et3N), 2,6-lutidine, pyridine and diisopropylethylamine (DIEA, Hünig’s 
base) were distilled from calcium hydride or potassium hydroxide prior to use. Brine 
refers to a saturated water solution of sodium chloride. Rochelle’s salt solution refers to 
2 M aqueous solution of sodium potassium tartrate. Solutions of dimethyldioxirane 
(DMDO)42 in acetone, 2-iodoxybenzoic acid (IBX)88 and pyrrole-2-carbonyl chloride61 
were prepared according to literature procedures. All other commercially available 
reagents were used as received unless specified otherwise. 
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1H-NMR chemical shifts are reported as δ values in ppm relative to solvent 
standard chemical shifts (CDCl3: 7.26 ppm, benzene-d6: 7.16 ppm, DMSO-d6: 2.50, 
CD3CN: 1.94, CD3OD: 3.31 ppm).89  1H-NMR coupling constants (J) are reported in 
Hertz (Hz), and multiplicity is indicated as follows: s (singlet), d (doublet), t (triplet), q 
(quartet), m (multiplet), bs (broad singlet), dd (doublet of doublets), dt (doublet of 
triplets), and so on. 13C-NMR chemical shifts are reported as δ values in ppm relative to 
solvent standard chemical shifts.89  1H-NMR and 13C-NMR spectra were obtained on a 
Varian Inova-300, Mercury-300, or Varian Inova-500 spectrometer.  Infrared spectra 
were recorded with a Nicolet Impact 410 FTIR spectrometer, or with a Bruker Tensor® 
27 FTIR sepectrometer.  Mass spectra were obtained on a VG analytical 70S high 
resolution, double focusing, sectored (EB) mass spectrometer (for FAB), a MDS Sciex 
(Concord, Ontario, Canada) API Qstar Pulsar (for ESI), or a ThermoFinnigan (San Jose, 
California) LCQ Deca Mass Spectrometer (for APCI) at the Mass Spectrometry 
Application and Collaboration Facility (Texas A&M University).  Flash column 
chromatography was performed using 60Å Silica Gel (EM Science, 230-400 mesh) as a 
stationary phase. Thin layer chromatography (TLC) was performed using silica gel 
60F254 glass TLC plates (EMD Chemicals Inc., 250 μm layer thickness).  Enantiomeric 
excess (ee) was determined by HPLC analysis (RAININ SD-200 with DYANMAX UV-
C DETECTOR) using a Chiralpak® AD column.  Microwave reactions were carried out 
in a CEM® ExplorerTM/DiscoverTM microwave system. Reverse phase preparative HPLC 
was carried out on a BECKMAN COULTER® HPLC system. 
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Experimental Procedures 
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Imidazolone ester 2.27: To a stirred solution of ester 2.2590 (3.80 g, 26.7 mmol) in 200 
mL of DMF at 25 °C was added 80% sodium hydride (722 mg, 24.1 mmol), the 
resulting mixture was stirred for 15 mins.  To the slurry was added dropwise a solution 
of 1,2-di-p-toluenesulfonylethylene46 (6.30 g, 18.7 mmol) in 100 mL of DMF. Stirring 
was continued for 13 h, the reaction was cooled to 0 °C and then ethyl acetate (200 mL) 
and water (200 mL) were added to quench the reaction.  The organic layer was washed 
with water (6 X 100 mL) and dried (MgSO4).  Solvents were removed in vacuo and the 
crude solid was purified by dissolving the impurties in ethyl acetate and filtering the 
residue to afford the Tsv protected imidazolone ester 2.37 (3.41 g, 56%) as a tan-
greenish powder. 2.37: Rf = 0.45 (8% MeOH/CH2Cl2); 1H-NMR (300 MHz, CDCl3) δ = 
~8.0 (bs, 1H), 7.76-7.81 (m, 3H), 7.34 (d, 2H), 7.06 (s, 1H), 6.79 (d, 1H), 3.88 (s, 3H), 
2.45 (s, 3H); IR (thin film) 1637, 1700, 2850 cm-1. 
To a solution of ester 2.37 (13.35 g, 41.4 mmol) in 300 mL of DMF at 25 °C was 
added potassium carbonate (6.30 g, 45.6 mmol), followed by DMBCl91 (8.10 g. 43.5 
mmol).  The reaction was warmed to 60 °C and stirring continued for 16 h, on cooling to 
25 °C the reaction was diluted with 200 mL of ethyl acetate and washed with water (6 X 
100 mL).  The organic layer was dried (MgSO4).  Solvents were removed in vacuo to 
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afford the ester 2.27 (19.56 g, 99%) which was of sufficient purity to be taken onto the 
next step without purification. A small sample of crude 2.27 was taken and purified by 
flash chromatography for analysis (silica gel, EtOAc/hexanes, 2/5) affording ester 2.27 
as a colorless foam: Rf = 0.31 (EtOAc/hexanes, 2/5); IR (Neat) 3073, 2843, 1716, 1632, 
cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.79 (d, J = 14.0 Hz, 1H), 7.77 (d, J = 8.0 Hz, 2H), 
7.32 (d, J = 8.0 Hz, 2H), 7.12 (s, 1H), 6.97 (d, J = 2.0 Hz, 1H), 6.91 (dd, J = 8.5, 2.0 Hz, 
1H), 6.85 (d, J = 14.0 Hz, 1H), 6.76 (d, J = 8.5 Hz, 1H), 5.13 (s, 2H), 3.84 (s, 3H), 3.83 
(s, 3H), 3.80 (s, 3H), 2.43 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 159.1, 151.3, 148.8, 
148.6, 144.5, 137.8, 132.9, 130.0, 129.3, 127.5, 120.8, 117.0, 116.6, 115.8, 111.7, 110.9, 
55.9, 55.8, 52.1, 45.4, 21.6; HRMS (ESI) calcd for C23H25N2O7S [M+H]: 473.1382; 
found: 473.1410. 
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Allylic alcohol 2.28: To a stirred solution of crude ester 2.27 (19.56 g, 41.4 mmol) in 
400 mL of THF/H2O (v/v; 3/1) at 25 °C was added LiOH (1.14 mg, 47.5 mmol) stirring 
continued for 2 h and then THF was removed in vacuo.  EtOAc (400 mL) was added and 
the mixture extracted (the organic phase was discarded).  1M HCl (500 mL) was added 
to the aqueous phase and extracted with EtOAc (3 X 500 mL).  Organic layers were 
combined and dried (MgSO4).  Solvents were removed in vacuo and the crude acid 2.38 
isolated as a yellow foam (18.20 g, 96%): Rf = 0.15 (EtOAc); 1H-NMR (300 MHz, 
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CDCl3) δ= 7.77-7.85 (m, 3H), 7.32 (d, 2H), 7.24(s, 1H), 6.87-6.98 (m, 3H), 6.75 (d, 1H), 
5.14 (s, 2H), 3.83 (s, 3H), 3.80 (s, 3H), 2.44 (s, 3H); IR (thin film) 1631, 1712 cm-1. 
The crude acid 2.38 (18.10 g, 39.5 mmol) was dissolved in 400 mL of THF and 
0.5 mL of DMF at 25 °C, oxalyl chloride (3.70 mL, 43.4 mmol) was added dropwise to 
the solution and the mixture was stirred for 1h.  The reaction mixture was cooled to -78 
°C and LiBH4 in THF (2M, 59.2 mL, 118.4 mmol) was added dropwise.  The reaction 
mixture was stirred for 2 h, 100 mL of H2O was added to quench the reaction and then 
THF was removed in vacuo.  EtOAc (500 mL) was added and the mixture extracted.  
1M HCl (500 mL) was added to the aqueous phase and extracted with EtOAc (3 X 500 
mL).  Organic layers were combined and dried (MgSO4).  Solvents were removed in 
vacuo and the crude alcohol 2.28 (17.08 g, 97%) isolated as a yellow solid which was of 
sufficient purity to be taken onto the next step without purification.  A small amount was 
purified by flash chromatography for analysis (SiO2, EtOAc/hexanes, 2/5) to afford 
alcohol 2.28 as a yellow solid.  Rf = 0.14 (EtOAc/hexanes, 4/1); 1H-NMR (500 MHz, 
CDCl3) δ 7.80 (d, J = 14.0 Hz, 1H), 7.75 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 
6.85 (d, J = 2.0, 1H), 6.81 (dd, J = 8.0, 2.0 Hz, 1H), 6.77 (d, J = 8.0 Hz, 1H), 6.46 (d, J = 
14.0 Hz, 1H), 6.31 (s, 1H), 4.87 (s, 2H), 4.29 (s, 2H), 3.827 (s, 3H), 3.825 (s, 3H), 2.50 
(br s, 1H), 2.42 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 152.2, 149.5, 149.0, 144.6, 
138.5, 133.9, 130.2, 129.0, 127.5, 127.4, 120.1, 113.2, 111.4, 111.1, 105.4, 56.2, 56.1, 
55.3, 45.2, 21.8; IR (film) 3466, 1711 cm-1; HRMS (ESI) calcd for C22H25N2O6S [M+H]: 
445.1407. Found: 445.1407. 
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Ethyl ester 2.29: To a solution of activated manganese dioxide (heated with heat gun 
under vacuum) (32.4 g, 373 mmol) in 60 mL of dichloromethane at 25 °C was added a 
solution of allylic alcohol 2.28 (13.8 g, 31.0 mmol) in 400 mL of dichloromethane. The 
resulting solution was stirred for 12 h and filtered through a pad of Celite®. Solvents 
were removed in vacuo and the crude aldehyde 2.39 (9.90 g, 72%) was isolated as a 
yellow solid: Rf = 0.63 (EtOAc); IR (thin film) 2937, 2837, 1672, 1731 cm-1; 1H-NMR 
(300 MHz, CDCl3) δ= 9.38 (s, 1H), 7.78-7.83 (m, 3H), 7.33 (d, 2H), 7.15 (s, 1H), 6.97-
7.05 (m, 3H), 6.76 (d, 1H), 5.13 (s, 2H), 3.85 (s, 3H), 3.84 (s, 3H), 2.44 (s, 3H). 
A solution of triethylphosphonoacetate (4.78 mL, 24.1 mmol) in 100 mL of THF 
was cooled to 0 °C and treated with 80% NaH (658 mg, 21.9 mmol), allowed to warm to 
25 °C and stirred for an additional 40 min.  The resulting solution was added dropwise to 
a solution of crude aldehyde 2.39 (9.70 g, 21.9 mmol) in 300 mL of THF and stirring 
was continued for 30 min.  The reaction was quenched with 50 mL of pH 4 buffer 
solution.  THF was removed in vacuo and the aqueous phase was extracted with EtOAc 
(3 X 300 mL). The organic layers were combined and dried (MgSO4).  Solvents were 
removed in vacuo and the crude ester 2.29 isolated as a yellow oil (13.2 g).  A small 
amount was taken and purified by flash chromatography for analysis (silica gel, 40% 
EtOAc/hexanes) to afford ester 2.29 as a colorless foam. Rf = 0.41 (EtOAc/hexanes, 2/3); 
IR (film) 3120, 2937, 2838, 1712 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.87 (d, J = 14.0 
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Hz, 1H), 7.79 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 8.5 Hz, 2H), 7.22 (d, J = 16.0 Hz, 1H), 
6.80-6.76 (m, 4H), 6.67 (d, J = 14.0 Hz, 1H), 6.14 (d, J = 16.0 Hz, 1H), 4.89 (s, 2H), 
4.20 (q, J = 7.0 Hz, 2H), 3.85 (s, 3H), 3.84 (s, 3H), 2.43 (s, 3H), 1.28 (t, J = 7.0 Hz, 3H);  
13C-NMR (125 MHz, CDCl3) δ 166.1, 151.8, 149.6, 149.1, 144.7, 138.7, 133.2, 130.2, 
128.8, 128.3, 127.7, 124.3, 119.7, 119.7, 115.3, 111.5, 110.6, 108.5, 61.2, 56.2, 56.1, 
45.5, 21.9, 14.4; HRMS (ESI) calcd for C26H29N2O7S [M+H]: 513.1695. Found: 
513.1692. 
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Diene 2.30: To a stirred solution of crude ester 2.29 (13.2 g, 25.8 mmol) in 400 mL of 
THF/H2O (v/v; 3/1) at 25 °C was added LiOH (788 mg, 32.9 mmol) and stirring was 
continued for 12h and then THF was removed in vacuo.  EtOAc (150 mL) was added 
and the mixture extracted, the organic phase was discarded. 1M HCl (150 mL) was 
added to the aqueous phase and extracted with EtOAc (3 x 300 mL).  Organic layers 
were combined and dried (MgSO4). Solvents were removed in vacuo and the crude acid 
2.40 was isolated as a yellow solid (8.10 g, 76%).   
Due to the instability of the diene, a portion of the acid 2.40 (1.0 g, 2.06 mmol) 
was dissolved in 100 mL of THF at 0 °C, to the solution was added triethylamine (288 
μL, 2.06 mmol), followed by methyl chloroformate (174 μL, 2.06 mmol) and the 
mixture was stirred for 15 min, or until TLC indicated complete formation of the mixed 
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anhydride.  The reaction mixture was cooled to -78 °C and LiBH4 in THF (2M, 2.06 mL, 
4.13 mmol) was added dropwise.  The reaction mixture was stirred for 15 min, 50 mL of 
H2O was added to quench the reaction and solvents were removed in vacuo.  
Dichloromethane (100 mL) was added and the mixture extracted.  1M HCl (100 mL) 
was added to the aqueous phase and extracted with CH2Cl2 (3 X 200 mL).  The organic 
layers were combined and dried (MgSO4) and solvents were removed in vacuo and the 
crude alcohol 2.30 (972.0 mg, 99%) isolated as a yellow foam.  Rf = 0.16 (EtOAc);  1H-
NMR (500 MHz, benzene-d6) δ = 8.11 (d, J = 14.0 Hz, 1H), 7.82 (d, J = 8.0 Hz, 2H), 
6.80 (d, J = 2.0 Hz, 1H), 6.77-6.73 (m, 4H), 6.48 (d, J = 8.0 Hz, 1H), 6.02 (dd, J = 16.0, 
1.0 Hz, 1H), 5.74 (dt, J = 16.0, 2.0 Hz, 1H), 5.45 (s, 1H), 4.55 (s, 2H), 3.77 (dd, J = 4.5, 
2.0 Hz, 2H), 3.40 (s, 3H), 3.30 (s, 3H), 1.86 (s, 3H); 13C-NMR (125 MHz, benzene-d6) δ 
151.7, 150.3, 149.8, 143.3, 140.1, 133.6, 132.7, 129.8, 129.75, 129.7, 125.9, 119.8, 
114.9, 113.9, 112.1, 111.8, 102.9, 62.3, 55.5, 55.4, 44.7, 21.0; IR (film) 3391, 3063, 
2935, 1721 cm-1; HRMS (ESI) calcd for C24H27N2O6S [M+H]: 471.1590.  Found: 
471.1609. 
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Tsv/DMB Diels-Alder adduct 2.32: To a solution of crude diene 2.30 (10.0 mg, 0.020 
mmol) in 1.0 mL of benzene at 25 °C in a sealed tube was added dienophile 2.3 (9.0 mg, 
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0.020 mmol), followed by 2,6-lutidine (1.85 μL, 0.016 mmol).  The resulting solution 
was stirred for 24 h at 95 °C.  Further portions (10.0 mg, 0.02 mmol) of crude 2.30 were 
added every 24 h until 4 equivalents had been added.  Solvents were removed in vacuo 
and the crude oil was purified by passing through a plug of silica gel (washing with 
EtOAc) to afford recovered dienophile 2.3 (5.0 mg) and a single Diels-Alder 
regioisomer as a colorless oil (~80% purity).  
A solution of the Diels-Alder adduct in 3 mL of dichloromethane at 25 °C was 
treated with TBDPSCl (3.20 μL, 0.011 mmol), followed by triethylamine (1.7 μL, 0.012 
mmol) and DMAP (catalytic).  After 24 h at 25 °C, solvents were removed in vacuo and 
the crude oil was purified by flash chromatography (SiO2, 30% EtOAc/hexanes) to 
afford silyl ether 2.32 (11.5 mg, 48%) as a clear oil: Rf = 0.73 (EtOAc/hexanes, 2/3);  
1H-NMR (500 MHz, benzene-d6) δ = 7.93 (d, J = 8.5 Hz, 2H), 7.79 (s, 2H), 7.76-7.73 (m, 
4H), 7.65 (d, J = 8.5 Hz, 2H), 7.27-7.24 (m, 6H), 6.88 (d, J = 2.0 Hz, 1H), 6.85 (d, J = 
8.5 Hz, 2H), 6.71 (dd, J = 8.0, 2.0 Hz, 1H), 6.61 (d, J = 8.5 Hz, 2H), 6.55 (d, J =8.0 Hz, 
1H), 4.68 (d, J = 15.0 Hz, 1H), 4.27 (dd, J = 10.5, 3.5 Hz, 1H), 4.23 (dd, J = 7.0, 3.5 Hz, 
1H), 4.19 (d, J = 8.0 Hz, 2H), 3.97 (dd, J =10.5, 7.0 Hz, 1H), 3.68 (d, J = 15.0 Hz, 1H), 
3.43 (s, 3H), 3.36 (s, 3H), 3.29 (dd, J = 6.0, 3.0 Hz, 1H), 3.20 (m, 1H), 2.13 (ddd, J = 
16.0, 5.0, 1.5 Hz, 1H), 1.95 (s, 3H), 1.88 (ddd, J = 16.0, 11.0, 3.0 Hz, 1H), 1.84 (s, 3H), 
1.71 (m, 1H), 1.17-1.13 (m, 30H); 13C-NMR (125 MHz, benzene-d6) δ 172.4, 151.9, 
150.5, 150.1, 145.0, 143.6, 140.0, 135.8, 135.4, 133.7, 133.6, 132.4, 130.1, 130.0, 129.5, 
129.2, 128.1, 127.5, 127.4, 123.9, 120.3, 116.6, 112.14, 112.09, 112.07, 64.8, 64.5, 62.4, 
55.6, 55.5, 44.5, 41.4, 36.7, 34.3, 27.0, 21.3, 21.0, 19.8, 19.3, 18.3, 18.2, 12.0; IR (film) 
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2941, 2864, 1723 cm-1; HRMS (ESI) calcd for C61H78N3O10S2Si2 [M+H]: 1132.4667. 
Found: 1132.4666. 
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Spirocycle 2.36: A solution of TBDPS-protected Diels-Alder adduct 2.34 (500 mg, 
0.440 mmol) and magnesium sulfate (100 mg) in 40 mL of dichloromethane was cooled 
to –50 °C and treated with dimethyldioxirane (0.06M in acetone, 8.1 mL, 0.48 mmol) 
after 3 h the reaction was quenched with 100 μL of methyl sulfide. Solvents were 
removed in vacuo to afford crude allylic alcohol 2.35 (500 mg, 99%) as a colorless foam.   
The crude allylic alcohol 2.35 was redissolved in 40 mL of dichloromethane and 
cooled to –50 °C.  Cyclohexene (223 μL, 2.20 mmol) was added, followed by 
magnesium sulfate (100 mg) and chloramine-T (200 mg, 0.88 mmol).  The reaction 
mixture was allowed to warm to 25 °C, and then stirred for a total of 12 h.  The reaction 
was quenched with 20 mL of water and the aqueous layer was extracted with CH2Cl2 (3 
X 50 mL).  The organic layers were combined, dried (MgSO4), concentrated in vacuo, 
and the crude oil was purified by flash chromatography (SiO2, EtOAc/hexanes, 1:3) to 
afford cyclopentane 2.36 as a colorless foam (339 mg, 65%).  Rf = 0.72 (60% 
EtOAc/hexanes); [α]D -33.6 (c 1.17, CH2Cl2); IR (film) 3067, 2859, 1776, 1723 cm-1; 
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1H-NMR (500 MHz, benzene-d6) δ 8.26 (d, J = 8.5 Hz, 2H), 7.96-7.94 (d, J = 8.0, 2.0 
Hz, 2H), 7.88 (d, J = 8.5 Hz, 2H), 7.81-7.79 (m, 2H), 7.46 (d, J = 2.0 Hz, 1H), 7.39 (dd, 
J = 8.0, 2.0 Hz, 1H), 7.28-7.20 (m, 6H), 6.84 (d, J = 8.5 Hz, 2H), 6.77 (d, J = 8.5 Hz, 
2H), 6.39 (d, J = 8.0 Hz, 1H), 5.87 (d, J = 16.0 Hz, 1H), 4.90 (s, 1H), 4.74 (d, J = 16.0 
Hz, 1H), 4.55 (t, J = 10.0 Hz, 1H), 4.50 (d, J = 12.5 Hz, 1H), 4.23 (dd, J = 10.0, 2.0 Hz, 
1H), 4.11 (m, 2H), 3.96 (t, J = 8.0 Hz, 1H), 3.80 (d, J = 8.0 Hz, 1H), 3.79-3.73 (m, 1H), 
3.62 (s, 3H), 3.58-3.53 (ddd, J = 15.0, 9.0, 3.0 Hz, 1H), 3.39-3.34 (ddd, J = 15.5, 7.0, 3.0 
Hz, 1H), 3.27 (s, 3H) 3.26-3.21 (ddd, J = 15.0, 9.0, 3.0 Hz, 1H), 2.95-2.90 (ddd, J = 15.5, 
7.0, 3.0 Hz, 1H), 1.87 (s, 3H), 1.84 (s, 3H), 1.20 (s, 9H), 0.98-0.90 (m, 21H); 13C NMR 
(125 MHz, benzene-d6) δ 173.23, 171.70, 156.73, 150.18, 149.81, 144.91, 144.73, 
136.37, 136.16, 135.95, 135.73, 133.82, 133.60, 129.83, 129.80, 129.76, 129.73, 129.57, 
129.41, 129.05, 129.03, 127.96, 126.62, 121.42, 112.93, 112.05, 76.67, 65.35, 61.09, 
60.47, 59.86, 55.67, 55.23, 50.49, 49.03, 48.47, 47.15, 45.92, 33.29, 26.98, 21.08, 21.03, 
19.41, 18.09, 18.03, 12.09; HRMS (ESI) calcd for C61H78ClN3O11S2Si2 [M+Li]: 
1190.4465, found: 1190.4477. 
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Tosylate 3.12: To a mixture of alcohol 3.4 (35 mg, 0.039 mmol) and TsCl (11 mg, 0.059 
mmol) was added anhydrous CH2Cl2, followed by triethylamine (~80 μL, excess). Let 
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stand at 20 °C and stirred vigorously. After 36 h, the reaction mixture was extracted with 
CH2Cl2 (3 X 10 mL) and H2O (10 mL). The organic layer was washed with sat’d 
NaHCO3 and brine, and then dried over Na2SO4. Purification by column chromatography 
(silica gel, 50 Æ 80% EtOAc/Hexane) afforded tosylate 3.12 as a colorless foam (35 mg, 
85%). Rf = 0.61 (EtOAc); [α]D -48.0 (c 1.00, CH2Cl2); IR (thin film) 2940, 2863, 1742, 
1690 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.75 (d, J = 8.0 Hz, 4H), 7.60 (d, J = 
8.0 Hz, 2H), 6.97 (d, J = 2.0 Hz, 1H), 6.81 (dd, J = 8.0, 2.0 Hz, 1H), 6.72 (d, J = 8.0 Hz, 
2H), 6.68 (d, J = 8.0 Hz, 2H), 6.65 (d, J = 8.0 Hz, 2H), 6.60 (d, J = 8.0 Hz, 1H), 4.58 (d, 
J = 15.5 Hz, 1H), 4.47 (dd, J = 8.0, 10.0 Hz, 1H), 4.38 (dd, J = 7.0, 10.0 Hz, 1H), 4.32 
(m, 2H), 4.04-4.17 (m, 4H), 3.88 (m, 1H), 3.74 (d, J = 6.5 Hz, 1H), 3.60 (s, 3H), 3.37 (s, 
3H), 3.22 (dd, J = 3.0, 7.0 Hz, 1H), 2.86 (dt, J = 4.0, 14.0 Hz, 1H), 2.06 (dd, J = 4.0, 
15.0 Hz, 1H), 1.92 (s, 3H), 1.86 (s, 3H), 1.85 (s, 3H), 1.76 (m, 1H), 1.17-1.20 (m, 21H); 
13C-NMR (125 MHz, benzene-d6) δ 172.83, 153.76, 150.50, 149.74, 144.78, 144.38, 
144.20, 137.76, 135.92, 133.94, 130.19, 129.86, 129.71, 129.43, 128.21, 128.03, 127.82, 
127.54, 119.89, 119.05, 114.32, 112.32, 111.88, 70.85, 66.60, 65.39, 64.59, 63.95, 59.93, 
55.75, 55.49, 52.77, 44.34, 41.77, 36.32, 34.82, 34.31, 30.86, 30.09, 21.16, 21.05, 21.01, 
19.73, 18.20, 18.19, 12.15; HRMS (ESI) calculated for C52H67N3O12S3Si [M+Li]: 
1056.3816. Found: 1056.3789. 
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Amine 3.13: To the tosylate 3.12 (18.5 mg, 0.0176 mmol) in a dry flask was added 
NaN3 (12 mg, 0.176 mmol) and anhydrous DMF (0.6 mL). The reaction vessel was 
purged with nitrogen and sealed with a polyethylene stopper (yellow cap). The reaction 
mixtures was heated to 100 °C and stirred for 16 h. Added water to the reaction mixture 
and extracted with CH2Cl2/H2O. The organic layer was washed with brine and dried over 
Na2SO4. Azide 3.13a was obtained in sufficient purity (16 mg, 99%) for next step 
reaction after removal of solvent in vacuo.  
To a mixture of azide 3.13a (38 mg, 0.041 mmol) and triphenylphosphine (54 mg, 
0.20 mmol) in a dry flask was added THF (0.8mL), followed by water (25 μL). The 
reaction mixture was stirred vigorously at 20 °C. After 12 h, the reaction was stopped. 
Solvent was removed in vacuo and azotroped with benzene. The crude mixture was 
subjected to silica gel column purification (2 Æ 5% MeOH/CH2Cl2) to yield amine 3.13 
(27.3 mg, 75%). Rf  = 0.19 (7% MeOH/ CH2Cl2); 1H-NMR (500 MHz, benzene-d6) δ = 
7.84 (d, J = 8.5 Hz, 2H), 7.63 (d, J = 8.5 Hz, 2H), 7.01 (d, J = 2.0 Hz, 1H), 6.84 (dd, J = 
2.0, 8.0 Hz, 1H), 6.75 (d, J = 8.5 Hz, 2H), 6.65 (d, J = 8.5 Hz, 2H), 6.62 (d, J = 8.0 Hz, 
1H), 4.83 (d, J = 15.5 Hz, 1H), 4.37-4.43 (m, 2H), 4.13-4.22 (m, 3H), 4.05 (d, J = 15.5 
Hz, 1H), 3.94 (m, 1H), 3.88 (d, J = 6.0 Hz, 1H), 3.58 (s, 3H), 3.50 (dd, J = 6.5, 3.0 Hz, 
1H), 3.36 (s, 3H), 3.00 (dd, J = 12.5, 8.0 Hz, 1H), 2.83 (m, 1H), 2.71 (m, 1H), 2.06 (dd, 
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1H), 1.94 (s, 3H), 1.79-1.85 (m, 4H), 1.19-1.22 (m, 21H); MS (M+H): 895 (molecular 
unit mass C45H62N4O9S2Si: 894).  
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Sulfonamide 3.5: To a mixture of amine 3.13 (27 mg, 0.030 mmol) and p-
toluenesulfonyl chloride (21 mg, excess) was added CH2Cl2 solvent (0.6 mL), followed 
by the addition of triethylamine (0.10 mL, excess). The reaction mixture was stirred at 
20 °C for 20 h (the reaction mixture turned from light yellow color to brown). After the 
reaction time, the mixture was partitioned between CH2Cl2 and H2O. The organic layer 
was washed with sat’d NaHCO3 and brine and dried over Na2SO4. Silica gel column (50 
Æ 75% EtOAc/Hexane) purification afforded sulfonamide 3.5 as a white solid (26 mg, 
83%). Rf = 0.48 (80% EtOAc/Hexane); [α]D -31.5 (c 0.80, CH2Cl2); IR (thin film) 2945, 
2868, 2361, 1690 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.79 (d, J = 8.0 Hz, 2H), 
7.77 (d, J = 8.0 Hz, 2H), 7.64 (d, J = 8.0 Hz, 2H), 7.03 (d, J = 2.0 Hz, 1H), 6.87 (dd, J = 
8.0, 2.0 Hz, 1H), 6.82 (d, J = 8.0 Hz, 2H), 6.73-6.76 (m, 4H), 6.64 (d, J = 8.0 Hz, 1H), 
4.94 (t, J = 6.5 Hz, 1H), 4.69 (d, J = 15.5 Hz, 1H), 4.35-4.38 (m, 2H), 4.10-4.24 (m, 4H), 
3.91 (dt, J = 14.0, 6.0 Hz, 1H), 3.84 (d, J = 7.0 Hz, 1H), 3.65 (s, 3H), 3.39 (s, 3H), 3.28 
(dd, J = 7.0, 3.0 Hz, 1H), 3.17-3.26 (m, 2H), 2.86 (dt, J = 14.0, 4.0 Hz, 1H), 2.11 (dd, J 
= 15.0, 3.5  Hz, 2H), 1.97 (s, 3H), 1.94 (s, 3H), 1.88 (s, 3H), 1.72 (m, 1H), 1.19-1.21 (m, 
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21H); 13C NMR (125 MHz, benzene-d6) δ 173.64, 153.81, 150.44, 149.67, 144.94, 
144.25, 142.79, 138.17, 137.79, 135.83, 130.30, 129.75, 129.67, 129.53, 128.20, 127.59, 
127.33, 119.94, 114.48, 112.31, 111.93, 65.29, 64.63, 55.83, 55.50, 52.74, 45.15, 44.35, 
42.83, 36.32, 35.14, 34.78, 30.08, 21.20, 21.02, 20.50, 18.23, 18.22, 18.10, 12.17, 12.08; 
HRMS (ESI) calculated for C52H68N4O11S3Si [M+Li]: 1055.3976. Found: 1055.3530.  
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Alcohol 3.18: To a solution of chlorocyclopentane 3.17 (4.0 mg, 0.0036 mmol) in 
anhydrous THF (0.15 mL) was added TBAF (1.0 M solution in THF, 8 μL, 0.008 mmol) 
at -12 °C. The reaction was stirred at -12 °C for 1h. Water (5 mL) was added to the 
reaction and the resulting mixture was partitioned between water and CH2Cl2 (3 X 10 
mL). The combined organics was washed with brine and dried over Na2SO4. After 
removal of solvent in vacuo, the crude product was purified by silica gel column (50 Æ 
60% EtOAc/Hexanes) to yield the deprotected alcohol 3.18 (4 mg, 99%): Rf = 0.32 (60% 
EtOAc/Hexanes); IR (thin film) 2919, 2853, 1716, 1153 cm-1; 1H-NMR (500 MHz, 
benzene-d6) δ 8.07 (d, J = 8.0 Hz, 2H), 7.87 (d, J = 8.0 Hz, 2H), 7.67 (d, J = 8.0 Hz, 2H), 
7.42 (d, J = 2.0 Hz, 1H), 7.38 (dd, J = 2.0, 8.0 Hz, 1H), 6.82 (d, J = 8.0 Hz, 2H), 6.73 (d, 
J = 8.0 Hz, 2H), 6.71 (d, J = 8.0 Hz, 2H), 6.56 (d, J = 8.0 Hz, 1H), 5.72 (d, J = 16.0 Hz, 
1H), 5.47 (t, J = 7.0 Hz, 1H), 4.72 (s, 1H), 4.58 (d, J = 16.0 Hz, 1H), 4.32 (d, J = 12.5 
116
Hz, 1H), 3.85 (m, 1H), 3.68 (s, 3H), 3.63 (m, 2H), 3.37-3.44 (m, 3H), 3.33 (s, 3H), 3.18-
3.24 (m, 2H), 3.06 (m, 1H), 2.89 (m, 1H), 1.87 (s, 3H), 1.85 (s, 3H), 1.79 (s, 3H), 0.68 
(bs, 1H); 13C-NMR (125 MHz, benzene-d6) δ 173.64, 171.57, 156.71, 150.31, 150.06, 
145.41, 144.66, 142.55, 138.07, 135.97, 135.13, 129.94, 129.60, 129.52, 129.48, 129.16, 
128.80, 127.39, 121.42, 112.87, 112.82, 112.24, 76.42, 63.48, 61.30, 60.60, 55.74, 55.29, 
50.62, 47.53, 47.07, 46.43, 45.87, 41.49, 33.18, 30.08, 21.09, 20.97; MS (ESI) calcd for 
C43H47ClN4O12S3: 942; found [M+Li]: 949. 
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Lactam 3.22: To a solution of the Diels-Alder adduct 3.4 (20 mg, 0.022 mmol) in 
anhydrous THF (0.2 mL) was added samarium diiodide (0.1 M solution in THF, 0.45 
mL, 0.045 mmol) at 0 ºC, until the reaction mixture stayed blue. After 15 min at 0 ºC the 
reaction was quenched with sat’d NaHCO3. The mixture was extracted with EtOAc. The 
organic layer was washed with water and brine, and dried over Na2SO4. Solvent was 
removed in vacuo to afford the free lactam 3.22 in high purity (12 mg, 73%). Rf = 0.17 
(EtOAc); [α]D -21.26 (c 1.25, CH2Cl2), IR (thin film) 3239, 2940, 2866, 1682, 1652 cm-1; 
1H-NMR (500 MHz, benzene-d6) δ = 7.64 (d, J = 8.0 Hz, 2H), 7.01 (d, J = 2.0 Hz, 1H), 
6.81 (dd, J = 8.0, 2.0 Hz, 1H), 6.70 (d, J = 8.0 Hz, 2H), 6.52 (d, J = 8.0 Hz, 1H), 6.48 (bs, 
1H), 5.48 (d, J = 10.0 Hz, 1H), 4.56 (d, J = 15.5 Hz, 1H), 4.44 (d, J = 15.5 Hz, 1H), 
117
4.04-4.11 (m, 1H), 3.95-4.02 (m, 3H), 3.80-3.86 (m, 1H), 3.69-3.71 (m, 2H), 3.60 (d, J = 
7.0 Hz, 1H), 3.54 (s, 3H), 3.35 (s, 3H), 3.23 (t, J = 5.0 Hz, 1H), 3.01-3.05 (dt, J = 4.5, 
14.0 Hz, 1H), 2.95 (dd, J = 7.5, 3.5 Hz, 1H), 2.83-2.88 (m, 1H), 2.15-2.19 (dd, J = 4.5, 
16.0 Hz, 1H), 1.85 (s, 3H), 1.70-1.75 (m, 1H), 1.10-1.15 (m, 21H); 13C-NMR (125 MHz, 
benzene-d6) δ 178.16, 154.02, 150.44, 149.68, 144.29, 137.77, 130.66, 129.79, 128.35, 
120.10, 119.86, 115.25, 112.28, 112.05, 65.86, 65.47, 60.16, 55.72, 55.55, 53.42, 45.68, 
44.46, 37.21, 36.26, 35.91, 21.17, 19.85, 18.31, 18.30, 12.25; HRMS (ESI) calculated 
for C38H55N3O8SSi [M+H]: 742.3557, found: 742.3552.  
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Initial Diels-Alder adduct 3.27a: To a mixture of dienophile 2.3 (24 mg, 0.057 mmol), 
diene 2.33 (68 mg, 0.14 mmol) and LiClO4 (~1 mg, 0.01 mmol) in anhydrous benzene 
(0.5 mL) was added 2,6-lutidine (5 μL, 0.043 mmol). The reaction vial was sealed and 
heated to 90 °C. After 12 h reaction time, the reaction mixture was cooled to 20 °C and 
filtered to remove excess amount of unreacted diene 2.33. The filtrate was concentrated 
in vacuo and purified by flash column (silica gel, 40 Æ 60% EtOAc/Hexanes) to yield 
the initial Diels-Alder adduct 3.27a along with its regioisomer (41 mg, 81%). The 
inseparable mixture of regioisomers was taken onto the subsequent TBDPS protection 
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reaction, and the resulting TBDPS-protected products could be separated by column 
chromatography. 
 A pure sample of initial Diels-Alder adduct 3.27a was obtained by the following 
procedure92: to a mixture of diene 2.33 (42 mg, 0.089 mmol) and cerium trichloride (11 
mg, 0.044 mmol) in anhydrous benzene (0.50 mL) was added iPrMgCl (2.0 M in THF, 
0.050 mL, 0.10 mmol) at 0 °C. The mixture was allowed to warm to 20 °C. After 20 min 
at 20 °C, a solution of dienophile 2.3 (38 mg, 0.089 mmol) in benzene (0.40 mL) was 
added to the reaction mixture and the reaction was heated to 80 °C for 96 h. Upon 
completion of the reaction time, the reaction was quenched with water (10 mL) and 
extracted with EtOAc (3 X 10 mL). The combined organics was washed with water and 
brine, and dried over Na2SO4. After solvent removal in vacuo, the crude product was 
subjected to column purification (Silica gel, 50 Æ 75% EtOAc/Hexanes) to afford the 
initial Diels-Alder adduct 3.27a (15 mg, 19%) and the rearranged adduct 3.4 (14 mg, 
18%). 3.27a: Rf = 0.72 (EtOAc); [α]D -84.7 (c 1.00, CH2Cl2); IR (thin film) 3519, 2940, 
2858, 1726, 1675 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.92 (d, J = 8.0 Hz, 2H), 
7.73 (d, J = 8.0 Hz, 2H), 6.98 (d, J = 2.0 Hz, 1H), 6.86 (dd, J = 8.0, 2.0 Hz, 1H), 6.78 (d, 
J = 8.0 Hz, 2H), 6.75 (d, J = 8.0 Hz, 2H), 6.64 (d, J = 8.0 Hz, 1H), 4.83 (d, J = 15.5 Hz, 
1H), 4.50 (t, J = 3.5 Hz, 1H), 4.31(m, 1H), 4.19-4.22 (m, 1H),  4.13-4.18 (dt, J = 5.5, 
14.5 Hz, 1H), 4.09-4.12 (dd, J = 5.5, 10.5 Hz, 1H), 3.98 (dd, J = 2.5, 10.0 Hz, 1H), 3.78 
(d, J = 15.5 Hz, 1H), 3.70-3.74 (m, 2H), 3.62-3.66 (m, 1H), 3.60 (s, 3H), 3.49-3.55 (m, 
1H), 3.32 (s, 3H), 3.06-3.10 (m, 1H), 2.90-2.95 (m, 3H), 1.83-1.88 (m, 7H), 1.11-1.17 
(m, 21H); 13C-NMR (125 MHz, benzene-d6) δ 174.73, 158.50, 150.58, 149.73, 144.59, 
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144.54, 137.37, 137.23, 136.48, 129.90, 129.55, 129.16, 128.72, 119.63, 112.54, 111.51, 
92.46, 66.09, 62.89, 60.35, 55.70, 55.47, 54.32, 52.63, 44.79, 44.65, 38.37, 36.52, 35.73, 
21.06, 21.04, 18.21, 18.16, 12.18; HRMS (ESI) calculated for C45H61N3O10S2Si [M+Li]: 
902.3728. Found: 902.3766.  
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TBDPS-protected initial adduct 3.27: To a solution of initial Diels-Alder adduct 3.27a 
(33 mg mixture of 3.27a and its regioisomer, 0.037 mmol) in CH2Cl2 was added 
triethylamine (8 μL, 0.055 mmol), followed by TBDPSCl (11 μL, 0.041 mmol) and 
catalytic amount of DMAP. The reaction mixture was stirred at 20 °C for 12 h, and then 
concentrated in vacuo. The crude product was purified by flash column chromatography 
(silica gel, 20 Æ 40% EtOAc/Hexanes) to afford the TBDPS silylether 3.27 as a 
colorless foam (25 mg, 60%): Rf = 0.74 (60% EtOAc/Hexanes); IR (thin film) 2940, 
2858, 1726, 1680 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 8.02 (d, J = 8.0 Hz, 2H), 
7.83 (d, J = 8.0 Hz, 2H), 7.75-7.77 (m, 4H), 7.21-7.28 (m, 6H), 6.98 (d, J = 2.0 Hz, 1H), 
6.81 (dd, J = 8.0, 2.0 Hz, 1H), 6.78 (d, J = 8.0 Hz, 2H), 6.75 (d, J = 8.0 Hz, 2H), 6.59 (d, 
J = 8.0 Hz, 1H), 4.93 (d, J = 15.0 Hz, 1H), 4.49-4.53 (dd, J = 10.0, 8.5 Hz, 1H), 4.39 (t, 
J = 3.5 Hz, 1H), 4.36(m, 1H), 4.05-4.16 (m, 5H),  3.58 (s, 3H), 3.52-3.56 (m, 1H), 3.48 
(d, J = 15.0 Hz, 1H), 3.39-3.43 (m, 1H), 3.32 (s, 3H), 3.22-3.25 (dd, J = 9.0, 3.5 Hz, 1H), 
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2.97-3.04 (m, 2H), 2.31 (m, 1H), 1.86 (s, 3H), 1.85 (s, 3H), 1.17 (s, 9H), 1.11-1.16 (m, 
21H); 13C-NMR (125 MHz, benzene-d6) δ 172.91, 158.39, 150.58, 149.67, 144.49, 
144.20, 137.17, 137.11, 137.01, 136.01, 135.87, 134.06, 134.01, 129.92, 129.88, 129.87, 
129.57, 129.14, 128.61, 128.23, 128.02, 127.99, 119.69, 112.38, 111.53, 93.22, 66.42, 
63.78, 59.23, 55.68, 55.47, 54.03, 52.39, 44.70, 42.36, 39.52, 36.57, 36.32, 27.06, 21.05, 
19.43, 18.23, 18.21, 18.17, 12.17; MS (MALDI): (M+H) 1134, (M+Na) 1156, (M+K) 
1172; HRMS (ESI) calcd for C61H79N3O10S2Si2 [M+Li]: 1140.4905. Found: 1140.4898.  
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Allylic alcohol 3.28: To a stirred slurry of TBDPS silylether 3.27 (6.0 mg, 0.0053 mmol) 
and MgSO4 (~50 mg) in anhydrous CH2Cl2 (0.30 mL) was added dimethyl dioxarane 
(DMDO, 0.07 M solution in acetone, 0.083 mL, 0.0058 mmol) at -78 °C. The reaction 
was stirred for 1h at -78 °C, then warmed to 20 °C and filtered. After concentration of 
the filtrate in vacuo, the crude product was subjected to column purification (silica gel, 
40 Æ 60% EtOAc/Hexanes) to afford the allylic alcohol 3.28 as a colorless foam (5 mg, 
83%): Rf = 0.44 (60% EtOAc/Hexanes); IR (thin film) 2925, 2858, 1737, 1690 cm-1; 1H-
NMR (500 MHz, benzene-d6) δ = 7.69-7.75 (m, 6H), 7.61 (d, J = 8.0 Hz, 2H), 7.19-7.22 
(m, 7H), 7.11 (dd, J = 8.0, 2.0 Hz, 1H), 6.75 (d, J = 8.0 Hz, 2H), 6.61 (d, J = 8.0 Hz, 1H), 
6.59 (d, J = 8.0 Hz, 2H), 4.92 (d, J = 15.0 Hz, 1H), 4.83-4.87 (dd, J = 10.5, 9.0 Hz, 1H), 
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4.76 (d, J = 15.0 Hz, 1H), 4.69 (dt, J = 9.0, 3.0 Hz, 1H), 4.36-4.40 (m, 2H), 4.22-4.28 (m, 
1H), 4.06-4.15 (m, 3H), 3.85 (dd, J = 7.0, 2.5 Hz, 1H), 3.80-3.85 (m, 1H), 3.69 (d, J = 
3.0 Hz, 1H), 3.55 (s, 3H), 3.38 (s, 3H), 3.15 (dd, J = 6.5, 3.5 Hz, 1H), 2.92-2.96 (m, 1H), 
2.07-2.13 (m, 1H), 1.89 (s, 3H), 1.88 (s, 3H), 1.13-1.17 (m, 21H), 1.11 (s, 9H); 13C-
NMR (125 MHz, benzene-d6) δ 172.41, 153.97, 150.06, 149.42, 144.92, 143.98, 137.71, 
135.79, 135.76, 132.87, 132.66, 131.22, 130.33, 130.27, 129.78, 129.52, 127.51, 127.38, 
121.94, 120.70, 115.12, 112.77, 112.13, 66.10, 65.18, 64.93, 63.96, 55.51, 55.42, 52.76, 
45.70, 44.61, 41.58, 36.89, 34.74, 30.08, 27.02, 26.91, 21.09, 19.13, 18.18, 18.15, 12.11; 
HRMS (MALDI) calcd for C61H79N3O11S2Si2 [M+H]: 1150.4773, found: 1150.4745; 
calcd [M+Na]: 1172.4592, found 1172.4604.  
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Iodospirohydantoin 3.37: To a slurry of allylic alcohol 2.35 (55.0 mg, 0.048 mmol) and 
MgSO4 (~100 mg) in CH2Cl2 at -50 °C was added N-iodosuccinimide (13.0 mg, 0.058 
mmol). The reaction was allowed to warm to 20 °C slowly and stirring was continued 
for 16 h. The reaction mixture was then filtered and the filtrate was concentrated in 
vacuo. Column purification (silica gel, 20 Æ 30% EtOAc/Hexanes) afforded the 
iodocyclopentane 3.37 as a colorless foam: 32.0 mg (52%): Rf = 0.39 (40% 
EtOAc:hexanes); [α]D –25.8 (c 1.03, CH2Cl2); IR (thin film) 2935, 2858, 1716 cm-1; 1H-
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NMR (500 MHz, benzene-d6) δ 8.26 (d, J = 8.0 Hz, 2H), 7.97 (m, 2H), 7.87 (d, J =8.0 
Hz, 2H), 7.83 (m, 2H), 7.48 (d, J = 2.0 Hz, 1H), 7.35 (dd, J = 2.0, 8.0 Hz, 1H), 7.20-7.29 
(m, 6H), 6.84 (d, J =8.0 Hz, 2H), 6.77 (d, J =8.0 Hz, 2H), 6.38 (d, J =8.0 Hz, 1H), 5.85 
(d, J = 16.0 Hz, 1H), 4.89 (s, 1H), 4.63 (d, J = 16.0 Hz, 1H), 4.60 (t, J = 10.0 Hz, 1H), 
4.39 (d, J = 13.5 Hz, 1H), 4.25 (dd, J = 2.0, 11.0 Hz, 1H), 4.19 (dd, J = 4.0, 10.0 Hz, 1H), 
4.14 (d, J = 11.0 Hz, 1H), 3.89 (m, 1H), 3.81 (d, J = 8.5 Hz, 1H), 3.63 (s, 3H), 3.56-3.61 
(m, 2H), 3.43 (m, 1H), 3.31 (s, 3H), 3.24 (m, 1H), 2.94 (m, 1H), 1.88 (s, 3H), 1.85 (s, 
3H), 1.21 (s, 9H), 0.91-0.99 (m, 21H); 13C-NMR (125 MHz, benzene-d6) δ 174.48, 
171.74, 156.60, 150.30, 150.01, 144.84, 144.68, 136.42, 136.18, 136.01, 135.70, 133.78, 
133.62, 130.39, 129.81, 129.76, 129.55, 129.10, 129.06, 128.20, 128.01, 127.95, 127.82, 
122.14, 113.79, 112.18, 77.86, 65.42, 61.42, 61.24, 55.68, 55.32, 50.56, 50.36, 48.59, 
48.44, 45.84, 33.25, 30.08, 26.99, 25.96, 21.06, 21.02, 19.40, 18.11, 18.05, 12.11; 
HRMS (MALDI) calcd for C61H78IN3O11S2Si2 [M+Na]: 1298.3559; found: 1298.3560. 
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Iodocyclopentane 3.39: To a solution of iodocyclopentane 3.37 (11.0 mg, 0.0086 mmol) 
in THF (0.20 mL) was added HF⋅pyridine (70%, 50 μL, excess) at 20 °C. After 21 h, the 
reaction was quenched with saturated NaHCO3 (1 mL) and H2O (3 mL) and extracted 
with EtOAc (3 X 10 mL). The combined organic layers were washed with brine and 
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further dried over Na2SO4. After removal of solvent, the crude product was purified by 
flash column chromatography (silica gel, 60 Æ 80% EtOAc/hexanes) to give alcohol 
3.39 as a colorless film (5.6 mg, 74%): Rf = 0.22 (60% EtOAc/hexanes); [α]D –35.2 (c 
1.00, CH2Cl2); IR (thin film) 3493, 2925, 1711 cm-1; 1H-NMR (500 MHz, benzene-d6) δ 
8.06 (d, J = 8.0 Hz, 2H), 7.84 (d, J =8.0 Hz, 2H), 7.41 (dd, J = 2.0, 8.0 Hz, 1H), 7.35 (d, 
J = 2.0 Hz, 1H), 6.83 (d, J = 8.0 Hz, 2H), 6.69 (d, J = 8.0 Hz, 2H), 6.57 (d, J = 8.0 Hz, 
1H), 5.62 (d, J = 16.0 Hz, 1H), 4.77 (s, 1H), 4.72 (d, J = 13.0 Hz, 1H), 4.47 (d, J = 16.0 
Hz, 1H), 4.02 (m, 1H), 3.91 (m, 2H), 3.73 (s, 3H), 3.66-3.72 (m, 2H), 3.48-3.52 (m, 1H), 
3.43 (d, J = 9.0 Hz, 1H), 3.35 (s, 3H), 3.18-3.23 (m, 1H), 3.10 (dd, J = 9.0, 6.0 Hz, 1H), 
3.06 (t, J = 9.0 Hz, 1H), 2.96 (m, 1H), 1.86 (s, 3H), 1.77 (s, 3H), 1.36 (s, 1H), 1.06 (s, 
1H); 13C-NMR (125 MHz, benzene-d6) δ 175.30, 174.26, 169.91, 156.60, 150.37, 150.09, 
145.27, 144.82, 135.90, 135.27, 130.20, 129.90, 129.51, 129.28, 128.80, 128.20, 127.56, 
122.29, 113.73, 112.38, 77.66, 63.70, 61.60, 59.93, 59.08, 55.71, 55.37, 50.78, 49.39, 
49.35, 47.45, 45.93, 33.12, 31.82, 30.09, 26.33, 22.91, 21.06, 21.05, 20.41, 14.21, 14.08; 
HRMS (ESI) calcd for C36H40IN3O11S2 [M+Li]: 888.1309; found: 888.1329. 
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Lactam 3.42: To a solution of iodocyclopentane 3.39 (3.7 mg, 0.0042 mmol) in THF 
(0.10 mL) was added SmI2 (0.1 M solution in THF, 130 μL, 0.013 mmol) at 0 °C. After 
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30 min, a further portion of SmI2 (0.10 mL) was added. The blue reaction mixture was 
stirred at 20 °C for 10 min. The reaction was then quenched with saturated NaHCO3 (2 
mL) and extracted with EtOAc (3 X 10 mL). The combined organic layers were washed 
sequentially with water and brine, and then dried over Na2SO4. Removal of solvent 
afforded lactam 3.42 as a colorless film and of sufficient purity for subsequent reactions 
(3.0 mg, 99%): Rf = 0.14 (EtOAc); [α]D +23.5 (c 1.00, CH2Cl2); IR (thin film) 3345, 
2925, 1711 cm-1; 1H-NMR (500 MHz, benzene-d6) δ 7.82 (d, J = 8.0 Hz, 2H), 7.27 (d, J 
= 2.0 Hz, 1H),7.12 (dd, J = 2.0, 8.0 Hz, 1H), 6.81 (d, J = 8.0 Hz, 2H), 6.61 (d, J = 8.0 Hz, 
1H), 5.31 (s, 1H), 4.97 (d, J = 16.0 Hz, 1H), 4.66 (d, J = 12.5 Hz, 1H), 4.42 (bs, 1H), 
4.16 (d, J = 12.5 Hz, 1H), 4.06 (d, J = 16.0 Hz, 1H), 3.95 (m, 1H), 3.74 (s, 3H), 3.60-
3.65 (m, 1H), 3.51-3.56 (m, 1H), 3.38 (s, 3H), 3.33 (t, J = 4.5 Hz, 1H), 3.18 (d, J = 8.5 
Hz, 1H), 3.10-3.15 (m, 3H), 2.98 (m, 1H), 2.90 (m, 1H), 2.68 (t, J = 8.5 Hz, 1H), 1.85 (s, 
3H), 1.32 (bs, 1H); 13C-NMR (125 MHz, benzene-d6) δ 178.02, 174.52, 156.83, 150.45, 
150.06, 144.83, 135.93, 130.05, 129.88, 128.73, 128.39, 127.37, 121.51, 113.31, 112.27, 
77.35, 65.16, 59.93, 59.18, 55.46, 50.79, 48.46, 48.16, 47.40, 45.31, 33.04, 30.08, 26.91, 
21.04, 14.21, 14.15, 14.08; HRMS (MALDI) calcd for C29H34IN3O9S [M+H]: 728.1139, 
found: 728.1118. 
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Azidocyclopentane 3.46: To a mixture of iodocyclopentane 3.37 (10 mg, 0.0078 mmol) 
and NaN3 (34 mg, 0.52 mmol) in a dry vial was added anhydrous DMF (0.40 mL). The 
reaction vessel was purged with nitrogen and sealed with a teflon cap and then heated to 
105 °C. After 12 h, the reaction was cooled to 20 °C, H2O (5 mL) was added, and the 
mixture was extracted with EtOAc (3 X 10 mL). The combined organics were washed 
with brine and then dried over Na2SO4. Concentration in vacuo and column purification 
(silica gel, 25% EtOAc/Hexanes) afforded the azidocyclopentane 3.46 as a colorless film: 
7.0 mg (75%): Rf = 0.38 (6:4-hexanes:EtOAc); [α]D  –25.8 (c 1.00, CH2Cl2); IR (thin 
film) 2926, 2113, 1716, 1113 cm-1; 1H-NMR (500 MHz, benzene-d6) δ 8.21 (d, J = 8.0 
Hz, 2H), 7.91 (m, 2H), 7.87 (d, J =8.0 Hz, 2H), 7.76 (m, 2H), 7.54 (d, J = 2.0 Hz, 1H), 
7.42 (dd, J = 2.0, 8.0 Hz, 1H), 7.19-7.27 (m, 6H), 6.84 (d, J =8.0 Hz, 2H), 6.77 (d, J 
=8.0 Hz, 2H), 6.50 (d, J =8.0 Hz, 1H), 5.94 (d, J = 16.0 Hz, 1H), 4.87 (s, 1H), 4.74 (d, J 
= 16.0 Hz, 1H), 4.60 (dd, J = 6.0, 11.0 Hz, 1H), 4.32 (d, J = 11.0 Hz, 1H), 4.17-4.22 (m, 
2H), 4.07 (d, J = 9.5 Hz, 1H), 3.67 (s, 3H), 3.55-3.62 (m, 4H),3.36(m, 1H), 3.35 (s, 3H), 
3.20 (m, 1H), 2.91 (m, 1H), 1.87 (s, 3H), 1.84 (s, 3H), 1.19 (s, 9H), 0.88-0.94 (m, 21H); 
13C-NMR (125 MHz, benzene-d6) δ 173.66, 172.29, 156.93, 150.72, 150.20, 144.88, 
144.67, 136.31, 136.19, 135.84, 135.78, 133.64, 133.52, 130.19, 129.80, 129.53, 129.09, 
129.01, 128.21, 128.02, 127.82, 127.63, 120.86, 112.72, 112.60, 75.24, 66.59, 65.29, 
62.29, 61.31, 55.76, 55.44, 50.48, 47.78, 47.37, 47.20, 45.80, 33.35, 30.08, 26.95, 21.07, 
21.01, 19.30, 18.06, 18.00, 12.04; HRMS (ESI) calcd for C61H78N6O11S2Si2 [M+Li]: 
1197.4869; found: 1197.4800.  
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Lactam 4.7: To a solution of the chlorocyclopentane 2.36 (30 mg, 0.025 mmol) in 
anhydrous THF (0.20 mL) was added samarium diiodide (0.1 M solution in THF) at 0 ºC, 
until the reaction mixture remained blue (about 1.5 mL, 0.15 mmol). The reaction was 
warmed to 20 °C and stirred for 30 min. Then the reaction was quenched with sat’d 
NaHCO3 (10 mL). The mixture was extracted with EtOAc (3 X 10 mL). The combined 
organic layer was washed with water and brine, and dried over Na2SO4. After solvent 
removal in vacuo, the crude product was subjected to column purification (Silica gel, 20 
Æ 30% EtOAc/Hexanes) to afford lactam 4.7 (25 mg, 96%): Rf = 0.64 (60% 
EtOAc/Hexanes); [α]D +25.1 (c 1.00, CH2Cl2); IR (thin film) 2971, 1738, 1217 cm-1; 1H-
NMR (500 MHz, benzene-d6) δ = 7.96 (m, 2H), 7.90 (m, 2H), 7.83 (d, J = 8.0 Hz, 2H), 
7.22-7.33 (m, 7H), 6.95 (dd, J = 8.0, 2.0 Hz, 1H), 6.81 (d, J = 8.0 Hz, 2H), 6.45 (d, J = 
8.0 Hz, 2H), 5.51 (s, 1H), 5.04 (d, J = 15.5 Hz, 1H), 4.60 (d, J =11.0 Hz, 1H), 4.42 (d, J 
= 15.5 Hz, 1H), 4.40 (t, J = 3.0 Hz, 1H), 4.27 (dd, J = 3.0, 10.0 Hz, 1H), 3.67 (m, 1H), 
3.65 (s, 3H), 3.46-3.62 (m, 6H), 3.41 (dd, J = 2.0, 8.0 Hz, 1H), 3.34 (s, 3H), 3.13-3.19 
(m, 1H), 3.01-3.06 (m, 1H), 1.85 (s, 3H), 1.26 (s, 9H), 1.04-1.06 (m, 21H); 13C-NMR 
(125 MHz, benzene-d6) δ 175.35, 173.11, 157.15, 150.40, 149.82, 144.61, 136.21, 
136.15, 136.02, 133.90, 133.50, 129.84, 129.81, 129.80, 129.62, 128.88, 128.20, 127.99, 
120.40, 112.51, 111.84, 76.60, 66.74, 59.90, 59.38, 55.70, 55.28, 55.25, 50.75, 48.08, 
127
47.97, 45.37, 44.31, 33.24, 30.08, 27.09, 21.04, 19.54, 18.09, 12.03; HRMS (ESI) 
calculated for C54H72ClN3O9SSi2 [M+Li]: 1036.4376, found: 1036.4366.  
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Diol 4.10: To a solution of iodocyclopentane 4.7 (24 mg, 0.0233 mmol) in THF (0.40 
mL) was added HF⋅pyridine (70%, 100 μL, excess) at 20 °C. The reaction mixture was 
stirred vigorously at 20 °C for 20 h. After the reaction time, the reaction was quenched 
with saturated NaHCO3 (2 mL) and H2O (6 mL) and extracted with EtOAc (3 X 10 mL). 
The combined organic layer was washed with brine and dried over Na2SO4. After 
removal of solvent, the crude product was purified by flash column chromatography 
(silica gel, 80% EtOAc/hexanes to EtOAc) to give diol 4.10 as a colorless film (15 mg, 
99%): Rf = 0.15 (EtOAc); [α]D +29.1 (c 1.00, CH2Cl2); IR (thin film) 3383, 1713, 1262 
cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.0 Hz, 2H), 7.39 (d, J =8.0 Hz, 2H), 
7.01 (d, J = 2.0 Hz, 1H), 6.91 (dd, J = 2.0, 8.0 Hz, 1H), 6.81 (d, J = 8.0 Hz, 1H), 6.61 (s, 
1H), 4.77 (d, J = 16.0 Hz, 1H), 4.44-4.48 (m, 2H), 3.98-4.03 (m, 1H), 3.79-3.94 (m, 3H), 
3.86 (s, 6H), 3.65 (s, 1H), 3.44-3.54 (m, 4H), 3.30 (t, J = 8.5 Hz, 1H), 3.17 (d, J = 8.5 Hz, 
1H), 3.07 (m, 1H), 2.47 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 178.57, 173.12, 171.43, 
156.99, 149.48, 149.47, 149.03, 149.01, 145.82, 135.25, 130.43, 129.05, 128.61, 120.43, 
111.52, 111.27, 76.42, 65.57, 60.65, 59.02, 57.91, 56.29, 56.15, 56.08, 51.34, 47.36, 
128
46.67, 46.08, 45.62, 33.31, 21.95, 21.31, 14.44; HRMS (ESI) calcd for C29H34ClN3O9S 
[M+Li]: 642.1864; found: 642.1853.  
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Lactam 4.13: To a solution of the TBDPS-protected Diels-Alder adduct 2.34 (40 mg, 
0.035 mmol) in anhydrous THF (0.30 mL) was added samarium diiodide (0.1 M solution 
in THF, excess) at 0 °C, until the reaction mixture stayed blue. After 30 min at 0 °C the 
reaction was quenched with sat’d NaHCO3. The mixture was extracted with EtOAc (2 X 
10 mL). The organic layer was washed with water and brine, and dried over Na2SO4. 
Solvent was removed in vacuo to afford the free lactam 4.13 in high purity (36 mg, 
100%): Rf = 0.29 (EtOAc); [α]D -29.9 (c 1.20, CH2Cl2); IR (thin film) 2929, 2864, 1693, 
1657 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.78-7.83 (m, 4H), 7.65 (d, J = 8.5 Hz, 
2H), 7.23-7.27 (m, 6H), 6.94 (d, J = 2.0 Hz, 1H), 6.90 (bs, 1H), 6.77 (dd, J = 8.0, 2.0 Hz, 
1H), 6.74 (d, J = 8.5 Hz, 2H), 6.53 (d, J = 8.0 Hz, 1H), 4.56 (dd, J = 10.0, 8.5 Hz, 1H), 
4.51 (d, J = 15.5 Hz, 1H), 4.37 (d, J = 15.5 Hz, 1H), 4.33 (dd, J = 10.0, 6.0 Hz, 1H), 4.12 
(m, 1H), 3.95 (m, 2H), 3.65 (m, 2H), 3.54 (d, J = 8.0 Hz, 1H), 3.51 (s, 3H), 3.37 (s, 3H), 
3.17 (t, J = 5.5 Hz, 1H), 3.10 (dt, J = 14.5, 5.0 Hz, 1H), 2.97 (dd, J = 7.5, 3.5 Hz, 1H), 
2.48 (m, 1H), 2.31 (m, 1H), 2.17 (bs, 1H), 1.89 (s, 3H), 1.20 (s, 9H), 1.14 (m, 21H); 13C-
NMR (125 MHz, benzene-d6) δ = 176.86, 153.73, 150.38, 149.50, 143.92, 137.62, 
129
135.96, 135.88, 134.16, 134.12, 130.56, 129.96, 129.50, 128.22, 128.05, 127.84, 127.78, 
119.77, 119.12, 115.84, 112.15, 111.72, 65.71, 65.68, 59.33, 55.55, 55.43, 53.19, 44.28, 
40.34, 38.67, 36.42, 35.11, 27.13, 21.10, 20.83, 19.46, 18.21, 12.14; HRMS (ESI) calcd 
for C54H73N3O8SSi2 [M+Li] 986.4817; found [M+Li] 986.4820. 
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Alcohol 4.14: To a solution of lactam 4.13 (34 mg, 0.035 mmol) in THF was added 
lithium aluminum hydride (LAH, 10 mg, 0.26 mmol) at 0 °C. The reaction mixture was 
warmed to 20 °C and stirred for 3 h. Then the reaction mixture was cooled to 0 °C and 
treated with water (2 mL) and 8% NaOH solution (1 mL). The resulting mixture was 
partitioned between water (10 mL) and methylene chloride (3 X 10 mL). The combined 
organic layer was washed with water and brine, and dried over Na2SO4. After solvent 
removal in vacuo, the crude product was subjected to column purification (silica gel, 10 
Æ 20% MeOH/CH2Cl2) to afford alcohol 4.14 as a colorless foam (19 mg, 86%): Rf = 
0.10 (8% MeOH/CH2Cl2); [α]D -35.2 (c 1.00, CH2Cl2); IR (thin film) 3231, 2931, 1671, 
1262 cm-1; 1H-NMR (500 MHz, CDCl3) δ = 10.26 (s, 1H), 7.63 (d, J = 8.0 Hz, 4H), 
7.35-7.43 (m, 6H), 6.69-6.77 (m, 3H), 6.29 (s, 1H), 4.78 (d, J = 15.5 Hz, 1H), 4.54 (d, J 
= 15.5 Hz, 1H), 4.45 (bs, 1H), 4.14 (m, 1H), 4.07 (m, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 
3.50 (s, 3H), 3.17 (d, J = 6.5 Hz, 1H), 2.94 (d, J = 6.5 Hz, 1H), 2.46 (d, J = 12.5 Hz, 1H), 
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2.16 (m, 2H), 2.04 (bs, 1H), 1.29 (s, 1H), 1.04 (s, 9H); 13C-NMR (125 MHz, CDCl3) δ = 
176.68, 154.92, 149.45, 148.80, 135.80, 135.77, 133.97, 133.87, 129.95, 129.74, 128.07, 
127.94, 120.20, 119.60, 115.41, 111.45, 110.85, 65.09, 64.52, 59.26, 56.16, 56.09, 44.53, 
39.84, 37.93, 35.66, 29.97, 27.12, 20.63, 19.49; MS (MALDI) unit mass C36H43N3O6Si: 
641, found [M+H] 642, [M+Na] 664, [M+K] 680. 
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Aminal 4.16a: To a solution of TBDPS-protected Diels-Alder adduct 2.34 (202 mg, 
0.178 mmol) in CH2Cl2 (1.2 mL) at -78 °C was added DIBAl-H (0.13 mL DIBAl-H in 
0.6 mL CH2Cl2, 0.712 mmol). The reaction mixture was stirred at -78 °C for 2 h. After 2 
h, the reaction was quenched with Rochelle’s salt solution (~ 5 mL). The reaction 
mixture was warmed to 20 °C and stirred vigorously for 8 h, after which the mixture was 
transferred into a separation funnel and extracted with CH2Cl2. The organic layer was 
washed with brine and dried further over Na2SO4. After removal of solvent in vacuo, 
aminal 4.16a was obtained in high purity as a foam (202mg, 99%): Rf = 0.26 (60% 
EtOAc/Hexanes); [α]D -22.9 (c 1.01, CH2Cl2); IR (thin film) 2938, 2866, 1692 cm-1; 1H-
NMR (500 MHz, benzene-d6) δ = 7.73-7.77 (m, 4H), 7.64 (d, J = 8.5 Hz, 2H), 7.48 (d, J 
= 8.0 Hz, 2H), 7.23-7.26 (m, 6H), 7.08 (d, J = 2.0 Hz, 1H), 6.87 (dd, J = 8.0, 2.0 Hz, 1H), 
6.77 (d, J = 8.5 Hz, 2H), 6.67 (d, J = 8.0 Hz, 1H), 6.63 (d, J = 8.0 Hz, 2H), 5.17 (dd, J = 
131
6.0, 2.5 Hz, 1H), 4.85 (d, J = 15.5 Hz, 1H), 4.32 (dd, J = 10.0, 3.5 Hz, 1H), 4.02-4.11 (m, 
3H), 3.89 (d, J = 15.5 Hz, 1H), 3.84 (dd, J = 10.5, 6.0 Hz, 1H), 3.73-3.80 (m, 3H), 3.63 
(bd, J = 10.0 Hz, 1H), 3.61 (s, 3H), 3.41 (s, 3H), 3.31 (d, J = 2.5 Hz, 1H), 2.94 (m, 1H), 
2.83 (m, 1H), 2.33-2.37 (dd, J = 15.5, 4.5 Hz, 1H), 2.19 (s, 3H), 1.93 (bs, 1H), 1.82 (s, 
3H), 1.54-1.59 (m, 1H), 1.19-1.23 (m, 21H), 1.17 (s, 9H); 13C-NMR (125 MHz, 
benzene-d6) δ = 153.46, 150.57, 149.62, 144.23, 143.98, 137.92, 135.93, 135.90, 135.44, 
134.02, 133.74, 130.49, 130.05, 129.62, 129.58, 128.21, 128.07, 128.05, 127.83, 126.80, 
119.60, 117.61, 114.50, 112.24, 111.92, 84.53, 66.16, 65.99, 64.07, 55.83, 55.55, 52.61, 
45.43, 44.25, 37.58, 36.73, 36.20, 27.01, 21.58, 21.05, 20.12, 19.33, 18.28, 12.16, 12.13; 
MS (ESI) calcd for C61H81N3O10S2Si2 [M+H] 1136; found [M+H] 1136. 
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Acetate 4.16: To a solution of aminal 4.16a (202 mg, 0.178 mmol) in CH2Cl2 (1.8 mL) 
at 0 ºC was added pyridine (0.43 mL, 5.34 mmol), followed by acetic anhydride (0.34 
mL, 3.56 mmol). The reaction mixture was warmed to 20 °C and stirred for 12 h. Upon 
completion of the reaction time, volatile compounds in the reaction mixture were 
removed in vacuo. Purification of the residue by silica gel column (60% EtOAc/ 
Hexanes) afforded the acetate 4.16 as a colorless foam (206 mg, 98%): Rf = 0.26 (60% 
EtOAc/Hexanes); [α]D -11.5 (c 1.03, CH2Cl2); IR (thin film) 2936, 2866, 1745, 1694  
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cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.71 (d, J = 8.5 Hz, 2H), 7.67 (m, 2H), 7.61-
7.64 (m, 4H), 7.21-7.25 (m, 6H), 7.02 (d, J = 2.0 Hz, 1H), 6.86 (dd, J = 8.0, 2.0 Hz, 1H), 
6.81 (d, J = 8.0 Hz, 2H), 6.63-6.66 (m, 4H), 4.93 (d, J = 15.5 Hz, 1H), 4.37 (dd, J = 10.0, 
3.0 Hz, 1H), 4.08-4.18 (m, 3H), 3.84-3.93 (m, 3H), 3.73 (d, J = 15.5 Hz, 1H), 3.71 (bd, J 
= 7.5 Hz, 1H), 3.66 (m, 2H), 3.62 (s, 3H), 3.42 (s, 3H), 3.06 (m, 1H), 2.94 (m, 1H), 2.33-
2.37 (dd, J = 16.0, 4.5 Hz, 1H), 2.15 (s, 3H), 1.98 (bs, 1H), 1.84-1.86 (m, 4H), 1.75 (s, 
3H), 1.21-1.23 (m, 21H), 1.10 (s, 9H); 13C-NMR (125 MHz, benzene-d6) δ = 169.75, 
153.47, 150.59, 149.57, 144.15, 144.04, 137.93, 135.80, 135.67, 134.87, 133.69, 133.48, 
130.38, 130.09, 130.03, 129.70, 129.65, 128.21, 128.04, 127.82, 127.06, 119.50, 117.68, 
114.30, 112.16, 111.53, 82.42, 66.39, 65.65, 65.30, 55.78, 55.52, 52.56, 44.27, 44.16, 
37.55, 36.89, 36.25, 26.90, 21.52, 21.15, 21.04, 20.08, 19.30, 18.28, 18.27, 12.19; 
HRMS (ESI) calcd for C63H83N3O11S2Si2 [M+H] 1178.5086; found [M+H] 1178.5101. 
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Ts-protected pyrrolidine 4.17: To a solution of acetate 4.16 (206 mg, 0.175 mmol) in 
CH2Cl2 (1.8 mL) at -50 ºC was added triethylsilane (0.42 mL, 2.62 mmol), followed by 
borontrifluoride etherate (BF3⋅OEt2, 0.10 mL, ~0.70 mmol) (The solution changed color 
from light yellow to orange-pink after addition of BF3⋅OEt2). The reaction mixture was 
stirred for 7 h at -50 ºC. Upon completion of the reaction, water (20 mL) was added at -
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50 °C to quench the reaction. After warming up to 20 °C, the reaction mixture was 
extracted with CH2Cl2 (3 X 15 mL). The combined organic layer was washed with brine 
and dried over Na2SO4. Removal of solvents in vacuo afforded pyrrolidine 4.17 in 
sufficient purity for the next step (196 mg, 100%): Rf = 0.30 (60% EtOAc/Hexanes); 
[α]D -20.8 (c 1.00, CH2Cl2); IR (thin film) 2945, 2863, 1696, 1655 cm-1; 1H-NMR (500 
MHz, benzene-d6) δ = 7.67-7.69 (m, 4H), 7.66 (d, J = 8.0 Hz, 2H), 7.60 (d, J = 8.0 Hz, 
2H), 7.26-7.28 (m, 6H), 7.04 (d, J = 2.0 Hz, 1H), 6.83 (m, 3H), 6.66 (m, 3H), 4.86 (d, J 
= 15.5 Hz, 1H), 4.31 (dd, J = 9.5, 3.5 Hz, 1H), 4.11-4.17 (m, 2H), 3.81-3.94 (m, 5H), 
3.60 (s, 3H), 3.55 (m, 1H), 3.47-3.51 (m, 1H), 3.41 (s, 3H), 3.33-3.35 (m, 2H), 3.02 (t, J 
= 10.0 Hz, 1H), 2.97 (m, 1H), 2.76 (m, 1H), 2.19 (s, 3H), 1.99 (m, 1H), 1.83 (s, 3H), 
1.75 (bs, 1H), 1.60-1.66 (m, 1H), 1.23-1.26 (m, 21H), 1.14 (s, 9H); 13C-NMR (125 MHz, 
benzene-d6) δ = 153.67, 150.62, 149.65, 143.91, 143.70, 138.02, 135.93, 135.91, 135.86, 
135.85, 134.35, 133.56, 133.51, 130.61, 130.22, 130.16, 129.61, 129.33, 128.20, 128.05, 
128.04, 128.02, 127.86, 127.83, 127.18, 119.46, 116.55, 114.59, 112.21, 111.90, 66.75, 
66.59, 64.73, 55.84, 55.55, 52.60, 47.34, 44.17, 38.42, 37.86, 36.51, 36.35, 27.01, 26.98, 
21.51, 21.01, 19.29, 19.02, 18.30, 18.27, 12.24; HRMS (ESI) calcd for C61H81N3O9S2Si2 
[M+Li] 1126.5113; found [M+Li] 1126.5116. 
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Chlorocyclopentane 4.18: To a mixture of pyrrolidine 4.17 (196 mg, 0.175 mmol) and 
MgSO4 (~200 mg) in CH2Cl2 (9.0 mL) at -60 ºC was added freshly prepared DMDO 
(~0.08 M in acetone, 2.6 mL, 0.21 mmol). The reaction mixture was stirred for two 
hours at -50 ºC. After 2 h, the reaction was quenched with 30 μL dimethylsulfide at -50 
ºC. The reaction mixture was warmed to 20 °C and filtered to remove MgSO4. 
Intermediate allylic alcohol 4.18a was obtained after removal of solvents and was used 
directly for next step.  
A mixture of alcohol 4.18a (199 mg, 0.175 mmol) and MgSO4 (~200 mg) in 
CH2Cl2 (16.0 mL) was cooled to -60 ºC and to this cooled slurry was added cyclohexene 
(90 μL, 0.875 mmol) and chloramine-T (80 mg, 0.35 mmol). The reaction mixture was 
allowed to warm to 20 °C slowly and stirred for 12 h. The reaction mixture was then 
partitioned between water and methylene chloride, and the combined organics were 
washed with brine and dried over Na2SO4. Column purification (silica gel, 25 Æ 30% 
EtOAc/Hexanes) after removal of solvents afforded chlorocyclopentane 4.18 as colorless 
foam (107 mg, 52% over two steps): Rf = 0.50 (40% EtOAc/Hexanes); [α]D -17.7 (c 
0.967, CH2Cl2); IR (thin film) 2937, 2861, 1774, 1715 cm-1; 1H-NMR (500 MHz, 
benzene-d6) δ = 7.87 (d, J = 8.0 Hz, 2H), 7.86 (d, J = 8.0 Hz, 2H), 7.68-7.72 (m, 4H), 
7.47 (d, J = 2.0 Hz, 1H), 7.31 (dd, J = 8.0, 2.0 Hz, 1H), 7.21-7.28 (m, 6H), 6.84 (d, J = 
8.0 Hz, 2H), 6.81 (d, J = 8.0 Hz, 2H), 6.49 (d, J = 8.0 Hz, 1H), 5.51 (d, J = 16.5 Hz, 1H), 
4.78 (d, J = 16.5 Hz, 1H), 4.68 (d, J = 12.0 Hz, 1H), 4.52 (s, 1H), 4.22 (dd, J = 10.0, 6.5 
Hz, 1H), 3.95 (m, 1H), 3.83-3.88 (m, 3H), 3.72-3.80 (m, 3H), 3.69 (s, 3H), 3.56 (m, 1H), 
3.34-3.41 (m, 2H), 3.32 (s, 3H), 3.23 (m, 1H), 3.12 (m, 1H), 1.90 (s, 3H), 1.85 (s, 3H), 
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1.16 (s, 9H), 0.99-1.03 (m, 21H); 13C-NMR (125 MHz, benzene-d6) δ = 173.68, 156.90, 
150.28, 149.62, 144.51, 143.10, 138.14, 136.21, 136.04, 135.97, 133.31, 133.04, 130.35, 
130.07, 130.06, 129.80, 129.77, 129.65, 129.38, 129.03, 128.22, 128.03, 127.84, 127.64, 
127.57, 127.03, 126.65, 120.65, 112.49, 111.98, 76.33, 65.82, 62.84, 61.68, 59.27, 55.70, 
55.28, 54.01, 53.21, 51.19, 50.18, 46.84, 45.49, 43.56, 33.42, 30.10, 27.06, 21.06, 20.97, 
19.31, 18.17, 18.12, 12.07; HRMS (ESI) calcd for C61H80ClN3O10S2Si2 [M+Li] 
1176.4672; found [M+Li] 1176.4744. 
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Pyrrolidine 4.19: To a solution of cyclopentane 4.18 (107 mg, 0.0914 mmol) in THF 
(1.0 mL) at -78 ºC was added 3.8 mL of freshly prepared sodium naphthalenide 
solution* (0.115 M, 0.457 mmol) dropwise. The reaction mixture was stirred at -78 ºC 
for 20 min. The reaction was quenched with pH 7 buffer at -78 ºC. After warming up to 
20 °C, the reaction mixture was partitioned between water (20 mL) and EtOAc (2 X 20 
mL). The combined organic layer was washed with brine and dried over Na2SO4. 
Column purification (silica gel, 30% EtOAc/Hexanes) after removal of solvents afforded 
pyrrolidine 4.19 (61 mg, 80%): Rf = 0.39 (40% EtOAc/Hexanes); IR (thin film) 3268, 
2944, 2865, 1725 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.72-7.74 (m, 4H), 7.31 (d, 
136
J = 2.0 Hz, 1H), 7.23-7.26 (m, 7H), 7.04 (dd, J = 8.0, 2.0 Hz, 1H), 6.52 (d, J = 8.0 Hz, 
1H), 4.86 (d, J = 15.5 Hz, 1H), 4.75 (d, J = 15.5 Hz, 1H), 4.51 (d, J = 12.0 Hz, 1H), 3.93 
(m, 1H), 3.75 (m, 1H), 3.61 (s, 3H), 3.40 (s, 3H), 3.34-3.39 (m, 2H), 3.24 (m, 1H), 3.21 
(m, 2H), 2.96 (t, J = 10.5 Hz, 1H), 2.90 (m, 1H), 2.77 (dd, J = 8.5, 2.0 Hz, 1H), 1.16 (s, 
9H), 1.02-1.04 (m, 21H); 13C-NMR (125 MHz, benzene-d6) δ = 174.59, 158.18, 150.15, 
149.48, 135.95, 135.93, 133.57, 133.25, 130.79, 130.08, 130.02, 128.20, 128.01, 127.82, 
120.65, 112.76, 111.69, 77.64, 63.98, 62.91, 62.11, 60.89, 59.36, 55.51, 55.26, 50.20, 
45.72, 45.56, 44.93, 43.03, 30.83, 30.08, 27.12, 27.04, 19.34, 19.23, 18.09, 18.05, 18.04, 
13.65, 12.05; HRMS (MALDI) calcd for C45H64ClN3O6Si2 [M+H] 834.4100; found 
[M+H] 834.4108. 
 
* Na naphthalenide preparation: to a solution of naphthalene (117 mg, 0.913 mmol) in 
8.0 mL anhydrous THF was added excess amount of sodium. The mixture was sonicated 
for 15 min and then stirred for 2 h at 20 °C to give a deep green solution. 
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Alcohol 4.23: To a solution of Diels-Alder adduct 2.34 (19 mg, 0.0167 mmol) in THF at 
(0.80 mL) -50 ºC was added TBAF (1.0 M in THF, 17 μL, 0.017 mmol). The reaction 
mixture was stirred for 2 h at -50 ºC. After 2 h, the reaction was quenched with pH 7 
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buffer at -50 °C. After warming up to 20 °C, the reaction mixture was partitioned 
between water and EtOAc. The combined organic layers were washed with brine and 
dried over Na2SO4. Column purification (silica gel, 60 Æ 80% EtOAc/Hexanes) after 
removal of solvents afforded alcohol 4.23 (15 mg, 94%): Rf = 0.06 (60% 
EtOAc/Hexanes); [α]D -50.0 (c 1.49, CH2Cl2); IR (thin film) 3300, 2930, 1734, 1684, 
1653 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.81 (d, J = 8.5 Hz, 2H), 7.71-7.74 (m, 
6H), 7.21-7.25 (m, 6H), 6.93 (d, J = 2.0 Hz, 1H), 6.77 (dd, J = 8.0, 2.0 Hz, 1H), 6.73 (d, 
J = 8.0 Hz, 4H), 6.60 (d, J = 8.0 Hz, 1H), 4.79 (d, J = 16.0 Hz, 1H), 4.37 (dd, J = 8.5, 4.0 
Hz, 1H), 4.32 (m, 1H), 4.12-4.18 (m, 3H), 4.04-4.10 (m, 2H), 3.91 (m, 1H), 3.62 (m, 
1H), 3.57 (s, 3H), 3.47 (d, J = 6.0 Hz, 1H), 3.38 (s, 3H), 3.18 (m, 2H), 2.77 (dd, J = 6.5, 
2.0 Hz, 1H), 2.35 (m, 1H), 1.93 (s, 3H), 1.90-1.93 (m, 2H), 1.85 (s, 3H), 1.13 (s, 9H); 
13C-NMR (125 MHz, benzene-d6) δ = 172.85, 153.93, 150.51, 149.59, 144.72, 144.45, 
137.14, 135.91, 135.86, 133.94, 133.84, 130.18, 130.05, 130.03, 129.86, 129.43, 128.22, 
128.02, 127.99, 127.84, 120.45, 119.43, 114.41, 112.21, 111.41, 65.01, 64.15, 63.29, 
55.68, 55.43, 53.80, 44.37, 41.56, 37.57, 35.94, 34.41, 27.02, 21.20, 21.08, 20.11, 19.38; 
HRMS (ESI) calcd for C52H59N3O10S2Si [M+H] 978.3489; found [M+H] 978.3446. 
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Diol 4.24: To a solution of alcohol 4.23 (157 mg, 0.160 mmol) in CH2Cl2 (1.0 mL) at -
78 °C was added DIBAl-H (0.14 mL DIBAl-H in 0.6 mL CH2Cl2, 0.80 mmol). The 
reaction was stirred at -78 °C for 5 h, and then quenched with Rochelle’s salt solution (5 
mL) at -78 °C. The reaction mixture was allowed to warm to 20 °C and stirred 
vigorously for 4 h. Then the mixture was transferred into a separation funnel and 
extracted with CH2Cl2 (3 X 10 mL). The combined organics were washed with brine and 
dried over Na2SO4. After removal of solvent in vacuo, diol 4.24 was obtained in 
sufficient purity (157mg, 99%): Rf = 0.21 (80% EtOAc/Hexanes); IR (thin film) 3380, 
2933, 2859, 1686, 1651 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.76-7.78 (m, 4H), 
7.71-7.73 (m, 2H), 7.56 (d, J = 8.0 Hz, 2H), 7.25-7.30 (m, 6H), 7.01 (d, J = 2.0 Hz, 1H), 
6.88 (d, J = 8.0 Hz, 2H), 6.85 (dd, J = 8.0, 2.0 Hz, 1H), 6.81 (d, J = 8.0 Hz, 2H), 6.68 (d, 
J = 8.0 Hz, 1H), 5.26 (m, 1H), 4.88 (d, J = 15.5 Hz, 1H), 4.34 (m, 1H), 4.14-4.18 (m, 
2H), 3.92-4.01 (m, 7H), 3.73 (m, 1H), 3.69 (s, 3H), 3.44 (s, 3H), 3.41 (s, 1H), 3.24-3.30 
(m, 2H), 2.65-2.69 (m, 1H), 2.46-2.51 (m, 1H), 2.27 (s, 3H), 1.94-1.99 (m, 2H), 1.90 (s, 
3H), 1.13 (s, 9H); 13C-NMR (125 MHz, benzene-d6) δ = 153.47, 150.53, 149.59, 144.44, 
137.26, 135.94, 135.90, 135.85, 135.10, 134.02, 133.84, 130.24, 130.11, 129.90, 129.66, 
128.22, 128.02, 126.94, 119.52, 117.69, 114.76, 112.30, 111.66, 84.90, 69.38, 66.35, 
65.16, 64.33, 55.91, 55.57, 53.37, 46.12, 44.31, 37.86, 36.87, 36.04, 31.05, 27.05, 21.68, 
21.15, 20.01, 19.35, 19.03; MS (ESI) calcd for C52H61N3O10S2Si [M+Li] 986; found 
[M+li] 986. 
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Lactam 4.30: To a mixture of alcohol 4.23 (80 mg, 0.082 mmol) and imidazole (14 mg, 
0.204 mmol) in anhydrous DMF (1.5 mL) at 20 °C was added TBSCl (14 mg, 0.090 
mmol). The reaction mixture was stirred for 12 h at 20 °C, and then partitioned between 
water and EtOAc after 12 h reaction time. Organic layer was washed with brine and 
dried over Na2SO4. Column purification (silica gel, 60 Æ 70% EtOAc/Hexanes) after 
removal of solvents afforded lactam 4.30 (85 mg, 96%): Rf = 0.50 (80% 
EtOAc/Hexanes); IR (thin film) 2932, 2861, 1737, 1694 cm-1; 1H-NMR (500 MHz, 
benzene-d6) δ = 7.78 (d, J = 8.5 Hz, 2H), 7.69-7.72 (m, 4H), 7.64 (d, J = 8.5 Hz, 2H), 
7.20-7.24 (m, 6H), 6.94 (d, J = 2.0 Hz, 1H), 6.76 (dd, J = 8.0, 2.0 Hz, 1H), 6.73 (d, J = 
8.5 Hz, 2H), 6.68 (d, J = 8.5 Hz, 2H), 6.60 (d, J = 8.0 Hz, 1H), 4.77 (d, J = 15.5 Hz, 1H), 
4.32 (dd, J = 7.0, 3.0 Hz, 1H), 4.22-4.26 (m, 2H), 4.06-4.18 (m, 3H), 3.98 (d, J = 15.5 
Hz, 1H), 3.92 (m, 1H), 3.67 (m, 1H), 3.56 (s, 3H), 3.39 (s, 3H), 3.10 (dd, J = 7.0, 3.0 Hz, 
1H), 2.96 (m, 1H), 2.23 (m, 2H), 1.93 (m, 1H), 1.95 (s, 3H), 1.85 (s, 3H), 1.82 (m, 1H), 
1.12 (s, 9H), 0.98 (s, 9H), 0.21 (s, 3H), 0.20 (s, 3H); 13C-NMR (125 MHz, benzene-d6) δ 
= 172.94, 153.80, 150.51, 149.56, 144.57, 144.10, 137.71, 136.04, 135.83, 133.84, 
133.79, 130.28, 130.00, 129.97, 129.65, 129.39, 128.21, 128.05, 128.03, 127.86, 120.29, 
119.44, 114.52, 112.16, 111.43, 65.05, 64.70, 64.31, 55.69, 55.44, 52.96, 44.26, 41.85, 
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37.71, 36.29, 34.88, 27.03, 26.12, 21.18, 21.04, 20.04, 19.33, 18.51, -5.36, -5.43; HRMS 
(MALDI) calcd for C58H73N3O10S2Si2 [M+H] 1092.4354; found [M+H] 1092.4388. 
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Acetate 4.32: To a solution of lactam 4.30 (85 mg, 0.078 mmol) in CH2Cl2 (0.8 mL) at -
78 °C was added DIBAl-H (0.10 mL DIBAl-H in 0.3 mL CH2Cl2, 0.56 mmol). The 
reaction was stirred at -78 °C for 3 h. Upon completion of the reaction, to the reaction 
mixture was added Rochelle’s salt solution (5 mL) at -78 °C. The mixture was allowed 
to warm to 20 °C and stirred vigorously for 4 h. Then the mixture was transferred into a 
separation funnel and extracted with CH2Cl2 (3 X 10 mL). The combined organic layer 
was washed with brine and dried further over Na2SO4. After removal of solvent in vacuo, 
aminal 4.31 was obtained in sufficient purity for next step (85mg, 100%). 
To a solution of aminal 4.31 (80 mg, 0.073 mmol) in CH2Cl2 (1.0 mL) at 0 ºC 
was added pyridine (0.18 mL, 2.19 mmol), followed by acetic anhydride (0.14 mL, 1.46 
mmol). The reaction mixture was warmed to 20 °C and stirred for 10 h. Then volatile 
compounds in the reaction mixture were removed in vacuo. Purification of the residue 
by column chromatography (silica gel, 60 Æ 70% EtOAc/ Hexanes) afforded the acetate 
4.32 as a colorless foam (83 mg, 99%): Rf = 0.45 (80% EtOAc/Hexanes); IR (thin film) 
2931, 2861, 1745, 1690 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.68-7.72 (m, 4H), 
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7.64-7.66 (m, 4H), 7.21-7.25 (m, 6H), 7.02 (d, J = 2.0 Hz, 1H), 6.86 (dd, J = 8.0, 2.0 Hz, 
1H), 6.80 (d, J = 8.0 Hz, 2H), 6.63-6.66 (m, 4H), 4.95 (d, J = 15.5 Hz, 1H), 4.31 (dd, J = 
10.0, 4.0 Hz, 1H), 4.03-4.15 (m, 3H), 3.87 (m, 1H), 3.81 (m, 1H), 3.73 (d, J = 15.5 Hz, 
1H), 3.67 (d, J = 8.0 Hz, 2H), 3.63 (s, 3H), 3.62 (m, 1H), 3.41 (s, 3H), 2.91-2.96(m, 2H), 
2.36 (m, 1H), 2.13 (s, 3H), 1.98 (m, 1H), 1.83 (s, 3H), 1.80 (m, 1H), 1.75 (s, 3H), 1.11 (s, 
9H), 1.06 (s, 9H), 0.27 (s, 6H); 13C-NMR (125 MHz, benzene-d6) δ = 169.74, 153.48, 
150.62, 149.58, 144.11, 144.04, 137.87, 135.82, 135.68, 134.88, 133.71, 133.48, 130.36, 
130.08, 130.04, 129.68, 129.66, 128.21, 128.05, 127.79, 127.06, 119.42, 117.65, 114.30, 
112.18, 111.46, 82.42, 66.11, 65.63, 65.22, 55.77, 55.50, 52.60, 44.19, 44.14, 37.48, 
36.92, 36.14, 26.90, 26.31, 21.50, 21.15, 21.02, 20.08, 19.30, 18.78, -5.22, -5.32; HRMS 
(MALDI) calcd for C60H77N3O11S2Si2 [M+H] 1136.4616; found [M+H] 1136.4585. 
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Chlorocyclopentane 4.34: To a mixture of pyrrolidine 4.33 (78 mg, 0.072 mmol) and 
MgSO4 (~100 mg) in CH2Cl2 (4.8 mL) at -60 ºC was added freshly prepared DMDO 
(~0.07 M in acetone, 1.2 mL, 0.084 mmol). The reaction mixture was stirred for 2 h at -
50 ºC. The reaction was quenched with 30 μL dimethylsulfide at -50 ºC after 2 h 
reaction time. The reaction mixture was then warmed to 20 °C and filtered to remove 
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MgSO4. Intermediate 4.34a was obtained in sufficient purity after removal of solvents in 
vacuo and was used directly for next step.  
A mixture of allylic alcohol 4.34a (79 mg, 0.072 mmol) and MgSO4 (~100 mg) 
in CH2Cl2 (7.0 mL) was cooled to -60 ºC and cyclohexene (37 μL, 0.36 mmol) was 
added, followed by chloramine-T (33 mg, 0.145 mmol). The reaction mixture was 
allowed to warm to 20 °C slowly and stirred for 12 h. Then the reaction mixture was 
partitioned between water and methylene chloride. Organics were combined and dried 
over Na2SO4. Column purification (silica gel, 30 Æ 40% EtOAc/Hexanes) after removal 
of solvents afforded chlorocyclopentane 4.34 (49 mg, 60% over two steps): Rf = 0.76 
(80% EtOAc/Hexanes); IR (thin film) 2959, 2858, 1771, 1716 cm-1; 1H-NMR (500 MHz, 
benzene-d6) δ = 7.85-7.88 (m, 4H), 7.68-7.73 (m, 4H), 7.47 (d, J = 2.0 Hz, 1H), 7.37 (dd, 
J = 8.0, 2.0 Hz, 1H), 7.22-7.28 (m, 6H), 6.82-6.85 (m, 4H), 6.50 (d, J = 8.0 Hz, 1H), 
5.52 (d, J = 16.0 Hz, 1H), 4.91 (d, J = 16.0 Hz, 1H), 4.64 (d, J = 11.5 Hz, 1H), 4.52 (s, 
1H), 4.24 (dd, J = 10.0, 6.0 Hz, 1H), 3.93 (m, 1H), 3.82-3.86 (m, 1H), 3.71-3.79 (m, 3H), 
3.70 (s, 3H), 3.62-3.68 (m, 2H), 3.44-3.53 (m, 3H), 3.32 (s, 3H), 3.27 (m, 1H), 3.04 (m, 
1H), 1.92 (s, 3H), 1.86 (s, 3H), 1.16 (s, 9H), 0.79(s, 9H), 0.01 (s, 3H), -0.18 (s, 3H); 13C-
NMR (125 MHz, benzene-d6) δ = 173.63, 156.89, 150.25, 149.61, 144.55, 142.95, 
137.94, 136.21, 135.98, 135.95, 133.32, 133.06, 130.39, 130.06, 130.03, 129.80, 129.67, 
129.38, 128.98, 128.21, 128.02, 127.82, 127.61, 127.03, 126.63, 120.81, 112.52, 112.04, 
76.40, 65.02, 63.95, 62.89, 61.90, 59.94, 59.28, 55.68, 55.29, 54.31, 50.97, 50.07, 47.03, 
45.48, 43.49, 33.32, 30.84, 27.04, 25.86, 25.62, 21.05, 20.96, 20.42, 19.30, 19.24, 18.05, 
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13.65, -5.73, -5.77; HRMS (ESI) calcd for C58H74ClN3O10S2Si2 [M+Na] 1150.3940, 
[M+K] 1166.3680; found [M+Na] 1150.4075, [M+K] 1166.3693. 
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Pyrrolidine 4.35: To a solution of spirocycle 4.34 (33 mg, 0.029 mmol) in THF (0.6 mL) 
at -78 ºC was added 1.4 mL of freshly prepared sodium naphthalenide solution (0.105 M, 
0.15 mmol) dropwise. The reaction was kept at -78 ºC for 5 min, and then quenched with 
pH 7 buffer (2 mL) at -78 ºC. After warming up to 20 °C, the reaction mixture was 
partitioned between water (5 mL) and EtOAc (3 X 10 mL). The combined organic layer 
was washed with brine and dried over Na2SO4. Column purification (silica gel, 40 Æ 
50% EtOAc/Hexanes) after removal of solvents afforded pyrrolidine 4.35 (13 mg, 56%): 
Rf = 0.50 (70% EtOAc/Hexanes); IR (thin film) 3272, 2955, 2858, 1723 cm-1; 1H-NMR 
(500 MHz, benzene-d6) δ = 7.71-7.73 (m, 4H), 7.27 (d, J = 2.0 Hz, 1H), 7.22-7.24 (m, 
7H), 7.03 (dd, J = 8.0, 2.0 Hz, 1H), 6.51 (d, J = 8.0 Hz, 1H), 4.81 (d, J = 15.5 Hz, 1H), 
4.77 (d, J = 15.5 Hz, 1H), 4.46 (d, J = 12.0 Hz, 1H), 3.92 (m, 1H), 3.72 (m, 1H), 3.59 (s, 
3H), 3.39 (s, 3H), 3.29-3.38 (m, 3H), 3.22 (m, 1H), 3.03 (m, 1H), 2.96 (m, 1H), 2.88 (t, J 
= 10.5 Hz, 1H), 2.82 (m, 1H), 2.60 (dd, J = 8.0, 2.0 Hz, 1H), 1.15 (s, 9H), 0.90 (s, 9H), -
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0.03 (s, 6H); HRMS (ESI) calcd for C42H58ClN3O6Si2 [M+H] 792.3631; found [M+H] 
792.3633. 
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Pyrrole 4.42: To a solution of pyrrolidine 4.19 (45 mg, 0.054 mmol) and pyrrole-2-
carbonyl chloride61 (35 mg, 0.27 mmol) in anhydrous methylene chloride (1.5 mL) was 
added triethylamine (12 μL, 0.085 mmol) at 20 °C. After being stirred for 20 min at 20 
°C, the reaction mixture was partitioned between water (10 mL) and EtOAc (3 X10 mL). 
The combined organic layer was washed with brine and dried over Na2SO4. After 
removal of solvents in vacuo, column purification (silica gel, 30 Æ 40% EtOAc/Hexanes) 
afforded pyrrole 4.42 as a pale-yellow foam (37 mg, 74%): Rf = 0.18 (40% 
EtOAc/Hexanes); IR (thin film) 3268, 2948, 2865, 1773, 1725 cm-1; 1H-NMR (500 MHz, 
benzene-d6) δ = 10.95 (s, 1H), 10.20 (s, 1H), 7.58-7.64 (m, 4H), 7.20-7.28 (m, 6H), 6.93-
6.95 (m, 2H), 6.77 (s, 1H), 6.69 (s, 1H), 6.46 (d, J = 2.5 Hz, 1H), 6.16 (s, 1H), 5.40 (d, J 
= 16.5 Hz, 1H), 4.94 (s, 1H), 4.21-4.31 (m, 3H), 4.04 (t, J = 9.5 Hz, 1H), 3.88 (m, 1H), 
3.79 (d, J = 8.5 Hz, 1H), 3.50-3.55 (m, 4H), 3.45 (s, 3H), 3.37 (s, 3H), 3.30-3.34 (m, 1H), 
1.02-1.11 (m, 30 H); 13C-NMR (125 MHz, benzene-d6) δ = 174.60, 160.50, 158.14, 
150.02, 149.43, 135.92, 135.80, 133.03, 132.99, 130.11, 130.08, 129.92, 128.20, 128.02, 
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127.82, 125.46, 122.84, 120.15, 114.25, 111.88, 111.20, 110.48, 77.23, 64.16, 61.97, 
61.47, 59.03, 55.18, 55.08, 50.54, 49.73, 46.67, 44.54, 43.74, 26.94, 19.24, 19.16, 18.09, 
12.07; HRMS (ESI) calcd for C50H67ClN4O7Si2 [M+Li] 933.4397; found [M+Li] 
933.4373. 
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Alcohol 4.43: To a solution of pyrrole 4.42 (60 mg, 0.065 mmol) in methanol (3.2 mL) 
was added p-toluenesulofonic acid (pTSA, 18 mg, 0.097 mmol). The reaction was stirred 
at 20 °C for 16 h. PH 7 buffer (10 mL) was added to the reaction after 16 h. The 
resulting mixture was partitioned between water (20 mL) and EtOAc (3 X20 mL). The 
combined organic layer was washed with brine and dried over Na2SO4. After removal of 
solvents in vacuo, column purification (silica gel, 80 Æ 100% EtOAc/Hexanes) afforded 
monodeprotected alcohol 4.43 (35 mg, 70%): Rf = 0.12 (80% EtOAc/Hexanes); IR (thin 
film) 3275, 2934, 2857, 1770, 1723 cm-1; 1H-NMR (500 MHz, acetone-d6) δ = 10.97 (s, 
1H), 10.11 (s, 1H), 7.61-7.68 (m, 4H), 7.40-7.50 (m, 6H), 7.10 (s, 1H), 6.55-6.65 (m, 
4H), 6.24 (m, 1H), 5.06 (d, J = 15.5 Hz, 1H), 4.67 (t, J = 4.5 Hz, 1H), 4.25 (d, J = 11.5 
Hz, 2H), 4.16 (s, 2H), 3.93 (dd, J = 3.5, 11.0 Hz, 1H), 3.88 (d, J = 16.0 Hz, 1H), 3.66-
3.75 (m, 4H), 3.63 (s, 3H), 3.46 (s, 3H), 3.33 (bs, 1H), 3.05 (bs, 1H), 0.97-1.03 (s, 9 H); 
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13C-NMR (125 MHz, acetone-d6) δ = 174.48, 160.13, 156.92, 149.49, 149.00, 135.81, 
135.71, 133.00, 130.21, 130.17, 128.14, 128.10, 125.85, 122.35, 120.01, 113.60, 111.70, 
111.20, 109.97, 76.77, 62.94, 61.81, 61.65, 59.65, 55.24, 54.93, 50.63, 48.97, 46.91, 
43.87, 43.58, 26.63, 19.05; HRMS (MALDI) calcd for C41H47ClN4O7Si [M+H] 
771.2975; found [M+H] 771.2967. 
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N,O-Acetal 4.46: To a reaction vial containing alcohol 4.43 (24 mg, 0.031 mmol) was 
added a solution of IBX in DMSO (17 mg IBX in 2.0 mL DMSO, 0.062 mmol). The 
reaction mixture was stirred for 21 h at 20 °C. After 21 h, the reaction mixture was 
partitioned between water (10 mL) and EtOAc (3 X10 mL). The combined organic layer 
was washed with brine and dried over Na2SO4. After removal of solvents in vacuo, the 
crude product was run through a silica gel plug to remove the baseline material to afford 
the aldehyde 4.45 (24 mg, 99%). 
 Aldehyde 4.45 (4.0 mg, 0.0052 mmol) was dissolved in anhydrous DMSO (0.50 
mL) and the resulting solution was heated to 70 °C and stirred for 18 h. After the 
reaction time, the reaction mixture was partitioned between water (10 mL) and EtOAc (3 
X10 mL). The combined organic layer was washed with brine and dried over Na2SO4. 
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After removal of solvents in vacuo, column purification (silica gel, 20 Æ 30% 
acetone/CH2Cl2) afforded N,O-acetal 4.46 (2.8 mg, 70%): Rf = 0.68 (50% 
acetone/CH2Cl2); IR (thin film) 3275, 2934, 2857, 1770, 1723 cm-1; 1H-NMR (500 MHz, 
acetone-d6) δ = 7.67-7.70 (m, 4H), 7.42-7.50 (m, 6H), 7.02 (d, J = 2.0 Hz, 1H), 6.73 (dd, 
J = 8.0, 2.0 Hz, 1H), 6.63 (s, 1H), 6.62 (s, 1H), 6.49 (d, J = 8.0 Hz, 1H), 6.08 (t, J = 3.5 
Hz, 1H), 5.81 (d, J = 7.5 Hz, 1H), 5.23 (d, J = 5.5 Hz, 1H), 4.83 (d, J = 12.0 Hz, 1H), 
4.56 (s, 2H), 4.12-4.16 (m, 2H), 4.02 (dd, J = 3.5, 11.0 Hz, 1H), 3.81-3.84 (m, 1H), 3.68 
(s, 3H), 3.64 (s, 3H), 3.62-3.66 (m, 1H), 3.51 (dd, J = 5.5, 9.0 Hz, 1H), 3.36-3.40 (m, 
1H), 3.08-3.12 (m, 1H), 1.09 (s, 9H); 13C-NMR (125 MHz, acetone-d6) δ = 174.24, 
158.11, 157.16, 149.71, 149.22, 135.76, 135.73, 133.39, 132.88, 130.42, 130.23, 130.19, 
128.17, 128.11, 124.03, 122.86, 120.11, 112.26, 111.88, 111.53, 109.42, 77.11, 76.49, 
61.74, 61.66, 58.43, 55.37, 55.11, 19.94, 46.11, 45.60, 44.70, 41.69, 26.71, 19.15; 
HRMS (MALDI) calcd for C41H45ClN4O7Si [M+H] 769.2819; found [M+H] 769.2789. 
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N,O-Acetal 4.46: N,O-Acetal 4.47 (6.0 mg, 0.0078 mmol) was dissolved in anhydrous 
DMSO (0.80 mL) and the resulting solution was heated to 70 °C and stirred for 16 h. 
After the reaction time, the reaction mixture was partitioned between water (10 mL) and 
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EtOAc (3 X10 mL). The combined organic layer was washed with brine and dried over 
Na2SO4. After removal of solvents in vacuo, column purification (silica gel, 10 Æ 20% 
acetone/CH2Cl2) afforded the epimerized N,O-acetal 4.46 (4.0 mg, 67%). 
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Azide 4.48 and pyrrolo-pyrazinone 4.48b: To a solution of alcohol 4.46 (6.0 mg, 
0.0078 mmol) in anhydrous THF (0.80 mL) was added DPPA (4 μL, 0.012 mmol) at 0 
°C, followed by DBU (3 μL, 0.020 mmol). The reaction was allowed to warm to 20 °C 
and stirred for 29 h. The reaction mixture was then partitioned between water (10 mL) 
and EtOAc (2 X 10 mL). The combined organic layer was washed with brine and dried 
over Na2SO4. After removal of solvents in vacuo, column purification (silica gel, 40 Æ 
60% EtOAc/Hexanes) afforded two products: azide 4.48 (4.0 mg, 67%) and pyrrolo-
pyrazinone 4.48b (1.5 mg, 25%). Azide 4.48: Rf = 0.76 (80% EtOAc/Hexanes); IR (thin 
film) 2928, 2854, 2117, 1729, 1637 cm-1; 1H-NMR (500 MHz, acetone-d6) δ = 10.30 (bs, 
1H), 7.68-7.70 (m, 4H), 7.44-7.50 (m, 6H), 7.05 (s, 1H), 7.03 (s, 1H), 6.81 (d, J = 6.5 Hz, 
1H), 6.72 (d, J = 3.5 Hz, 1H), 6.51 (d, J = 8.5 Hz, 1H), 6.23 (t, J = 3.0 Hz, 1H), 5.58 (d, 
J = 10.0 Hz, 1H), 4.86 (d, J = 12.5 Hz, 1H), 4.65 (s, 2H), 4.20-4.24 (dd, J = 8.0, 12.0 Hz, 
1H), 4.02-4.05 (dd, J = 4.0, 11.5 Hz, 1H), 3.82-3.86 (dd, J = 7.0, 11.0 Hz, 1H), 3.75-3.79 
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(m, 1H), 3.68 (s, 3H), 3.61 (s, 3H), 3.51-3.58 (m, 2H), 3.34-3.41 (m, 1H), 3.04-3.09 (m, 
1H), 1.09 (s, 9H); 13C-NMR (125 MHz, acetone-d6) δ = 174.44, 157.52, 156.21, 149.78, 
149.36, 135.79, 135.75, 135.74, 133.22, 132.90, 130.26, 130.24, 129.93, 128.17, 128.12, 
128.09, 125.02, 120.81, 120.51, 113.54, 112.20, 111.43, 110.44, 77.27, 73.63, 61.80, 
61.63, 58.29, 55.31, 55.11, 51.87, 46.28, 46.04, 45.01, 42.49, 26.68, 19.14. MS (ESI) 
calcd for C41H44ClN7O6Si [M+H] 794, found [M+H] 794. 
Pyrrolo-pyrazinone 4.48b: Rf = 0.62 (80% EtOAc/Hexanes); IR (thin film) 2919, 
2851, 1773, 1729 cm-1; 1H-NMR (500 MHz, acetone-d6) δ = 10.1 (bs, 1H), 7.65-7.68 (m, 
4H), 7.42-7.50 (m, 7H), 7.27 (dd, J = 1.5, 2.5 Hz, 1H), 6.93 (m, 1H), 6.85 (d, J = 2.5 Hz, 
1H), 6.50-6.53 (m, 2H), 6.40 (d, J = 8.5 Hz, 1H), 4.63-4.66 (d, J = 16.0 Hz, 1H), 4.54-
4.57 (d, J = 12.5 Hz, 1H), 4.41-4.45 (dd, J = 10.0, 13.0 Hz, 1H), 4.21-4.25 (m, 1H), 
4.03-4.06 (dd, J = 3.0, 11.0 Hz, 1H), 3.81-3.84 (dd, J = 6.5, 11.0 Hz, 1H), 3.70 (s, 3H), 
3.61 (dd, J = 3.0, 6.5 Hz, 1H), 3.57 (s, 3H), 3.45-3.48 (d, J = 16.0 Hz, 1H), 3.06-3.12 (m, 
1H), 1.09 (s, 9H); 13C-NMR (125 MHz, acetone-d6) δ = 173.68, 156.77, 154.25, 149.54, 
149.08, 135.80, 135.79, 135.76, 133.28, 132.80, 130.24, 130.18, 129.83, 128.16, 128.09, 
127.34, 124.26, 119.61, 119.47, 112.25, 111.52, 111.33, 108.87, 106.31, 77.31, 61.39, 
59.25, 55.23, 55.07, 50.63, 47.72, 46.02, 44.48, 41.04, 29.94, 26.70, 19.12; HRMS (ESI) 
calcd for C41H43ClN4O6Si [M+Li] 757.2800; found [M+Li] 757.2851. 
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Isothiourea 4.51: To a solution of azide 4.48 (2.0 mg, 0.0025 mmol) in anhydrous THF 
(0.20 mL) was added samarium diiodide (0.1 M solution in THF, 0.2 mL, 0.02 mmol) at 
-78 °C. The reaction was warmed to 20 °C and stirred for 10 min. Then the reaction was 
quenched with sat’d NaHCO3. The mixture was extracted with EtOAc. The organic layer 
was washed with water and brine, and dried over Na2SO4. After removal of solvents in 
vacuo, column purification (silica gel, 60 Æ 80% EtOAc/Hexanes) afforded the amine 
4.49 (2 mg, 99%): Rf = 0.35 (80% EtOAc/Hexanes); 1H-NMR (500 MHz, benzene-d6) δ 
= 10.2 (bs, 1H), 7.68-7.71 (m, 4H), 7.44-7.52 (m, 6H), 7.07-7.10 (m, 2H), 6.84 (dd, J = 
2.0, 8.0 Hz, 1H), 6.69 (m, 1H), 6.52 (d, J = 8.0 Hz, 1H), 6.14 (t, J = 3.0 Hz, 1H), 4.79 (d, 
J = 12.0 Hz, 1H), 4.76 (d, J = 16.5 Hz, 1H), 4.66-4.72 (dd, J = 9.5, 19.5 Hz, 1H), 4.46 (d, 
J = 16.0 Hz, 1H), 4.29-4.33 (dd, J = 8.0, 12.0 Hz, 1H), 4.01-4.04 (m, 1H), 3.80-3.84 (dd, 
J = 7.0, 10.5 Hz, 1H), 3.75-3.78 (m, 2H), 3.71 (s, 3H), 3.62 (s, 3H), 3.53-3.58 (t, J = 
12.0 Hz, 1H), 3.47-3.50 (dd, J = 4.0, 9.0 Hz, 1H), 3.26-3.33 (m, 1H), 3.02-3.08 (m, 1H), 
2.58-2.62 (m, 2H), 1.10 (s, 9H); HRMS (ESI) calcd for C41H46ClN5O6Si [M+H] 
768.2984; found [M+H] 768.2980. 
To a solution of amine 4.49 (4.4 mg, 0.0057 mmol) in CH2Cl2 (0.60 mL) at 21 
°C was added imidochloride (TcesN=C(SMe)Cl) (4.0 mg, 0.0114 mmol), followed by 
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Et3N (3 μL, 0.0228 mmol). After 11 h at 21 °C, the reaction mixture was partitioned 
between water and EtOAc. The organic layer was washed with water and brine, and 
dried over Na2SO4. After removal of solvents in vacuo, column purification (silica gel, 
50 % EtOAc/Hexanes) afforded the isothiourea 4.51 (4.6 mg, 77%): Rf = 0.60 (70% 
EtOAc/Hexanes); IR (thin film) 3420, 2931, 2857, 1741, 1700 cm-1; 1H-NMR (500 MHz, 
acetone-d6) δ = 7.65-7.67 (m, 4H), 7.42-7.52 (m, 6H), 7.10 (s, 1H), 7.09 (d, J = 2.0 Hz, 
1H), 6.77 (dd, J = 2.0, 8.0 Hz, 1H), 6.68 (dd, J = 1.5, 3.5 Hz, 1H), 6.44 (d, J = 8.0 Hz, 
1H), 6.12 (t, J = 3.0 Hz, 1H), 5.04 (s, 2H), 4.91-4.98 (d, J = 16.0 Hz, 1H), 4.85 (d, J = 
12.0 Hz, 1H), 4.71-4.77 (dd, J = 9.5, 19.0 Hz, 1H), 4.52 (d, J = 16.0 Hz, 1H), 4.30-4.34 
(dd, J = 8.5, 12.5 Hz, 1H), 4.01-4.04 (dd, J = 3.0, 10.5 Hz, 1H), 3.79-3.85 (m, 2H), 3.74 
(s, 3H), 3.57-3.62 (m, 2H), 3.59 (s, 3H), 3.33-3.40 (m, 1H), 2.92-2.98 (m, 1H), 2.79 (s, 
3H), 2.44-2.54 (bs, 1H), 1.08 (s, 9H); 13C-NMR (125 MHz, acetone-d6) δ = 169.68, 
156.94, 149.97, 149.40, 135.76, 133.27, 132.80, 130.26, 130.22, 129.12, 128.17, 128.09, 
125.02, 120.30, 119.93, 113.00, 111.54, 111.36, 108.87, 79.70, 68.56, 61.32, 59.01, 
55.39, 55.15, 46.75, 46.26, 45.94, 42.29, 36.57, 29.94, 26.69, 19.13, 16.42; HRMS (ESI) 
calcd for C45H50Cl4N6O9S2Si [M+H] 1051.1682; found [M+H] 1051.1678. 
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N,N-hemiacetal 5.14 and 5.15: To a stirred solution of N,O-acetal 5.9 (325 mg, 1.69 
mmol) in THF (17 mL) was added DPPA (0.40 mL, 1.86 mmol) dropwise at 0 °C, 
followed by the dropwise addition of DBU (0.28 mL, 1.86 mmol). The reaction was 
stirred at 21 °C for 10 h. The reaction mixture was then partitioned between water and 
EtOAc. Following extraction with EtOAc (3 X 50mL), the combined organic layers were 
washed with H2O, brine, and then dried over anhydrous Na2SO4. Solvents were removed 
in vacuo and the residue was purified by flash chromatography (silica gel, 60 Æ 80% 
EtOAc/hexanes) to furnish the azide product as a ~1:1 mixture of diastereomers (230 mg, 
63%).  
A portion of azides 5.13 produced above (inseparable mixture of diastereomers, 
dr ~3:4) (56 mg, 0.26 mmol) were dissolved in anhydrous MeOH, the solution was 
charged with Pd/C (~ 10 mg), and then purged with hydrogen gas. The reaction mixture 
was stirred under H2 atmosphere at 21 °C for 18 h. The reaction mixture was filtered 
through Celite® and concentrated to give aminals 5.14 and 5.15 which were separated by 
flash column chromatography (silica gel, EtOAc to 5% MeOH/EtOAc) to give aminal 
5.14 (15 mg, 31%) and the diastereomeric aminal 5.15 (20 mg, 39%). Aminal 5.14: Rf = 
0.26 (10% MeOH/EtOAc); [α]D: +91.2 (0.90, CHCl3); IR (thin film) 3381, 2975, 2881, 
1629 cm-1; 1H-NMR (500 MHz, CDCl3) δ 7.04 (dd, J = 2.0, 2.5 Hz, 1H), 6.87 (dd, J = 
2.0, 4.0 Hz, 1H), 6.21 (dd, J = 2.5, 4.0 Hz, 1H), 4.61 (d, J = 10.0 Hz, 1H), 3.68 (m, 1H), 
3.50-3.61 (m, 2H), 2.45 (bs, 2H), 2.34 (m, 1H), 2.02-2.06 (m, 1H), 1.80-1.87 (m, 2H); 
13C-NMR (125 MHz, CDCl3) δ 158.26, 125.46, 119.47, 113.70, 110.13, 69.21, 64.11, 
45.02, 30.79, 23.14; HRMS (ESI) Calcd for C10H13N3O [M+H]: 192.1137, found: 
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192.1141. Aminal 5.15: Rf = 0.15 (10% MeOH/EtOAc); IR (thin film) 3378, 2973, 2878, 
1629 cm-1; 1H-NMR (500 MHz, CDCl3) δ 6.88 (dd, J = 1.5, 3.5 Hz, 1H), 6.86 (dd, J = 
2.0, 2.5 Hz, 1H), 6.22 (dd, J = 2.5, 3.5 Hz, 1H), 5.02 (d, J = 3.0 Hz, 1H), 4.13 (m, 1H), 
3.78 (m, 1H), 3.56 (m, 1H), 2.09-2.26 (m, 5H), 1.89-1.95 (m, 1H); 13C-NMR (125 MHz, 
CDCl3) δ 158.36, 123.77, 121.74, 113.48, 110.76, 65.13, 61.17, 44.57, 28.19, 23.61; 
HRMS (ESI) Calcd for C10H13N3O [M+H]: 192.1137, found: 192.1141. 
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Tces-protected guanidine 5.17: To a stirred solution of aminal 5.14 (0.843 g, 4.40 
mmol) and imidochloride 4.50 (2.12 g, 6.60 mmol) in CH2Cl2 (30.0 mL) was added 
triethylamine (1.86 mL, 13.2 mmol) dropwise at 21 °C. The reaction mixture was stirred 
for 16 h and then concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel eluting with 80% EtOAc/hexanes to EtOAc to give the 
isothiourea intermediate 5.17a (1.95 g, 93%).  
The isothiourea 5.17a (1.9 g, 4.0 mmol) was dissolved in CH3CN and the 
reaction mixture was charged with HMDS (2.1 mL, 10 mmol) and HgCl2 (1.2 g, 4.4 
mmol) sequentially. After being stirred for 18 h at 21 °C, the reaction mixture was 
filtered to remove solid residue. The filtrate was concentrated in vacuo and purified by 
flash chromatography (silica gel, 80% EtOAc/hexanes to EtOAc) to give Tces-protected 
154
guanidine 5.17 as a white solid (1.4 g, 77%). The product was recrystallized in MeOH to 
give slightly pink thin needle crystals. After slow evaporation of an EtOH solution of the 
compound, a colorless needle crystal was obtained and was suitable for X-ray 
crystallography. The crystal structure of 5.17 confirmed its identity (crystallographic 
data submitted to the Cambridge Crystallographic Data Centre, reference number: 
CCDC-652212). Rf = 0.12 (EtOAc); [α]D: -49.1 (0.91, CH3CN); IR (thin film) 3440, 
3323, 2952, 1628 cm-1; 1H-NMR (500 MHz, CD3CN) δ 7.25 (d, J = 9.5 Hz, 1H), 6.92 
(bs, 2H), 6.85 (t, J = 2.0 Hz, 1H), 6.69 (dd, J = 1.5, 3.5 Hz, 1H), 6.17 (dd, J = 2.5, 3.5 Hz, 
1H), 5.88 (bs, 1H), 4.62 (s, 2H), 3.89 (m, 1H), 3.54 (m, 1H), 3.42 (m, 1H), 2.20 (m, 1H), 
2.02 (m, 1H), 1.80-1.85 (m, 2H); 13C-NMR (125 MHz, CD3CN) δ 157.90, 157.79, 
125.02, 121.07, 113.39, 110.22, 94.42, 78.15, 66.17, 61.05, 44.96, 29.55, 22.83; HRMS 
(ESI) Calcd for C13H16Cl3N5O4S [M+Li]: 450.0149, found: 450.0143.  
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Tces-protected guanidine 5.12: To a slurry of guanidine 5.17 (5.0 mg, 0.011 mmol) in 
CH2Cl2 (0.30 mL) was added NBS (4.0 mg, 0.023 mmol). The reaction was stirred for 2 
h at 21 °C and then concentrated in vacuo. Column purification of the crude product 
(silica gel, 50 Æ 90 % EtOAc/Hexanes) afforded the Tces-guanidine 5.12 (6.7 mg, 99%): 
Rf = 0.21 (EtOAc); [α]D: -13.8 (c 0.33, 1:2 MeOH:CH2Cl2); IR (thin film) 3443, 3368, 
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1642 cm-1; 1H-NMR (500 MHz, CD3CN) δ 6.89 (s, 1H), 6.60-6.76 (bs, 2H), 6.56 (d, J = 
10.0 Hz, 1H), 6.18-6.23 (t, J = 10.0 Hz, 1H), 4.64 (s, 2H), 3.95-4.06 (m, 1H), 3.61-3.65 
(m, 1H), 3.44-3.50 (m, 1H), 2.23-2.26 (m, 1H), 2.03-2.08 (m, 1H), 1.84-1.90 (m, 2H); 
13C-NMR (125 MHz, CD3CN) δ 157.25, 155.54, 128.88, 118.22, 115.23, 104.12, 102.62, 
78.19, 68.39, 61.04, 44.98, 29.59, 22.44; HRMS (ESI) Calcd for C13H14Br2Cl3N5O4S 
[M+H]: 599.8277, found: 599.8248. 
 
5.17
N
N
O
H
H
N
H2N
TcesN
O
H
N
HN
TcesN
N
N
5.18  
 
Tces-protected phakellin 5.18: To a mixture of guanidine 5.17 (8.0 mg, 0.018 mmol), 
PhI(OAc)2 (23 mg, 0.072 mmol) and MgO (2.0 mg, 0.036 mmol) in a microwave 
reaction tube was added 1.0 mL of CH3CN. The reaction tube was placed in a 
microwave reactor and heated (150 Watts) for 10 min. The reaction mixture was 
concentrated in vacuo and subjected to column chromatography (silica gel , 60 Æ 80% 
EtOAc/hexanes) to yield the cyclized product 5.18 (3.0 mg, 38%): Rf = 0.35 (EtOAc); 
[α]D: +40.4 (0.70, CH2Cl2); IR (thin film) 3362, 2923, 2851, 1611 cm-1; 1H-NMR (500 
MHz, CD3CN) δ 7.86 (s, 1H), 7.42 (s, 1H), 7.03 (dd, J = 1.5, 2.5 Hz, 1H), 6.76 (dd, J = 
1.5, 4.0 Hz, 1H), 6.33 (dd, J = 2.5, 4..0 Hz, 1H), 5.80 (s, 1H), 4.54 (s, 2H), 3.72-3.76 (m, 
1H), 3.51-3.57 (m, 1H), 2.29-2.34 (m, 2H), 2.07-2.12 (m, 2H); 13C-NMR (125 MHz, 
CD3CN) δ 157.63, 156.04, 123.94, 122.24, 112.59, 112.08, 94.20, 81.97, 78.07, 68.16, 
156
45.16, 38.92, 19.88; HRMS (ESI) Calcd for C13H14Cl3N5O4S [M+Li]: 447.9992, found: 
447.9972.  
 
Note: On ~10 mg scale, the reaction reproducibly gave 30-38% yield; in one instance, 
scaling up to 83 mg led to a decrease of yield (22%). 
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Guanidine 5.23: To a mixture of Tces-protected guanidine 5.17 (91 mg, 0.205 mmol) 
and zinc powder (67 mg, 1.025 mmol) in MeOH (3.0 mL) was added acetic acid (35 μL, 
0.615 mmol). The reaction mixture was heated to 50 °C and stirred vigorously for 3 h. 
After cooling to 20 °C, the reaction mixture was filtered through Celite® to remove zinc 
residues. The filtrate was concentrated in vacuo and the crude product was purified by 
column chromatography (silica gel, 5 Æ 30 % MeOH/CH2Cl2) to give the guanidine 
5.23 (35 mg, 75%): Rf = 0.09 (20% CH3OH/CH2Cl2); [α]D: -26.6 (c 1.60, CH3OH); IR 
(thin film) 3429, 3331, 2979, 1623 cm-1; 1H-NMR (500 MHz, CD3OD) δ 7.01 (dd, J = 
1.5, 2.5 Hz, 1H), 6.83 (dd, J = 1.5, 4.0 Hz, 1H), 6.20 (dd, J = 2.5, 4.0 Hz, 1H), 5.85 (d, J 
= 10.5 Hz, 1H), 3.92-3.97 (m, 1H), 3.69-3.74 (m, 1H), 3.55-3.60 (m, 1H), 2.30-2.34 (m, 
1H), 2.10-2.14 (m, 1H), 1.92-1.98 (m, 2H); 13C-NMR (125 MHz, CD3OD) δ 160.12, 
157
156.86, 125.02, 122.92, 114.83, 110.80, 67.05, 62.59, 46.02, 30.49, 23.84; MS (ESI) 
calcd for C11H15N5O [M+H]: 234, found: [M+H]: 234. 
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Tosyl-guanidine 5.25: To a stirred solution of aminal 5.14 (23.0 mg, 0.120 mmol) and 
imidochloride 5.26 (TsN=C(SMe)Cl) (38 mg, 0.144 mmol) in anhydrous CH3CN (1.2 
mL) was added Hünig’s base (diisopropylethylamine, 105 μL, 0.600 mmol) dropwise at 
21 °C. The reaction mixture was heated to 45 °C and stirred for 24 h. After removal of 
solvents in vacuo, the crude product was purified by flash chromatography on silica gel 
eluting with 80% EtOAc/hexanes to EtOAc to give the isothiourea intermediate 5.27 (15 
mg, 30%): Rf = 0.17 (EtOAc); [α]D: +17.4 (c 1.20, CH2Cl2); IR (thin film) 3248, 2925, 
1629 cm-1; 1H-NMR (500 MHz, CDCl3) δ 8.77 (d, J = 10.5 Hz, 1H), 7.82 (d, J = 8.0 Hz, 
2H), 7.33 (d, J = 8.0 Hz, 2H), 6.97(m, 1H), 6.72 (m, 1H), 6.26 (m, 1H), 5.57-5.61 (t, J = 
10.0 Hz, 1H), 3.92-3.97 (m, 1H), 3.79-3.83 (m, 1H), 3.57-3.63 (m, 1H), 2.45 (s, 3H), 
2.44 (s, 3H), 2.29-2.34 (m, 1H), 2.11-2.17 (m, 1H), 1.85-1.98 (m, 2H); 13C-NMR (125 
MHz, CDCl3) δ 168.77, 157.50, 143.91, 138.62, 129.80, 126.59, 125.19, 120.08, 114.86, 
111.23, 69.19, 61.95, 44.88, 29.91, 22.97, 21.75, 14.73; MS (ESI) calcd for 
C19H22N4O3S2 [M+H]: 419, found: [M+H]: 419. 
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The isothiourea 5.27 (10 mg, 0.024 mmol) was dissolved in CH3CN (1.0 mL) 
and the solution was charged with HMDS (12 μL, 0.060 mmol) and HgCl2 (13 mg, 
0.048 mmol) sequentially. After being stirred for 3 h at 21 °C, the reaction mixture was 
filtered to remove solid residue. The filtrate was concentrated in vacuo and purified by 
flash chromatography (silica gel, EtOAc to 5% MeOH/EtOAc) to give tosyl-protected 
guanidine 5.25 as a white solid (10 mg, 99%): Rf = 0.09 (EtOAc); [α]D: -19.8 (c 0.92, 
CH3CN); IR (thin film) 3435, 3331, 2922, 1623 cm-1; 1H-NMR (500 MHz, CD3CN) δ 
7.69 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 6.68 (dd, J = 1.5, 3.5 Hz, 1H), 6.60 
(dd, J = 1.5, 2.5 Hz, 1H), 6.48 (bs, 1H), 6.11 (dd, J = 2.5, 3.5 Hz, 1H), 5.80 (m, 1H),  
3.82-3.87 (m, 1H), 3.56-3.61 (m, 1H), 3.41-3.47 (m, 1H), 2.40 (s, 3H), 2.05-2.09 (m, 
1H), 1.97-2.02 (m, 1H), 1.80-1.85 (m, 1H), 1.66-1.72 (m, 1H); 13C-NMR (125 MHz, 
CD3CN) δ 158.03, 157.62, 143.62, 141.61, 130.26, 126.82, 126.13, 121.13, 113.51, 
110.48, 66.93, 61.49, 45.44, 30.14, 23.47, 21.43; MS (ESI) calcd for C18H21N5O3S 
[M+H]: 388, found: [M+H]: 388. 
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Tces-guanidine 5.29: To a solution of guanidine 5.17 (105 mg, 0.236 mmol) in 
anhydrous THF (5.0 mL) was added Belleau’s reagent (124 mg, 0.236 mmol). The 
reaction mixture was heated to 60 °C. After 16 h, the reaction was quenched with sat’d 
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NaHCO3 solution (5 mL) and the resulting mixture was partitioned between water (15 
mL) and EtOAc (2 X 20 mL). The combined organics were washed with brine and dried 
further over Na2SO4. After removal of solvents in vacuo, the residue was purified by 
column chromatography (silica gel, 60 % EtOAc/Hexanes to EtOAc) to yield the 
piperazine-thione 5.29 (45 mg, 42%): Rf = 0.73 (EtOAc); [α]D: -9.4 (c 0.20, 1:1 
CH3OH:CH2Cl2); IR (thin film) 3458, 3343, 2946, 1626 cm-1; 1H-NMR (500 MHz, 
CD3CN) δ 7.01 (dd, J = 1.5, 4.0 Hz, 1H), 6.90 (dd, J = 2.0, 2.5 Hz, 1H), 6.60-6.80 (bs, 
3H), 6.19 (dd, J = 2.5, 4.0 Hz, 1H), 5.98 (bs, 1H), 4.62 (s, 2H), 4.05-4.10 (m, 1H), 3.90-
3.98 (m, 1H), 3.72-3.78 (m, 1H), 2.30-2.35 (m, 1H), 2.09-2.15 (m, 1H), 1.91-1.97 (m, 
2H); 13C-NMR (125 MHz, CD3CN) δ 178.94, 157.49, 131.11, 120.96, 117.75, 110.84, 
94.33, 78.17, 65.66, 62.60, 51.62, 29.66, 22.25; HRMS (ESI) Calcd for 
C13H16Cl3N5O3S2 [M+H]: 459.9838, found: [M+H]: 459.9859. 
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Urea 5.31: To a solution of amine 5.14 (40 mg, 0.21 mmol) in anhydrous THF (2.0 mL) 
was added trichloroacetyl isocyanate (62 μL, 0.52 mmol) at 20 °C. The reaction mixture 
was stirred for 10 min at 20 °C, then MeOH (3.0 mL) was added, followed by some 
silica gel (~ 1 g). The resulting slurry was heated to 45 °C and stirred vigorously for 24 h. 
The reaction mixture was then filtered (to remove silica gel) and the filtrate was 
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concentrated in vacuo. Due to the limited solubility of urea 5.31 in EtOAc, the crude 
product was washed with a small amount of EtOAc (~ 2 mL) to remove any impurities, 
affording urea 5.31 as a white solid (40 mg, 82%): Rf = 0.06 (EtOAc); [α]D: -19.6 (c 0.13, 
CH3OH); IR (thin film) 3266, 3206, 1658, 1596 cm-1; 1H-NMR (500 MHz, CD3OD) δ 
6.89 (dd, J = 1.5, 2.5 Hz, 1H), 6.84 (dd, J = 1.5, 4.0 Hz, 1H), 6.23 (dd, J = 2.5, 4.0 Hz, 
1H), 5.67 (d, J = 10.5 Hz, 1H), 3.89-3.94 (m, 1H), 3.71-3.75 (m, 1H), 3.56-3.62 (m, 1H), 
2.27-2.32 (m, 1H), 2.12-2.16 (m, 1H), 1.91-1.97 (m, 2H); 13C-NMR (125 MHz, CD3OD) 
δ 160.78, 160.13, 125.28, 122.03, 114.94, 111.02, 66.98, 62.66, 46.04, 30.67, 23.83; MS 
(ESI) calcd for C11H14N4O2 [M+H]: 235, found: [M+H]: 235, [M+Na]: 257. 
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Tces-guanidine 5.32: To a stirred solution of aminal 5.15 (170 mg, 0.890 mmol) and 
imidochloride 4.50 (TcesN=C(SMe)Cl) (342 mg, 1.07 mmol) in CH2Cl2 (9.0 mL) was 
added triethylamine (370 μL, 2.67 mmol) dropwise at 21 °C. The reaction mixture was 
stirred for 12 h and then concentrated in vacuo. The crude product was purified by flash 
chromatography on silica gel eluting with 80% EtOAc/hexanes to EtOAc to give the 
isothiourea intermediate 5.32a (420 mg, 99%).  
The isothiourea 5.32a (420 mg, 0.890 mmol) was dissolved in CH3CN and the 
reaction mixture was charged with HMDS (460 μL, 2.23 mmol) and HgCl2 (266 mg, 
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0.980 mmol) sequentially. After being stirred for 12 h at 21 °C, the reaction mixture was 
filtered to remove solid residue. The filtrate was concentrated in vacuo and purified by 
flash chromatography (silica gel, 80% EtOAc/hexanes to EtOAc) to give Tces-guanidine 
5.32 as a white solid (230 mg, 59%): Rf = 0.26 (EtOAc); [α]D: +170.5 (c 0.15, 1:1 
CH3OH:CH2Cl2); IR (thin film) 3449, 3337, 2978, 1626 cm-1; 1H-NMR (500 MHz, 
CD3OD) δ 7.17 (dd, J = 1.5, 2.5 Hz, 1H), 6.84 (dd, J = 1.5, 4.0 Hz, 1H), 6.39 (d, J = 2.5 
Hz, 1H), 6.23 (dd, J = 2.5, 4.0 Hz, 1H), 4.67-4.72 (dd, J = 11.5, 13.5 Hz, 2H), 4.29-4.33 
(m, 1H), 3.73-3.78 (m, 1H), 3.50-3.55 (m, 1H), 2.22-2.27 (m, 1H), 2.10-2.16 (m, 1H), 
1.96-2.03 (m, 1H), 1.85-1.92 (m, 1H); 13C-NMR (125 MHz, CD3OD) δ 160.10, 158.56, 
125.52, 124.52, 114.55, 111.54, 95.59, 79.25, 62.24, 61.60, 45.33, 28.61, 24.01; MS 
(ESI) calcd for C13H16Cl3N5O4S [M+H]: 444, found: [M+H]: 444.  
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(+)-Phakellin ent-1.9: To a solution of Tces-protected phakellin 5.18 (9.0 mg, 0.020 
mmol) in MeOH/AcOH (0.15 mL/0.15 mL) was added zinc powder (7.0 mg, 0.10 
mmol). The reaction mixture was heated to 40 °C and stirred vigorously for 30 min. The 
mixture was filtered through a cotton plug to remove zinc residue. Water (~10 mL) was 
added to the filtrate and the mixture was extracted with EtOAc (10 mL) to remove 
organic impurities. The aqueous phase was concentrated by lyophilization and the solid 
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residue was redissolved in 1.0 mL of water and purified by reversed phase prep-HPLC 
(C18 column, 0Æ90% CH3CN/H2O over 25 min, with 0.1% trifluoroacetic acid). The 
retention time of (+)-phakellin was 6 min. The fraction collected between 5.3-6.8 min 
was lyophilized to give (+)-phakellin (4.0 mg, 85%). Spectral data of synthetic (+)-
phakellin correlated well with that reported previously (Chapter V, Table 9). (+)-
Phakellin ent-1.9: Rf = 0 (EtOAc); [α]D: +5.6 (0.90, CH3OH); IR (thin film) 3000-3500, 
1697, 1552, 1383 cm-1; 1H-NMR (500 MHz, CD3CN) δ 7.19 (s, 1H), 6.91 (m, 1H), 6.40 
(t, J = 3.5 Hz, 1H), 6.00 (s, 1H), 3.85 (m, 1H), 3.67 (m, 1H), 2.42 (m, 2H), 2.20 (m, 2H); 
13C-NMR (125 MHz, CD3CN) δ 157.38, 154.02, 122.91, 122.86, 113.60, 112.13, 82.81, 
68.25, 45.41, 38.73, 19.69; HRMS (ESI) Calcd for C11H13N5O [M+H]: 232.1198, found: 
232.1191. 
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(+)-Monobromophakellin ent-1.10: To a solution of Tces-protected phakellin 5.18 (7.0 
mg, 0.016 mmol) in CH3CN (1.0 mL) was added NBS (6.0 mg, 0.032 mmol). The 
reaction mixture was stirred for 16 h at 21 °C, and then concentrated in vacuo. Column 
purification (silica gel, 70Æ80% EtOAc/hexanes) yielded the dibrominated product 5.22 
(8.0 mg, 84%).  
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To a solution of the Tces-protected dibromophakellin 5.22 (6.0 mg, 0.010 mmol) 
in MeOH/AcOH (0.20 mL/0.10 mL) was added zinc powder (3.0 mg, 0.050 mmol). The 
reaction mixture was heated to 40 °C and stirred vigorously for 40 min. The mixture was 
filtered through a cotton plug to remove zinc residue and the filtrate was partitioned 
between water (10 mL) and EtOAc (10 mL). The aqueous phase was concentrated by 
lyophilization and the solid residue was redissolved in 1.0 mL of water and purified by 
reversed phase prep-HPLC (0Æ90% CH3CN/H2O over 25 min, with 0.1% 
trifluoroacetic acid). The solution collected between 8-10 min was lyophilized to give 
(+)-monobromophakellin ent-1.10 (2.0 mg, 67%): Rf = 0 (EtOAc); [α]D: +118.3 (0.10, 
CH3OH); IR (thin film) 3000-3500, 1634, 1244 cm-1; 1H-NMR (500 MHz, CD3OD) δ 
7.24 (d, J = 2.0 Hz, 1H), 6.88 (d, J = 2.0 Hz, 1H), 6.03 (s, 1H), 3.84-3.88 (m, 1H), 3.62-
3.68 (m, 1H), 2.41-2.45 (m, 2H), 2.17-2.21 (m, 2H), NH2 and NH, NH+ protons were not 
observed due to relatively large amount of H2O; 13C-NMR (125 MHz, CD3OD) δ 157.21, 
154.87, 124.93, 123.57, 116.12, 100.96, 84.04, 69.51, 46.87, 39.95, 20.69; HRMS (ESI) 
Calcd for C11H12BrN5O [M+H]: 310.0303, found: 310.0302. 
 
Note: To compare directly with reported literature data, the synthetic (+)-monobromo- 
phakellin was treated with 0.01 M HCl in MeOH. Rotation and 1H-NMR data were 
retaken and correlated well with literature values (Chapter V, Table 10). 
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Alcohol 6.10: To a solution of chlorocyclopentane 2.36 (134 mg, 0.113 mmol) in 
anhydrous THF (2.0 mL) at -50 °C was added TBAF (1.0 M in THF, 136 μL, 0.136 
mmol). The reaction mixture was stirred for 1 h at -50 ~ -40 °C. Upon completion of the 
reaction as indicated by TLC, the reaction was quenched with pH 7 buffer (5 mL) and 
partitioned between water (10 mL) and EtOAc (3 X 15 mL). The combined organics 
were washed with brine and dried further over Na2SO4. Column purification (silica gel, 
30 Æ 50% EtOAc/Hexanes) after removal of solvents afforded TIPS-removed product 
6.10  as a white foam (114 mg, 98%): Rf = 0.59 (60% EtOAc/Hexanes); [α]D -26.1 (c 
1.70, CH2Cl2); IR (thin film) 3063, 2932, 2856, 1717, 1652 cm-1; 1H-NMR (500 MHz, 
benzene-d6) δ = 8.14 (d, J = 8.0 Hz, 2H), 7.91 (m, 2H), 7.85 (d, J = 8.0 Hz, 2H), 7.80 (m, 
2H), 7.46 (d, J = 2.0 Hz, 1H), 7.38 (dd, J = 8.0, 2.0 Hz, 1H), 7.21-7.29 (m, 6H), 6.81 (d, 
J = 8.0 Hz, 2H), 6.71 (d, J = 8.0 Hz, 2H), 6.37 (d, J = 8.0 Hz, 1H), 5.80 (d, J = 15.5 Hz, 
1H), 4.79 (s, 1H), 4.71 (d, J = 16.0 Hz, 1H), 4.54 (d, J = 12.5 Hz, 1H), 4.45-4.49 (dd, J = 
8.5, 10.5 Hz, 1H), 4.13-4.16 (dd, J = 4.0, 10.5 Hz, 1H), 3.93-3.96 (m, 1H), 3.72-3.74 (d, 
J = 11.5 Hz, 1H), 3.65-3.70 (m, 1H), 3.64 (s, 3H), 3.54-3.61 (m, 1H), 3.50 (d, J = 8.5 Hz, 
1H), 3.40-3.46 (m, 2H), 3.29 (s, 3H), 3.19-3.24 (m, 1H), 2.94-2.99 (m, 1H), 1.86 (s, 3H), 
1.76 (s, 3H), 1.17 (s, 9H), 0.99 (bs, 1H); 13C-NMR (125 MHz, benzene-d6) δ = 173.22, 
171.85, 156.86, 150.30, 149.94, 145.07, 144.97, 136.34, 136.21, 136.01, 135.77, 134.12, 
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133.78, 130.06, 129.98, 129.92, 129.80, 129.59, 129.33, 128.95, 128.35, 121.58, 112.97, 
112.14, 76.70, 63.75, 60.71, 60.57, 60.19, 55.81, 55.36, 50.82, 48.90, 48.13, 46.76, 
46.04, 33.30, 27.23, 21.21, 19.58; MS (MALDI) calcd for C52H58ClN3O11S2Si [M+H]: 
1028, [M+Na]: 1050, [M+K]: 1066; found  [M+H]: 1028, [M+Na]: 1050, [M+K]: 1066. 
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Methyl ester 6.11: To a solution of alcohol 6.10 (80 mg, 0.078 mmol) in freshly 
distilled methanol (6.0 mL) was added potassium tert-butoxide (1.0 M solution  in THF, 
0.24 mL, 0.24 mmol) dropwise at 20 °C. The reaction was heated to 60 °C and stirred 
for 12 h. After 12 h, the reaction was quenched with pH 4 buffer (~ 5 mL) and the 
resulting mixture was partitioned between water (20 mL) and EtOAc (3 X 30 mL). The 
combined organics were washed with brine and dried further over Na2SO4. Column 
purification (silica gel, 50 Æ 70% EtOAc/Hexanes) after removal of solvents afforded 
epimerized methyl ester 6.11 as a colorless film (60 mg, 73%): Rf = 0.46 (60% 
EtOAc/Hexanes); [α]D +26.0 (c 2.20, CH2Cl2); IR (thin film) 3511, 3271, 2934, 1776, 
1717 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 7.83-7.86 (m, 4H), 7.80-7.82 (m, 2H), 
7.57 (d, J = 8.0 Hz, 2H), 7.24-7.36 (m, 7H), 7.03-7.06 (dd, J = 8.0, 2.0 Hz, 1H), 6.84 (d, 
J = 8.0 Hz, 2H), 6.76 (d, J = 8.0 Hz, 2H), 6.38 (d, J = 8.0 Hz, 1H), 5.76 (d, J = 9.5 Hz, 
1H), 5.14 (d, J = 11.5 Hz, 1H), 4.88-4.96 (m, 2H), 4.16-4.20 (t, J = 11.0 Hz, 1H), 3.93-
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3.97 (t, J = 11.5 Hz, 1H), 3.70-3.82 (m, 5H), 3.77 (s, 3H), 3.63 (s, 3H), 3.60-3.64 (m, 
1H), 3.38-3.45 (m, 3H), 3.32 (s, 3H), 3.08-3.13 (m, 1H), 2.74-2.79 (t, J = 11.5 Hz, 1H), 
1.91 (s, 3H), 1.84 (s, 3H), 1.25 (s, 9H); 13C-NMR (125 MHz, benzene-d6) δ = 174.70, 
173.28, 157.38, 150.35, 149.61, 144.86, 142.86, 139.64, 136.16, 136.07, 135.68, 133.94, 
133.12, 130.27, 130.17, 130.10, 129.87, 128.99, 128.94, 128.35, 128.31, 127.03, 120.39, 
112.23, 111.67, 74.49, 62.01, 60.45, 58.04, 55.63, 55.28, 54.91, 52.55, 52.50, 49.55, 
48.48, 46.59, 46.21, 33.54, 27.31, 21.20, 19.78; MS (MALDI) calcd for 
C53H62ClN3O12S2Si  [M+Na]: 1082, [M+K]: 1098; found  [M+Na]: 1082, [M+K]: 1098. 
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Imidazolone 6.13: To a solution of alcohol 6.11 (47 mg, 0.044 mmol) in CH2Cl2 (3.0 
mL) was added Dess-Martin periodinane (56 mg, 0.13 mmol), and the resulting reaction 
mixture was stirred at 20 °C for 5 h. Upon completion of the reaction as indicated by 
TLC, anhydrous ether (Et2O, ~20 mL) was added to the reaction mixture and the solid 
residue was removed by filtration through Celite. Removal of solvents in vacuo afforded 
the aldehyde 6.12a (47 mg, 99%). 
 A portion of the aldehyde 6.12a (7.0 mg, 0.0066 mmol) obtained above was 
dissolved in anhydrous CH2Cl2 (0.6 mL) and cooled to 0 °C. To the solution was added 
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MgSO4 (~10 mg) and TseNH2 (2.0 mg, 0.010 mmol). The reaction mixture was warmed 
to 20 °C and stirred for 40 min. Removal of MgSO4 solid residue by filtration and 
concentration in vacuo yielded the Tse-imine intermediate 6.12, which was used directly 
for next step without purification. The Tse-imine 6.12 was dissolved in anhydrous THF 
(0.6 mL) and cooled to 0 °C. To the solution was added Et3N (4 μL, 0.028 mmol) and 
triphosgene (~ 5 mg, 0.017 mmol) sequentially. The reaction mixture was warmed to 20 
°C and stirred for 20 min, then it was heated to 60 °C and stirred for 2.5 h. Upon 
completion of the reaction time, sat’d NaHCO3 solution (2 mL) was added, and the 
resulting mixture was partitioned between water (10 mL) and EtOAc (2 X 10 mL). The 
combined organics were washed with brine, dried further over Na2SO4 and concentrated 
in vacuo. Purification by column chromatography (silica gel, 40 Æ 60% EtOAc/Hexanes) 
afforded imidazolone 6.13 as a colorless film (5.2 mg, 63% over three steps): Rf = 0.63 
(60% EtOAc/Hexanes); [α]D -44.7 (c 0.75, CH2Cl2); IR (thin film) 2955, 1723, 1640  
cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 8.18 (d, J = 8.0 Hz, 2H), 7.72-7.75 (m, 4H), 
7.66-7.68 (m, 2H), 7.51 (d, J = 2.0 Hz, 1H), 7.39 (d, J = 8.0 Hz, 2H), 7.23-7.33 (m, 7H), 
6.75 (d, J = 8.0 Hz, 2H), 6.70 (d, J = 1.5 Hz, 1H), 6.65 (d, J = 8.0 Hz, 2H), 6.63 (d, J = 
8.0 Hz, 2H), 6.40 (d, J = 8.0 Hz, 1H), 5.45-5.50 (m, 2H), 4.92 (d, J = 11.5 Hz, 1H), 4.54 
(d, J = 16.5 Hz, 1H), 4.33-4.38 (m, 1H), 4.11-4.17 (m, 1H), 3.78-3.92 (m, 4H), 3.69-3.74 
(m, 1H), 3.68 (s, 3H), 3.36-3.41 (m, 1H), 3.34 (s, 3H), 3.28 (s, 3H), 3.19-3.26 (m, 2H), 
2.83-2.88 (m, 1H), 2.32-2.36 (m, 1H), 1.81 (s, 3H), 1.79 (s, 3H), 1.74 (s, 3H), 1.23 (s, 
9H); 13C-NMR (125 MHz, benzene-d6) δ = 173.66, 171.74, 157.28, 150.72, 150.17, 
149.36, 145.44, 144.61, 143.88, 136.78, 136.61, 136.00, 135.78, 134.62, 133.35, 133.05, 
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130.34, 130.18, 130.12, 129.85, 129.79, 129.63, 129.29, 128.57, 128.21, 120.66, 118.64, 
115.40, 112.51, 111.69, 73.34, 59.82, 58.28, 55.65, 55.13, 54.08, 53.24, 51.99, 47.07, 
44.48, 43.93, 43.19, 37.05, 34.19, 30.08, 27.21, 27.15, 21.05, 21.03, 21.01, 19.58; 
HRMS (ESI) calcd for C63H69ClN4O14S3Si  [M+Li]: 1271.3590; found  [M+Li]: 
1271.3604. 
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Alcohol 6.14: To a solution of imidazolone 6.13 (15 mg, 0.012 mmol) in CH2Cl2 (1.0 
mL) at -78 °C was added DIBAl-H (~40 μL, 0.22 mmol). The reaction mixture was 
stirred at -78 °C for 30 min and then quenched with Rochelle’s salt solution (~2 mL) at -
78 °C, warmed to 20 °C and stirred vigorously for 3 h. Then the mixture was transferred 
into a separation funnel and partitioned between water and CH2Cl2. The organic layer 
was washed with brine and dried further over Na2SO4. After removal of solvent in vacuo, 
alcohol 6.14 was obtained in high purity as a foam (15mg, 99%): Rf = 0.24 (60% 
EtOAc/Hexanes); [α]D -20.7 (c 0.63, CH2Cl2); IR (thin film) 3520, 2931, 2857, 1774, 
1717 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 8.11 (d, J = 8.0 Hz, 2H), 7.75-7.77 (m, 
2H), 7.69-7.71 (m, 4H), 7.39 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 2.0 Hz, 1H), 7.21-7.33 (m, 
7H), 6.78 (d, J = 8.0 Hz, 2H), 6.66 (d, J = 8.0 Hz, 2H), 6.65 (d, J = 8.0 Hz, 2H), 6.59 (d, 
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J = 1.5 Hz, 1H), 6.52 (d, J = 8.0 Hz, 1H), 5.19 (d, J = 16.5 Hz, 1H), 4.86 (d, J = 11.5 Hz, 
1H), 4.79 (d, J = 10.0 Hz, 1H), 4.59 (d, J = 16.0 Hz, 1H), 4.32-4.38 (m, 1H), 4.12-4.18 
(m, 1H), 3.85-3.94 (m, 2H), 3.74-3.80 (m, 2H), 3.68-3.72 (m, 2H), 3.67 (s, 3H), 3.51-
3.54 (m, 2H), 3.34 (s, 3H), 2.85-2.89 (m, 1H), 2.73-2.79 (m, 2H), 2.56-2.61 (m, 1H), 
2.40-2.50 (bs, 1H), 1.82 (s, 3H), 1.80 (s, 3H), 1.78 (s, 3H), 1.22 (s, 9H); 13C-NMR (125 
MHz, benzene-d6) δ = 174.19, 157.42, 150.71, 150.01, 149.26, 145.41, 144.63, 144.00, 
136.80, 136.58, 136.04, 135.86, 134.95, 133.35, 133.07, 130.31, 130.29, 130.17, 129.84, 
129.71, 129.05, 128.43, 128.29, 120.65, 119.67, 115.57, 112.41, 111.90, 74.33, 62.54, 
60.16, 59.17, 55.69, 55.25, 54.04, 53.29, 45.87, 44.75, 42.83, 42.44, 37.22, 34.02, 30.08, 
27.24, 21.08, 21.06, 21.03, 18.51; HRMS (MALDI) calcd for C62H69ClN4O13S3Si 
[M+H]: 1237.3559, [M+Na]: 1259.3379, [M+K]: 1275.3118; found [M+H]: 1237.3911, 
[M+Na]: 1259.4053, [M+K]: 1275.3740. 
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Tosylate 6.15: To a mixture of alcohol 6.14 (10 mg, 0.0081 mmol) and TsCl (3 mg, 
0.016 mmol) was added anhydrous CH2Cl2 (0.50 mL), followed by triethylamine (4 μL, 
0.032 mmol) and a few crystals of DMAP. The reaction mixture was stirred vigorously 
at 20 °C. Upon completion of the reaction as indicated by TLC (~3 h), the reaction 
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mixture was quenched with pH 7 buffer (~ 3 mL) and partitioned between water (10 mL) 
and EtOAc (15 mL). The organic layer was washed with brine, and dried further over 
Na2SO4. After removal of solvents in vacuo, the residue was purified by column 
chromatography (silica gel, 40 Æ 50% EtOAc/Hexane) to afford tosylate 6.15 as a 
colorless foam (8 mg, 73%): Rf = 0.40 (60% EtOAc/Hexanes); IR (thin film) 2958, 2857, 
1774, 1723 cm-1; 1H-NMR (500 MHz, benzene-d6) δ = 8.23 (d, J = 8.0 Hz, 2H), 7.84 (d, 
J = 8.0 Hz, 2H), 7.69 (m, 4H), 7.60-7.62 (m, 2H), 7.45 (d, J = 8.0 Hz, 2H), 7.44 (d, J = 
2.0 Hz, 1H), 7.20-7.35 (m, 7H), 6.94 (d, J = 8.0 Hz, 2H), 6.81 (d, J = 8.0 Hz, 2H), 6.70 
(s, 1H), 6.68 (d, J = 8.0 Hz, 2H), 6.66 (d, J = 8.0 Hz, 2H), 6.46 (d, J = 8.0 Hz, 1H), 5.37 
(d, J = 16.0 Hz, 1H), 4.87 (d, J = 10.0 Hz, 1H), 4.80 (d, J = 11.5 Hz, 1H), 4.41 (d, J = 
16.0 Hz, 1H), 4.31-4.37 (m, 2H), 4.08-4.15 (m, 2H), 3.83-3.89 (m, 1H), 3.71-3.78 (m, 
2H), 3.65 (s, 3H), 3.52-3.62 (m, 2H), 3.38 (d, J = 9.5 Hz, 1H), 3.31 (s, 3H), 2.94-3.04 (m, 
2H), 2.70 (t, J = 11.0 Hz, 1H), 2.55-2.60 (m, 1H), 1.90 (s, 3H), 1.83 (s, 3H), 1.81 (s, 3H), 
1.77 (s, 3H), 1.17 (s, 9H); 13C-NMR (125 MHz, benzene-d6) δ = 173.30, 157.09, 150.76, 
150.04, 149.33, 145.66, 144.93, 144.65, 144.02, 136.69, 136.56, 135.95, 135.75, 134.70, 
133.29, 133.01, 132.89, 130.36, 130.27, 130.20, 130.03, 129.89, 129.84, 129.31, 128.45, 
128.37, 128.21, 128.15, 120.84, 118.72, 115.50, 112.76, 111.66, 74.07, 68.91, 59.58, 
58.32, 55.65, 55.18, 54.18, 53.27, 45.19, 44.54, 43.11, 39.19, 37.24, 34.03, 30.07, 27.21, 
27.14, 21.14, 21.09, 21.07, 21.04, 19.41; MS (MALDI) calcd for C69H75ClN4O15S4Si 
[M+H]: 1391, [M+Na]: 1413, [M+K]: 1429; found [M+H]: 1391, [M+Na]: 1413, [M+K]: 
1429. 
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Azide 6.16: To the tosylate 6.15 (40 mg, 0.029 mmol) in a dry flask equipped with a 
septum was added NaN3 (19 mg, 0.29 mmol) and anhydrous DMF (3.0 mL). The septum 
was replaced by a yellow polyethylene stopper, and then the reaction mixture was heated 
to 50 °C and stirred for 12 h, after which the reaction mixture was partitioned between 
water (10 mL) and EtOAc (15 mL). The organic layer was washed with water, brine, and 
dried over Na2SO4. After removal of solvents in vacuo, the residue was purified by 
column chromatography (silica gel, 50 Æ 60% EtOAc/Hexane) to afford azide 6.16 as a 
light-yellow foam (29 mg, 81%): Rf = 0.49 (60% EtOAc/Hexanes); [α]D -12.8 (c 1.20, 
CH2Cl2); IR (thin film) 2931, 2857, 2102, 1774, 1720 cm-1; 1H-NMR (500 MHz, 
benzene-d6) δ = 8.06 (d, J = 8.0 Hz, 2H), 7.68-7.70 (m, 2H), 7.66 (d, J = 8.0 Hz, 2H), 
7.58-7.60 (m, 2H), 7.41 (d, J = 2.0 Hz, 1H), 7.35 (d, J = 8.0 Hz, 2H), 7.21-7.30 (m, 7H), 
6.75 (d, J = 8.0 Hz, 2H), 6.59 (d, J = 8.0 Hz, 4H), 6.56 (d, J = 1.0 Hz, 1H), 6.49 (d, J = 
8.0 Hz, 1H), 5.26 (d, J = 16.5 Hz, 1H), 4.80 (d, J = 11.0 Hz, 1H), 4.51 (d, J = 8.5 Hz, 
1H), 4.45 (d, J = 16.5 Hz, 1H), 4.30-4.36 (m, 1H), 4.07-4.13 (m, 1H), 3.80-3.86 (m, 2H), 
3.67-3.73 (m, 1H), 3.64 (s, 3H), 3.51 (d, J = 11.0 Hz, 1H), 3.44-3.47 (m, 2H), 3.29 (s, 
3H), 3.01-3.09 (m, 2H), 2.75-2.80 (m, 1H), 2.66-2.70 (m, 2H), 2.39 (dt, J = 14.5, 5.0 Hz, 
1H), 1.76 (s, 3H), 1.74 (s, 3H), 1.70 (s, 3H), 1.19 (s, 9H); 13C-NMR (125 MHz, benzene-
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d6) δ = 173.82, 157.32, 150.64, 150.08, 149.38, 145.62, 144.60, 143.95, 136.79, 136.61, , 
136.02, 135.85, 134.86, 133.07, 133.06, 130.39, 130.29,  130.22, 129.82, 129.81, 129.66, 
129.12, 128.48, 128.33, 128.20, 128.01, 127.83, 120.88, 119.03, 115.25, 112.75, 111.78, 
74.24, 59.55, 58.36, 55.69, 55.21, 53.99, 53.27, 52.92, 46.38, 44.63, 44.36, 39.16, 37.25, 
34.09, 30.08, 27.25, 27.18, 21.05, 21.04, 21.01, 19.45; MS (MALDI) calcd for 
C62H68ClN7O12S3Si [M+Na]: 1284, [M+K]: 1300; found [M+Na]: 1284, [M+K]: 1300. 
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Pyrrole-imidazolone 6.18: To a solution of azide 6.16 (15 mg, 0.012 mmol) in THF 
(0.40 mL) was added SmI2 (0.1 M solution in THF, 0.95 mL, 0.095 mmol) at -78 °C. 
The reaction was warmed to 20 °C and stirred for 15 min, and then quenched with 
saturated NaHCO3 (4 mL) and the resulting mixture was partitioned between water (~10 
mL) and EtOAc (2 X 10 mL). The combined organic layers were washed with brine, and 
then dried over Na2SO4. Removal of solvent in vacuo afforded primary amine 6.17 
quantitatively with sufficient purity for subsequent reaction. 
 To a solution of amine 6.17 (13 mg, 0.012 mmol) and pyrrole-2-carbonyl 
chloride (16 mg, 0.12 mmol) in anhydrous methylene chloride (1.0 mL) was added 
triethylamine (17 μL, 0.12 mmol) at 0 °C. The reaction mixture was warmed to 20 °C 
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and stirred for 15 min, after which it was partitioned between NaHCO3 solution (~10 mL) 
and EtOAc (2 X10 mL). The combined organic layer was washed with brine and dried 
over Na2SO4. After concentration in vacuo, purification by flash chromatography (silica 
gel, EtOAc) afforded pyrrole-imidazolone 6.18 as a colorless film (9 mg, 64% over two 
steps): Rf = 0.18 (EtOAc); IR (thin film) 3381, 2931, 1771, 1714, 1682 cm-1; MS 
(MALDI) calcd for C60H67ClN6O11S2Si [M+H]: 1175, [M+Na]: 1197, [M+K]: 1213; 
found [M+H]: 1175, [M+Na]: 1197, [M+K]: 1213. 
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 N
N
O
Hb
H2N
N
N
O
Hb
H2N
Ha Ha
Jab = 10.0 Hz Jab = 3.0 Hz
N
N
O
Hb
HO
Br Br
N
N
O
Hb
HO Ha
Ha
Jab = 9.7 Hz * Jab = 2.6 Hz *
structures coupling constants structures coupling constants
N
N
O
Hb
H
N
H2N
TcesN Ha
Jab not observed
structure confirmed
by X-ray analysis N
N
O
Hb
H
N
H2N
TcesN Ha
Jab = 2.5 Hz
N
N
O
Hb
H
N
H2N
TcesN Ha
Br Br
Jab = 10.0 Hz
N
N
O
Hb
H
N
H2N
TcesN Ha
Br Br
Jab not observed
structure confirmed
by X-ray analysis **
N
N
O
Hb
H
N
H2N
HN Ha
Jab = 10.5 Hz
N
N
O
Hb
H
N
H2N
O Ha
Jab = 10.5 Hz
N
N
O
N
HN
O
DMB
O
Cl
OTBDPS
HO
Hb
Ha
Jab = 3.0 HzN
N
O
Hb
N
HN
O
DMB
O
Cl
OTBDPS
H2N
Ha
Jab = 10.0 Hz
*: Lindel and co-workers: Tetrahedron Lett . 2002, 43, 3699-3702.
**: Francisco M. Franco-Torres, M.S. thesis, Texas A&M University, 2007.  
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